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Executive Summary 
The Medicare-Medicaid Coordination Office and the Innovation Center at the Centers for 
Medicare & Medicaid Services (CMS) have created the Medicare-Medicaid Financial Alignment 
Initiative to test, in partnerships with States, integrated care models for Medicare-Medicaid 
enrollees. CMS contracted with RTI International to monitor the implementation of the 
demonstrations and to evaluate their impact on beneficiary experience, quality, utilization, and 
cost. The evaluation will include a final aggregate evaluation and State-specific evaluations.  
The demonstration in Massachusetts, known as One Care, was implemented October 1, 
2013. Three health plans were competitively selected by the Commonwealth and CMS to operate 
Medicare-Medicaid Plans (MMPs), but one health plan withdrew from participation in the 
demonstration as of September 30, 2015. One MMP operates in nine counties, with partial 
coverage in one county; the second MMP operates in three counties, with partial coverage in one 
county. MMPs provide care coordination and flexible benefits under a capitated payment model. 
CMS and the Commonwealth provide payments to finance all Medicare and Medicaid services. 
One Care is the only demonstration under the Financial Alignment Initiative that limits 
enrollment to Medicare-Medicaid beneficiaries aged 21 to 64 at the time of enrollment. 
Medicare-Medicaid beneficiaries enrolled in Medicare Parts A and B and eligible for Part D and 
MassHealth Standard or MassHealth CommonHealth are eligible to enroll in One Care. 
Beneficiaries who have any other comprehensive private or public insurance, receive home and 
community-based service (HCBS) waiver services, or reside in an intermediate care facility for 
individuals with intellectual disabilities are not eligible to enroll in One Care. One Care enrollees 
who turn 65 may remain in the demonstration if they meet certain eligibility requirements. One 
Care operates in 9 of Massachusetts’ 14 counties, including Essex, Franklin, Hampden, 
Hampshire, Middlesex, Norfolk, Plymouth, Suffolk, and Worcester Counties.1  
This Third Evaluation Report for the Massachusetts One Care demonstration describes 
the demonstration’s implementation and early analysis of its impacts. The report includes 
findings from qualitative data for 2017 and quantitative results for October 1, 2013, through 
December 31, 2016. Data sources include key informant interviews, beneficiary focus groups, 
the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey results, 
Medicare claims data, the Minimum Data Set nursing facility assessments, MMP encounter data 
for Medicare and Medicaid services, and other demonstration data. Future analyses also will 
include Medicaid claims and encounters as those data become available. 
Highlights  
• Overall, MassHealth, CMS, the MMPs, and the stakeholder community continue to 
express strong support for One Care, emphasizing it is the right care model for this 
population. MassHealth continues to be committed to sustaining One Care.  
                                                 
1 Partial coverage of Plymouth County includes the towns Billerica, Chelmsford, Dracut, Lowell, North Billerica, 
North Chelmsford, Tewksbury, Tyngsborough, and Westford. 
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• The most significant changes in 2017 to One Care involved eligibility and enrollment 
requirements. During the timeframe of this report, changes to MassHealth eligibility 
requirements expanded the group of individuals able to remain in the demonstration 
after the age of 65. Enrollment changes included implementing regularly scheduled 
passive enrollment on a quarterly basis targeting new Medicare-Medicaid 
beneficiaries as well as other eligible beneficiaries and allowing passive enrollment in 
counties with only one MMP and counties only partially served by the demonstration. 
In an effort to increase enrollment, one MMP increased its service coverage area into 
parts of Middlesex County.  
• As of December 31, 2017, a total of 102,909 Medicare-Medicaid beneficiaries were 
eligible for the demonstration and a total of 18,563 beneficiaries, or approximately 
18 percent of beneficiaries, were enrolled in One Care. From December 31, 2016, to 
December 31, 2017, enrollment in One Care increased by almost 30 percent.  
• The MMPs continue to report differing financial experiences. One MMP that initially 
reported gains in the early implementation period now reports projected financial 
losses. Another MMP that initially reported losses in the early demonstration period 
now reports improved financial performance with projected gains. 
• Although the demonstration has matured, representatives from the MMPs reported 
that some operational design features of the demonstration, including submission of 
encounter data and other regulatory requirements, continue to lack integration 
between Medicare and Medicaid.  
• Results from the 2017 CAHPS survey show that most respondents reported a high 
degree of satisfaction with their health and drug plans; almost 90 percent of One Care 
respondents reported that their plans usually or always provided them the information 
they needed.  
• Strong stakeholder engagement continues to be a key feature of One Care: 
MassHealth and CMS added two new CAHPS questions into the 2018 survey as a 
result of stakeholder feedback; MassHealth officials attended a meeting of Rhode 
Island’s Implementation Council and shared observations with the One Care 
Implementation Council; and MassHealth reported wanting to replicate the robust 
structure of One Care’s stakeholder processes across its other initiatives.  
• Some RTI focus group participants reported that services received from One Care had 
helped them to engage, or re-engage, in life activities or hobbies they enjoyed. In 
some cases, participants attributed improved quality of life and well-being to 
receiving appropriate behavioral health services. 
• As reported by One Care plans, the number of grievances per 1,000 enrollees in 2017 
did not exceed 38.3 in any one quarter; the number of appeals per 1,000 enrollees in 
2017 did not exceed 9.0 in any one quarter. MassHealth officials reported that 
generally, many of these involved enrollment issues or involved dental or 
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transportation services. Through broader MassHealth reforms, the Commonwealth is 
attempting to streamline programs and create consistent metrics to allow for 
comparison across programs, including One Care. MassHealth has leveraged lessons 
learned from One Care in the design of these broader reforms. 
• The results of preliminary Medicare cost savings analyses using a difference-in-
differences regression approach do not indicate gross savings or losses due to the 
Massachusetts demonstration. Neither savings nor losses were identified in 
demonstration year 1, demonstration year 2, or demonstration year 3. The cost 
savings analyses do not include Medicaid data due to current data availability, but 
these data will be incorporated into future calculations as they become available. 
• Difference-in-differences regression analyses show that the Massachusetts 
demonstration resulted in statistically significant changes in utilization patterns. The 
cumulative experience through demonstration year 3 shows higher monthly inpatient 
admissions and readmissions. Conversely, there was a lower probability of any long-
stay nursing facility (NF) use over any year. The undesirable impacts on ambulatory 
care sensitive admissions (ACSC) and inpatient admissions were concentrated in 
demonstration years 1 and 2, suggesting that the demonstration was making progress 
by demonstration year 3 in reducing these types of inpatient admissions since the 
demonstration year 3 result was not statistically significant. The desirable impacts on 
long-stay NF use were concentrated in demonstration years 2 and 3.  
Table ES-1 
Summary of Massachusetts cumulative demonstration impact estimates for 
demonstration period (October 1, 2013–December 31, 2016) 
(p < 0.1 significance level) 
Measure 
All demonstration 
eligible 
beneficiaries 
Demonstration 
eligible beneficiaries 
with LTSS use 
Demonstration 
eligible beneficiaries 
with SPMI 
Inpatient admissions Increased NS NS 
Probability of ambulatory care sensitive 
condition (ACSC) admissions, overall 
Increased NS Increased 
Probability of ACSC admissions, chronic Increased Increased Increased 
All-cause 30-day readmissions Increased Increased Increased 
Emergency room (ER) visits NS NS NS 
Preventable ER visits NS NS NS 
30-day follow-up after mental health discharges NS N/A NS 
Probability of skilled nursing facility (SNF) 
admission 
NS Increased NS 
Probability of any long-stay nursing facility 
(NF) use 
Decreased N/A N/A 
Physician evaluation and management (E&M) 
visits 
NS NS NS 
LTSS = long-term services and supports; N/A = not applicable; NS = not statistically significant; SPMI = severe and 
persistent mental illness. 
SOURCE: RTI analysis of Medicare and Minimum Data Set data. 
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Table ES-2 
Massachusetts annual demonstration impact estimates for all 
demonstration eligible beneficiaries (October 1, 2013–December 31, 2016) 
(p < 0.1 significance level) 
Measure 
Demonstration 
year 1 
Demonstration 
year 2 
Demonstration 
year 3 
Inpatient admissions NS Increased NS 
Probability of ambulatory care 
sensitive condition (ACSC) 
admissions, overall 
Increased Increased NS 
Probability of ACSC admissions, 
chronic 
Increased Increased NS 
All-cause 30-day readmissions Increased Increased Increased 
Emergency room (ER) visits NS NS NS 
Preventable ER visits NS NS NS 
30-day follow-up after mental health 
discharges 
NS Decreased NS 
Probability of skilled nursing facility 
(SNF) admission 
NS NS NS 
Probability of any long-stay nursing 
facility (NF) use 
NS Decreased Decreased 
Physician evaluation and management 
(E&M) visits 
Increased NS NS 
NS = not statistically significant. 
SOURCE: RTI analysis of Medicare and Minimum Data Set data. 
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1. Evaluation Overview 
1.1 Purpose 
The Medicare-Medicaid Coordination Office (MMCO) and the Innovation Center at the 
Centers for Medicare & Medicaid Services (CMS) have created the Medicare-Medicaid 
Financial Alignment Initiative to test, in partnerships with States, integrated care models for 
Medicare-Medicaid enrollees. CMS contracted with RTI International to monitor the 
implementation of the demonstrations under the Financial Alignment Initiative and to evaluate 
their impact on beneficiary experience, quality, utilization, and cost. This report includes 
qualitative evaluation information for the fourth demonstration year (calendar year [CY] 2017), 
with key updates from early 2018. This report provides updates to the previous reports in key 
areas, including enrollment, care coordination, beneficiary experience, and stakeholder 
engagement activities, and discusses the challenges, successes, and emerging issues identified 
during the reporting period. Results on quality of care, service utilization, and costs for the entire 
predemonstration and demonstration periods spanning October 1, 2011 to December 31, 2016 
are also presented. 
The First Annual Report, which includes extensive background information about the 
demonstration, can be found here: https://www.cms.gov/Medicare-Medicaid-
Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/Downloads/MASSFirstAnnualEvalReport.pdf. The Second 
Evaluation Report can be found here: https://www.cms.gov/Medicare-Medicaid-
Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/FinancialModelstoSupportStatesEffortsinCareCoordination.
html. 
1.2 Data Sources 
Data sources used to prepare this report include the following. 
Key informant interviews. The RTI evaluation team conducted a virtual site visit 
through telephone interviews in Massachusetts from October 2017 to January 2018. The team 
interviewed the following individuals: Commonwealth of Massachusetts (the Commonwealth) 
officials, including MassHealth (Massachusetts’ Medicaid program) policy leaders, operations, 
contract and quality management staff; officials from CMS’ regional and central offices; 
representatives from One Care Medicare-Medicaid plans (MMPs); representatives from 
community-based organizations (CBOs), including the Independent Living Centers (ILCs), 
Recovery Learning Communities (RLCs), and Aging Services Access Points (ASAPs); 
stakeholders from the Implementation Council; and representatives from the One Care 
Ombudsman program.  
Focus groups. The RTI evaluation team conducted eight focus groups in Massachusetts 
in calendar year 2017. Two focus groups were held in Springfield on April 4, 2017 with Hispanic 
participants. Six focus groups were held in Boston on April 5–6, 2017 consisting of two groups 
with African Americans, two groups with participants with behavioral health needs, and two 
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groups with participants with long-term services and supports (LTSS) needs. A total of 44 One 
Care enrollees participated.  
Surveys. Medicare requires all Medicare Advantage plans, including One Care plans, to 
conduct an annual assessment of beneficiary experiences using the Medicare Advantage and 
Prescription Drug Plan Consumer Assessment of Healthcare Providers and Systems (CAHPS) 
survey instrument. In addition, the RTI evaluation team added 10 supplemental questions to the 
CAHPS survey and MassHealth added nine questions. This report includes survey results for a 
small subset of the 2017 survey questions. Findings are available at the MMP level only. The 
frequency count for some survey questions may be suppressed because too few enrollees 
responded to the question. Comparisons with findings from all Medicare Advantage plans are 
available for core CAHPS survey questions but not for the RTI supplemental questions. In 
addition to survey requirements specific to the demonstration, MassHealth conducted 
Commonwealth-sponsored surveys of beneficiary experience. Results were only available for the 
Fallon Transition Survey at the time of reporting, and are included in this report.  
Demonstration data. The RTI evaluation team reviewed data provided quarterly by 
Massachusetts through the State Data Reporting System (SDRS). These reports include 
eligibility, enrollment, opt-out, and disenrollment data, and information reported by 
Massachusetts on its integrated delivery system, care coordination, benefits and services, quality 
management, stakeholder engagement, financing and payment, and a summary of successes and 
challenges. This report also uses data for quality measures reported by One Care plans and 
submitted to CMS’ implementation contractor, NORC at the University of Chicago (hereafter 
referred to as NORC).2,3 Data reported to NORC include core quality measures that all MMPs 
are required to report, as well as State-specific measures that One Care plans are required to 
report. Due to reporting inconsistencies, plans occasionally resubmit data for prior demonstration 
years; therefore, these data are considered preliminary. 
Demonstration policies, contracts, and other materials. The RTI evaluation team 
reviewed a wide range of demonstration documents, including demonstration and 
Commonwealth-specific information on the CMS website;4 and other publicly available 
materials on Massachusetts’ One Care website5 and the Massachusetts’ Executive Office of 
Health and Human Services (EOHHS) website.6 The RTI evaluation team routinely reviewed 
                                                 
2 Data are reported for January 2017 through December2017. 
3 The technical specifications for reporting requirements are in the Medicare-Medicaid Capitated Financial 
Alignment Model Core Reporting Requirements document, which is available at 
https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-Coordination/Medicare-
Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/MMPReportingRequirements.html. 
4 https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-Coordination/Medicare-
Medicaid-Coordination-
Office/FinancialAlignmentInitiative/FinancialModelstoSupportStatesEffortsinCareCoordination.html 
5 https://www.mass.gov/one-care  
6 https://www.mass.gov/orgs/executive-office-of-health-and-human-services  
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available minutes and presentations from MassHealth Open Meetings7 and Implementation 
Council meetings.8  
Conversations with CMS and MassHealth officials. To monitor demonstration 
progress, the RTI evaluation team engages in periodic phone conversations with officials from 
MassHealth and CMS. These might include discussions about new policy clarifications designed 
to improve plan performance, quality improvement work group activities, and contract 
management team actions. 
Complaints and appeals data. Complaint (also referred to as grievance) data are from 
three separate sources: (1) complaints from beneficiaries reported by One Care plans to 
MassHealth, and separately to CMS’ implementation contractor, NORC;9 (2) complaints 
received by MassHealth or 1-800-Medicare and entered into the CMS electronic Complaint 
Tracking Module; and (3) qualitative data obtained by RTI on complaints. Appeals data are 
generated by MMPs and reported to MassHealth and NORC. This report also includes data 
compiled and received by the Medicare Independent Review Entity (IRE), Maximus, for January 
2014–December 2017, as well as critical incidents and abuse data reported by One Care MMPs 
to MassHealth and NORC. 
Service utilization data. Evaluation Report analyses used data from many sources. First, 
the Commonwealth provided quarterly finder files containing identifying information on all 
demonstration eligible beneficiaries in the demonstration period. Second, RTI obtained 
administrative data on beneficiary demographic, enrollment, and service use characteristics from 
CMS data systems for both demonstration and comparison group members. Third, these 
administrative data were merged with Medicare claims and Medicare and Medicaid encounter 
data, as well as the Minimum Data Set. 
Cost savings data. Two primary data sources were used to support the savings analyses, 
capitation payments and Medicare claims. Medicare capitation payments paid to One Care plans 
during the demonstration period were obtained for all demonstration enrollees from CMS 
Medicare Advantage and Part D Inquiry System (MARx) data. The capitation payments were the 
final reconciled payments paid by the Medicare program after taking into account risk score 
reconciliation and any associated retroactive adjustments in the system at the time of the data 
pull (July 2018). Quality withholds were applied to the capitation payments (quality withholds 
are not reflected in the MARx data), as well as to quality withhold repayments for the first three 
demonstration period and risk corridor payments or recoupments through 2015 based on data 
provided by CMS. Fee-for-service (FFS) Medicare claims were used to calculate expenditures 
for all comparison group beneficiaries, demonstration beneficiaries in the baseline period, and 
                                                 
7 https://www.mass.gov/service-details/one-care-open-meetings  
8 https://www.mass.gov/service-details/one-care-implementation-council  
9 The technical specifications for reporting requirements are in the Medicare-Medicaid Capitated Financial 
Alignment Model Core Reporting Requirements document, which is available at: 
https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-Coordination/Medicare-
Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/MMPReportingRequirements.html. 
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demonstration eligible beneficiaries who were not enrolled during the demonstration period. FFS 
claims included all Medicare Parts A and B services. 
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2. Demonstration Overview 
2.1 Demonstration Description and Goals 
Key objectives of the Massachusetts demonstration, known as One Care, include 
improving the beneficiary experience in accessing care, delivering person-centered care, 
promoting independence in the community, improving quality, and eliminating cost shifting 
between Medicare and Medicaid (MOU, 2012, pp. 2–3). Implemented October 1, 2013, One 
Care integrates the full array of functions performed by Medicare and Medicaid. Massachusetts 
received federal funding to support the implementation of the demonstration as well as federal 
funding to support the One Care Ombudsman program and options counseling for Medicare-
Medicaid enrollees.  
Targeted case management services and rehabilitation option services are not included as 
part of the integrated One Care benefit; they continue to be provided as part of the Medicaid FFS 
system. As in Medicare Advantage, Medicare hospice services continue to be provided as part of 
the Medicare FFS system. One Care is the only demonstration under the Financial Alignment 
Initiative that limits enrollment to Medicare-Medicaid beneficiaries age 21 to 64 at the time of 
enrollment.10 One Care enrollees who turn 65 may remain in the demonstration if they meet 
eligibility requirements for MassHealth Standard or MassHealth CommonHealth. One Care 
operates in nine of the Commonwealth’s 14 counties11 and is served by two MMPs. CMS and 
MassHealth have agreed to extend the demonstration through December 31, 2019.12, 13  
In interviews with the RTI evaluation team, Commonwealth and MMP officials, as well 
as stakeholders, voiced strong support of the demonstration’s integrated care model to serve the 
needs of One Care’s population. MassHealth officials at the leadership level reiterated their 
continuing support for One Care: 
We think One Care is exactly the right sort of model. We want to double down 
and continue investing in it to make it work. There’s no question in our mind 
about it. We do have to work together with our federal partners, our plans, local 
folks to figure out how to make the program stable and sustainable. We believe 
we’re seeing good results in the interim.  
The First Annual Report, which includes extensive background information about the 
demonstration, can be found here: https://www.cms.gov/Medicare-Medicaid-
                                                 
10 Beneficiaries enrolled in any of the following programs are eligible for the demonstration only if they disenroll 
from the program and meet the other eligibility criteria: a Medicare Advantage plan; Program of All-Inclusive 
Care for the Elderly (PACE); Employer Group Waiver Plans (EGWPs), other employer-sponsored plans, or 
plans receiving a Retiree Drug Subsidy (RDS); or the CMS Independence at Home (IAH) demonstration. 
Enrollees using home and community-based services (HCBS) waiver services or residing in an intermediate care 
facility for individuals with intellectual disabilities (ICF/IDD) are not eligible to enroll (MOU, 2012, pp. 8–9). 
11 Essex, Franklin, Hampden, Hampshire, Middlesex, Norfolk, Plymouth (partial), Suffolk and Worcester. 
12 See https://www.mass.gov/files/documents/2018/06/15/fifth-one-care-contract-addendum.pdf 
13 In June 2018, MassHealth released a draft concept paper for a proposed Dual Demonstration 2.0, which would 
provide Federal authorities and flexibilities for Medicare-Medicaid beneficiaries served by One Care and Senior 
Care Options (SCO). The proposal will be discussed as part of the next Evaluation Report. See: 
https://www.mass.gov/files/documents/2018/06/13/duals-demonstration-2-0.pdf 
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Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/Downloads/MASSFirstAnnualEvalReport.pdf. The Second 
Evaluation Report can be found here: https://www.cms.gov/Medicare-Medicaid-
Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/FinancialModelstoSupportStatesEffortsinCareCoordination.
html. 
2.2 Changes in Demonstration Design 
The changes in demonstration design that occurred in 2017 primarily impacted eligibility 
and enrollment. As described more fully in Section 3.2.1, eligibility requirements were modified 
to expand the group of individuals able to remain in the demonstration after the age of 65; these 
changes did not impact eligibility requirements for enrolling in the demonstration (see Section 
3.2, Eligibility and Enrollment). The initial design of One Care did not allow passive enrollment 
in counties with only one MMP or in counties only partially served by the demonstration. This 
requirement was changed effective January 1, 2017, to allow passive enrollment in both of those 
situations. Other modifications to the three-way contract have been under discussion primarily 
between CMS and the Commonwealth but have yet to be finalized as of the writing of this 
report. Finalized contract changes will be discussed in the next Evaluation Report.  
2.3 Overview of State Context 
MassHealth has historically mandated Medicaid managed care enrollment for most of its 
members. Until One Care, Medicare-Medicaid enrollees under age 65 remained ineligible to 
enroll in Medicaid managed care. This group of beneficiaries included those with the most 
complex conditions, highest costs, and in greatest need of care coordination and care 
management. They encompassed a high proportion of people with behavioral health needs who 
did not have access to the diversionary behavioral health services available to the MassHealth-
only members with similar needs. One Care provided a mechanism for the Commonwealth to 
provide comprehensive care coordination and integrated service delivery. 
More recently, MassHealth has leveraged its 1115(a) demonstration waiver to enact 
broad restructuring reforms of its healthcare delivery system.14 Although these reforms do not 
directly include One Care, MassHealth officials reported leveraging its experience with One 
Care as part of its 1115(a) demonstration waiver reforms. In March 2018, MassHealth began the 
full implementation of its Medicaid Accountable Care Organizations (ACOs) with 17 health care 
organizations. At the same time, MassHealth completed a re-procurement process for managed 
care organizations (MCOs) and intends to bring LTSS into the scope of covered services and 
capitation for MCOs in 2020. Both the ACO and MCO models are designed to provide greater 
integration of behavioral health and LTSS services.  
ACOs and MCOs are expected to contract with Community Partners to enhance 
behavioral health and LTSS expertise in the delivery of care coordination as well as assessment 
and care planning activities. MassHealth officials reported that these new ACO and MCO 
                                                 
14 The 1115(a) waiver demonstration includes requests for Delivery System Reform Incentive Payment (DSRIP) 
funding for upfront investments to support delivery system transformation over 5 years, with explicit funding to 
build community capacity for behavioral health and LTSS providers and health-related social services. 
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models will largely align with the principles of One Care to provide member-centered, 
coordinated, and culturally competent care, and that these reforms were modeled off of “what we 
saw and really liked about the One Care program.”  
 8 
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3. Update on Demonstration Implementation 
In this section, we provide updates on important aspects of the demonstration that have 
occurred since the Second Evaluation Report. This includes updates on integration efforts, 
enrollment, care coordination activities, stakeholder engagement activities, financing and 
payment, and quality management strategies.  
Highlights 
• CMS and MassHealth officials who serve on the Contract Management Team (CMT) 
continue to report a collaborative relationship in jointly managing the demonstration; 
the CMT structure changed to consolidate CMT operational and policy meetings. 
• Enrollment processes were changed in 2017 to allow for passive enrollment in counties 
served only by one MMP or in counties partially served by the demonstration and to 
implement regularly scheduled passive enrollment on a quarterly basis.  
• Although the overall design of the care coordination model has not changed, MMPs 
continue to modify and refine their practices based on their experiences to better meet 
the needs of One Care beneficiaries.  
• Strong stakeholder engagement continues to be a key feature of One Care. The 
Implementation Council began its second term in June 2017 with the selection and 
onboarding of 13 new and returning Council members. 
• The two MMPs participating in the demonstration reported different cost experiences, 
with one plan reporting projected profits and the other projecting losses for 2017. 
• Massachusetts initiated a restructuring of its ombudsman services for implementation 
in 2018, including ombudsman services for One Care, across multiple MassHealth 
managed care and accountable care programs to better track trends and identify 
systematic issues and improvements.  
 
3.1 Integration of Medicare and Medicaid 
This section discusses the joint management of the demonstration, as well as updates to 
the successes and challenges of developing an integrated delivery system at the plan and provider 
level. This section also describes the development of new or innovative service delivery models.  
3.1.1 Joint Management of Demonstration 
Management of the demonstration continues through the CMS-State Contract 
Management Team (CMT).15 According to CMT members from CMS, the CMT no longer holds 
a separate operational meeting but rather has incorporated operational components into the CMT 
policy group meeting. The CMT now meets monthly, rather than biweekly, with the MMPs. 
                                                 
15 The design and structure of the CMT is described in prior Evaluation Reports. 
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During demonstration year 4, the CMT focused on programmatic improvements, the future 
procurement for new MMPs, passive enrollment, and review of CAHPS and other data. Set 
agenda items include routine review of items such as grievances and appeals and monitoring 
access to care issues.  
CMS officials described a high degree of transparency from the MMPs that has allowed 
for “a very information-rich oversight” of the demonstration, which, in their experience, is 
unique to One Care. Representatives from CMS, the Commonwealth and MMPs continue to 
describe the partnership as highly collaborative. One CMS official noted that, “Massachusetts, in 
my opinion, is among the States with the strongest, unwavering commitment to making sure this 
demonstration is successful.”  
3.1.2 Operational Integration  
Although the demonstration has matured over several years, representatives from the 
MMPs reported that some operational design features of the demonstration continue to lack 
integration between Medicare and Medicaid. One MMP official reported that streamlining 
encounter data submissions as well as marketing and materials submissions would “be 
administratively beneficial for both the plans and the State.” Another MMP official noted that, 
“with respect to utilization management, there’s a lot of Medicare activity that is living inside of 
a Medicaid sort of infrastructure, so that definitely poses a challenge for us.” One MMP official 
described their experience as follows:  
I think that if you’re building a program like this from the ground up and you’re 
not necessarily building it on a Medicare Advantage platform, it’s a very heavy 
lift to do …all of the data validation, and all of the reporting and audit 
requirements for the Medicare Advantage…. [Y]ou have to be an expert at 
Medicare Advantage, and you have to understand Medicaid so it’s twice as much 
work than to do one or the other. And becoming compliant with CMS 
requirements … is a heavy lift in and of itself…it’s hard to get the admin that 
supports that. 
One MMP official commented that One Care did not seem to provide any significant 
opportunities for operational efficiencies that were not already available through Senior Care 
Options (SCO), a MassHealth program serving Medicare-Medicaid beneficiaries age 65 years 
and older.  
3.1.3 Integrated Service Delivery 
Under One Care, a single entity (the One Care plan) is responsible for coordinating all 
medical, acute, behavioral health, LTSS, and pharmacy benefits. Each plan is responsible for 
coordinating medical and behavioral health services through its internal care coordinator or 
clinical case manager; and for coordinating LTSS through an LTS Coordinator, located at a 
community-based organization. For beneficiaries, the demonstration provides a single point of 
contact and accountability for coordination of care. The care coordination components of the 
demonstration represent new services for this population; prior to the One Care demonstration, 
enrollees had limited, if any, access to care coordination services. Care coordination processes 
are discussed more fully in Section 3.3. 
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MassHealth has continued investing in training efforts to support the integrated care 
model being provided by MMPs and contracted One Care providers through an online platform 
that includes webinars, online modules, and taped conferences.16 Two webinars were offered in 
2017: “Engaging One Care Enrollees in Assessments and Care Planning” and “The Role of Peers 
in One Care.” 
The One Care model has provided the opportunity for plans to develop or pilot new 
service delivery models.17 One stakeholder views this as an important contribution of the 
demonstration:  
One Care is providing one of the greatest opportunities for innovation, at a 
population-based level, to develop best practices in integrated care and being 
creative in the delivery of LTSS and BH [behavioral health] services. If we do not 
take advantage of the opportunity of the demonstration, not only will the 
consumer community be directly harmed that’s in One Care, but also other 
consumers, in the State and nationally, will be negatively impacted because they 
won’t benefit from what could be a great incubator of new ways of doing things. 
As noted in the First Annual Report, one MMP developed two new community-based 
residential programs as an alternative to inpatient psychiatric services. Another initiative aims to 
improve access to care and decrease care costs by partnering with community paramedics to 
deliver on-site primary care treatment. According to MMP officials, this pilot has diverted 
almost 90 percent of individuals who have used the service from utilizing the emergency room.18 
According to an MMP official: 
It’s an incredible service for our members and something that all of the healthcare 
system needs to look toward. The members really like it, the clinicians really like 
it, and it is incredibly satisfying to be able to keep people out of the hospital, 
people who don’t want to go to the hospital in the first place. 
Other examples of innovative services being offered or facilitated by MMPs include one 
MMP providing medically tailored home delivered meals aimed at reducing more costly 
healthcare;19 an MMP partnering with a homeless shelter to provide cellphones to enrollees who 
are homeless so that they can communicate with their care coordinator; and a pilot program 
aimed at reducing home health visits by utilizing a system of medication reminders. Examples of 
new or innovative services reported by One Care beneficiaries are included in Section 4.1, 
Beneficiary Experience. 
With limited exceptions, MMP officials reported that they have continued to reimburse 
most contracted providers on an FFS basis. Representatives from one MMP reported the plan 
had been exploring alternate payment models and that it anticipates taking steps toward alternate 
payment arrangements in 2018. Both MMPs reported that, overall, providers have been wary of 
                                                 
16 MassHealth’s training initiatives are described in more detail in prior Evaluation Reports. The One Care Shared 
Learning website can be accessed at: https://onecarelearning.ehs.state.ma.us/   
17 Some of these pilots include, but are not limited to, One Care enrollees. 
18 https://nam.edu/event/improving-care-high-need-patients-webinar-series/   
19 https://www.healthaffairs.org/doi/10.1377/hlthaff.2017.0999   
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taking on potential risk that is associated with a small base of members, especially by providers 
who view the One Care population as challenging, and because of early financial instability in 
the demonstration. MassHealth officials reported considering how to more strongly encourage 
and incentivize plans to pursue alternative payment models, including value-based purchasing, as 
well as “innovation in general and the plans being able to test things out.”  
3.2 Eligibility and Enrollment 
This section provides updates on eligibility and enrollment processes, including 
integration of eligibility systems, enrollment methods, and outreach. This section also outlines 
significant events affecting enrollment patterns during the timeframe covered by this report. The 
Commonwealth reported via RTI’s SDRS that as of December 31, 2017, a total of 18,563 
beneficiaries were enrolled in One Care out of a total of 102,909 Medicare-Medicaid 
beneficiaries eligible for the demonstration. From December 31, 2016, to December 31, 2017, 
enrollment in One Care increased by almost 30 percent. Approximately 85 percent of the 
demonstration’s enrollees were served by CCA, and approximately 15 percent were served by 
Tufts Health Unify.  
3.2.1 Eligibility and Enrollment Processes 
Massachusetts is the only demonstration under the Financial Alignment Initiative that 
limits eligibility to Medicare-Medicaid beneficiaries age 21 through 64 at the time of enrollment. 
A change in the MassHealth eligibility requirements occurred during the timeframe of this report 
which expanded the group of individuals able to remain in the demonstration after the age of 
65.20 This eligibility change was viewed by MassHealth officials as a beneficial mechanism for 
continued growth in One Care enrollment. 
MassHealth continues to report the same challenges in integrating Medicare and 
Medicaid eligibility and enrollment processes as those reported in previous years, such as 
enrollment errors caused by discrepancies in beneficiary information between Medicare and 
MassHealth systems.21 In the latter part of 2017, MassHealth implemented an online enrollment 
system for One Care enrollees to supplement other MassHealth enrollment processes. The online 
enrollment process allows beneficiaries to enroll, re-enroll, or change MMPs.22 Initial use was 
modest, with about 40 enrollments in the first few months of operations; MassHealth officials 
reported they are now engaged in more active promotion of the system: 
                                                 
20 MassHealth offers several types of Medicaid coverage to eligible individuals. Previously, the opportunity to 
remain in the demonstration after the age of 65 was limited to individuals who met eligibility requirements for 
MassHealth Standard. As part of the Commonwealth’s amendment to its 1115(a) waiver, MassHealth received 
approval for a new Medicaid eligibility group based on the Commonwealth’s state funded CommonHealth 
eligibility. This change conveyed MassHealth eligibility on certain individuals who otherwise were not eligible 
for MassHealth Standard. Implementation of this change began year-end 2016 and continued into the first 
quarter of 2017.  
21 Implementation and operational issues related to integrated Medicare and Medicaid eligibility and enrollments 
processes are described more fully in prior Evaluation Reports. 
22 As implemented, the online system does not allow beneficiaries to disenroll or opt-out of the demonstration.  
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For the most part, the reactions [to the online system] have been very positive. 
Over the past couple years, we have had a lot of stakeholder interest in setting up 
an online enrollment portal, so we were very excited that this was something we 
were able to do for members. 
3.2.2 Phases of Enrollment  
During demonstration year 4, beneficiaries were able to opt into the demonstration at any 
time or be passively (automatically) enrolled. MassHealth described enrollment efforts in 2017 
as evolving from stabilizing the demonstration after the withdrawal of an MMP in 2015 to 
moving forward and engaging in efforts to grow the demonstration.23 
Beginning January 1, 2017, MassHealth implemented quarterly passive enrollment 
targeting new Medicare-Medicaid beneficiaries as well as other eligible beneficiaries. As part of 
the selection process for passive enrollment, MassHealth developed a matching system to ensure 
that, where possible, beneficiaries were assigned to MMPs based on existing relationships with 
in-network providers. In assessing overall plan capacity, MassHealth also took into consideration 
passive enrollment activities in other MassHealth programs in which the MMP participated.24 
MMPs may choose whether to participate in passive enrollment enrollments in a given quarter 
based on their ability to support increased enrollment.  
Implementation of quarterly passive enrollment coincided with changes to the design of 
passive enrollment. Initially, passive enrollment was not allowed in counties with only one MMP 
or in counties only partially served by the demonstration. Effective January 1, 2017, CMS and 
MassHealth modified One Care’s enrollment guidance to allow for passive enrollment in both of 
these situations. This change primarily impacted CCA as it operates as the sole MMP in six 
counties and part of Middlesex County. CCA accepted passive enrollment in all quarterly phases 
of passive enrollment conducted in 2017. CCA officials expressed strong support for continued 
passive enrollment activities. Approximately 1,000 beneficiaries were being assigned to the 
MMP per quarter but the plan expressed an interest in bringing passive enrollment assignments 
closer to 1,000 beneficiaries per month.  
In an effort to grow enrollment, Tufts expanded its coverage area to include ten towns in 
Middlesex County effective February 1, 2017.25 Tufts previously had operated only in Suffolk 
and Worcester counties. The quarterly passive enrollment phase effective April 1, 2017 included 
beneficiaries who were assigned to Tufts in the new coverage area.26 Tufts declined passive 
enrollment for the quarterly phase effective October 1, 2017. Although representatives from 
Tufts reported they had established an initial enrollment goal of 6,000 enrollees for calendar year 
                                                 
23 The withdrawal of Fallon Total Care from participation in the demonstration is discussed in the Second  
Evaluation Report. 
24 At times, MassHealth passively enrolled individuals meeting MassHealth eligibility for the Commonwealth’s 
Senior Care Options (SCO) program simultaneously with One Care passive enrollment; both MMPs participate 
in the SCO program.  
25 Billerica, Chelmsford, Dracut, Lowell, North Billerica, North Chelmsford, Tewksbury, Tyngsborough, and 
Westford. 
26 Before its expansion into parts of Middlesex County, Tufts had operated only in Suffolk and Worcester counties. 
CCA operates in Essex, Franklin, Hampden, Hampshire, Middlesex, Norfolk, Plymouth (partial), Suffolk, and 
Worcester counties. 
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2017, the number of enrollees was approximately half that in December 2017. In part, both the 
plan and MassHealth officials noted that application of the provider matching system, described 
above, did not support continued passive enrollment for the MMP in the new areas of Middlesex 
County on that basis. Additionally, representatives of the plan also reported that they suspended 
participation in passive enrollment activities due to financial considerations. The financial 
structure of the demonstration and the cost experiences of the MMPs are discussed in Section 3.5 
below. 
3.2.3 Disenrollment Experience  
Both MMPs reported focusing efforts on involuntary disenrollment due to beneficiaries 
not completing financial reviews required for Medicaid eligibility. This gap in eligibility and the 
subsequent disenrollment has been a consistent challenge throughout the demonstration. 
MassHealth and the MMPs reported working together to more proactively identify enrollees who 
have been identified for redetermination to prevent loss of, or to quickly restore, Medicaid 
eligibility. As reported in the Second Evaluation Report, one MMP in particular had reported 
concerns about the impact of voluntary disenrollments. Although representatives from the MMP 
reported that they were beginning to see some stabilization in these rates, disenrollments 
continued to be an area of focus:  
Generally, what we’ve experienced since day one is we’ll take in [enrollees] at 
any given time…and within 6 months we’ll have somewhere between [a] 30 
percent and 40 percent decay rate….We’re rendering a lot of services up front, 
doing everything we need to get the members situated and care plans and meet 
their needs, so we have this big bump up [in costs]. And then before you have the 
long tail that would actually offset some of those costs, the members are 
disenrolling from us, for a variety of reasons. 
To better understand the disenrollment patterns and factors, MassHealth conducted a 
survey in 2017 of beneficiaries who voluntarily disenrolled from One Care. Those results were 
not available as of the writing of this report and will be reported in the next Evaluation Report.  
3.2.4 Enrollment Outreach 
MassHealth has continued to partner with the University of Massachusetts Medical 
School (UMMS) for “drop-in” events where beneficiaries could start the enrollment process and, 
in some cases, complete enrollment on-site. At a number of these events, MassHealth provided 
snacks and token items branded for One Care, such as gloves and tote bags, to encourage 
participation and increase demonstration visibility. As one example, MassHealth partnered with 
the City of Boston for an event attended by staff from both MMPs that targeted chronically 
homeless individuals; individuals were able to connect with housing and health care resources 
including information on the demonstration. MassHealth has also continued to market and 
present on One Care at selected conferences and meetings. One MassHealth official noted: 
It’s been really important to work collectively with the [Implementation] Council 
to provide these opportunities… On the one hand, admittedly we get very few 
folks who specifically receive the passive enrollment notice and flyer who come 
by. But I think having a stronger presence in the community—and we’ve started 
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to do some repeat places where we feel like we get a lot of action—has been 
helpful in strengthening our presence, and the general knowledge about who’s 
aware of One Care. It’s something that we continue to evaluate, and I don’t know 
that we’ve found the perfect strategy yet.  
3.2.5 Contacting and Locating Enrollees 
As reported in the previous Evaluation Reports, MMPs continue to report some 
difficulties in locating enrollees for the initial assessments, particularly enrollees who had been 
passively enrolled. However, both MMPs reported increasing success based on efforts to better 
connect with hard-to-reach beneficiaries. As one plan noted: 
We are reaching almost 70 percent of people within 30 days. This is remarkable 
compared to what we were doing in July of 2014, when we were reaching about 
half the assigned population in 90 days. We have gotten much better at [reaching 
enrollees] and that has been really impactful.  
Some examples of approaches used by the MMPs include using claims data to track 
individuals, establishing dedicated units of staff to find hard-to-reach enrollees, and maintaining 
flexibility about when and where enrollees want to communicate, whether by phone or in person, 
and meeting in the enrollee’s home or elsewhere in the community. 
Table 1 shows the percentage of enrollees that the plans were unable to reach. By the last 
quarter of 2014, One Care plans were unable to reach nearly one-third of their enrollees (32.8 
percent). This percentage gradually decreased in subsequent years. The lowest percentage of 
unreachable members (17.5 percent) occurred in the fourth quarter of 2017; however, the 2017 
data have not yet been validated and should be considered preliminary.  
Table 1 
Percentage of members that One Care plans were unable to reach following three attempts, 
within 90 days of enrollment, by quarter 
Quarter CY 2014 CY 2015 CY 2016 CY 2017aa 
Q1 38.0% 31.0% 19.9% 31.7% 
Q2 36.6% 26.3% 14.0% 30.7% 
Q3 39.1% 23.5% 28.0% 20.3% 
Q4 32.8% 21.9% 19.5% 17.5% 
CY = calendar year. 
NOTES: Data are not available for Quarter 4, 2013. Fallon Total Care withdrew from the demonstration on 
September 30, 2015. Data for Fallon are available through Quarter 3, 2015. Data presented for Quarter 4, 2015 and 
after represent totals for the remaining two plans. 
a CY 2017 data have not yet been validated and should be considered preliminary. 
SOURCE: RTI analysis of MMP reported data for Core Measure 2.1, as of March 2018. The technical specifications 
for this measure are in the Medicare-Medicaid Capitated Financial Alignment Model Core Reporting Requirements 
document, which is available at: https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-
Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/MMPReportingRequirements.html. 
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3.3 Care Coordination 
This section provides a summary of the care coordination model for One Care. It 
highlights the status of and major accomplishments in key care coordination components and 
processes: assessment, care planning, LTSS coordination and the Independent Living and Long-
term Services and Supports coordinator role, and information exchange. 
3.3.1 Assessment and Care Coordination Model 
Care coordination continues to be the hallmark of the One Care delivery model and is 
seen by many as integral to helping beneficiaries access the full spectrum of needed services and 
to improving quality and ultimately, reducing costs. For medical and behavioral health services, 
MMPs must offer care coordination to all enrollees through a care coordinator or, for members 
with complex needs, a clinical case manager. Furthermore, plans are required to conduct a 
comprehensive assessment of the full range of members’ needs and preferences; to work with an 
Integrated Care Team to meet those needs; and to develop an individualized care plan for each 
member. Of note, One Care provides all enrollees the option of having an LTS Coordinator from 
a community-based organizations (CBOs) to coordinate long-term services and supports.27 The 
design of One Care’s assessment and care coordination model is more fully described in the First 
Annual Report. Although the care coordination design has not changed, the approach to 
implementing the model continues to evolve over time and differs by plan.  
3.3.2 The Assessment and Care Planning Process 
Plans have continued to focus on improving their assessment processes. As one plan 
noted, “when you get out earlier, you can start care management earlier.” With the return of 
passive enrollment, both plans use contracted services, rather than their own staff for at least 
some initial assessments. For example, one MMP reported working with a contracted agency of 
community health nurses to ensure there were no delays in completing assessments on new 
passively enrolled members. The plan reported that this model also allowed the plan to decrease 
labor costs when it did not have assessment demand. The MMP noted it was important to have 
assessors that understood the complexity of One Care beneficiaries and their service needs. 
The MMPs continue to refine and modify their care coordination practices to better meet 
the needs of One Care beneficiaries. For example, one plan broadened the requirements for 
licensure and types of care coordination services it provides, matching enrollees with high social 
service needs to outreach workers, people with substance use disorders to social workers, and 
those who are medically complex with advance practice clinicians. For members who do not 
want to engage with the MMP, staff check in telephonically to ensure that services are well-
coordinated. As one MMP represented noted:  
Truly, what we’ve found is that the population overall is very complex, not 
surprisingly, and it also created a need for us to be nimble and provide a fairly 
complex care coordination/care management model.  
                                                 
27 The design of the Independent Living and Long-term Services and Supports (LTS) Coordinator role is described 
in prior reports.  
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Membership of the Integrated Care Team also varies based on the complexity of an 
enrollee’s care needs, from multiple participants including supports for behavioral health and 
LTSS to a team consisting solely of a telephonic care coordinator and the enrollee’s primary care 
practitioner. In the latter case, that care coordinator has access to other integrated team members 
should a need arise (e.g. the enrollee is hospitalized and needs a discharge visit). One MMP 
provides every enrollee with a nurse or a behavioral health clinician as the primary care 
coordinator, although these individuals work in partnership, at times, based on an enrollee’s 
needs.  
One MMP has also focused on enhanced care coordination approaches aimed at more 
effectively and efficiently meeting enrollees’ needs. Examples included tracking and reaching 
out to enrollees with reoccurring admissions, or those who do not get prescriptions filled or miss 
medical appointments. Representatives from both plans, as well as MassHealth officials and 
other stakeholders, provided anecdotal stories about the success of care coordination services for 
One Care enrollees. As a representative of one MMP noted, “The best letters [and phone calls] I 
get are from members that say how their care coordinator changed their life.”  
Representatives from both plans provided examples about the importance of integrated 
care and incorporating principles of integration into MMP and provider practices. As discussed 
in prior Evaluation Reports, the exchange of behavioral health information continues to be an 
area of focus for plans and stakeholders. A few participants in the RTI focus groups reported a 
reluctance to share information, particularly behavioral health information, among providers and 
their plans. As one MMP representative noted: 
There remains a structural issue that is a barrier to integration that I can’t see any 
of us being able to overcome, which is that around consent and confidentially. It 
remains a requirement, for obvious reasons, that members and patients have to 
give some degree of consent for free exchange of information. That has and will 
probably continue to be a major barrier in terms of integration.  
MMPs are required to report certain staffing data for care coordination, as set forth in 
Table 2. The care coordinator turnover rate increased from 11.5 to 20.1 percent over the 2014 to 
2016 period, but decreased to 10.7 percent in 2017. However, as described in Section 4.1, 
Beneficiary Experience, a number of participants in the 2017 RTI focus groups still reportedly 
experienced a lack of continuity with their care coordinators, which they believed to be due to 
care coordinator turnover. Care coordinator caseloads increased each year from 2014 to 2017. 
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Table 2 
Care coordination staffing 
Calendar 
year 
Total number of 
care coordinators 
(FTE) 
Percentage of care 
coordinators assigned to 
care management and 
conducting assessments 
Member load per care 
coordinator assigned to care 
management and conducting 
assessments 
Turnover 
rate 
2014 234 70.9% 107.90 11.5% 
2015 125 80.0% 122.90 16.8% 
2016 144 68.1% 146.26 20.1% 
2017 218 44.5% 191.58 10.7% 
NOTES: Data are not available for the fourth quarter of 2013. Fallon Total Care withdrew from the demonstration 
on September 30, 2015. Data presented for 2015 represent totals for the remaining two plans. 
SOURCE: RTI analysis of MMP reported data for Core Measure 5.1, as of April 2018. The technical specifications 
for this measure are in the Medicare-Medicaid Capitated Financial Alignment Model Core Reporting Requirements 
document, which is available at: https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-
Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/MMPReportingRequirements.html 
As part of the demonstration, MassHealth required plans to track and report data on 
assessment completion. Those data (see Table 3) show overall assessment completion rates 
increasing over time, both among those documented and willing to participate in an assessment 
and accounting for those unable to be located and unwilling to participate.  
Table 3 
Total percentage of enrollees whose assessment was completed within 90 days of enrollment 
Quarter 
Total number of enrollees 
whose 90th day of 
enrollment occurred within 
the reporting period 
Assessment completed within 90 days of enrollment % 
All enrollees 
All enrollees willing to participate 
and who could be located 
2014       
Q1  7,469  34.1 55.8 
Q2  3,973  34.7 56.8 
Q3  6,338  34.9 59.9 
Q4  890  57.8 92.9 
2015       
Q1  1,389  53.4 84.3 
Q2  750  68.1 99.8 
Q3  616  69.6 96.6 
Q4  827  64.2 85.8 
(continued) 
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Table 3 (continued) 
Total percentage of enrollees whose assessment was completed within 90 days of enrollment 
Quarter 
Total number of enrollees whose 
90th day of enrollment occurred 
within the reporting period 
Assessment completed within 90 days of enrollment % 
All enrollees 
All enrollees willing to participate 
and who could be located 
2016       
Q1  815  42.1 57.5 
Q2  301  69.1 83.9 
Q3  1,205  59.6 93.4 
Q4  1,315  59.8 79.6 
2017a       
Q1  2,686  60.4 95.2 
Q2  2,045  60.0 93.3 
Q3  1,770  56.4 76.1 
Q4 1,466 50.6 63.1 
NOTES: Data are not available for Quarter 4 2013. Fallon Total Care withdrew from the demonstration on 
September 30, 2015. Data for Fallon are available through Quarter 3 2015. Data presented for Quarter 4 2015 and 
after represent totals for the remaining two plans.  
a Calendar year 2017 data have not yet been validated and should be considered preliminary. 
SOURCE: RTI analysis of MMP reported data for Core Measure 2.1, as of March 2018. The technical specifications 
for this measure are in the Medicare-Medicaid Capitated Financial Alignment Model Core Reporting Requirements 
document, which is available at: https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-
Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/MMPReportingRequirements.html. 
As part of the demonstration, MassHealth requires plans to track and report data on care 
plan development (see Table 4). For all enrollees, the percentage of enrollees with a care plan 
completed within 90 days of enrollment varied slightly throughout the demonstration, after 
noticeably lower percentages in 2014 as compared to subsequent years. This pattern was similar 
for enrollees not documented as unwilling to complete a care plan or unreachable, although the 
percentages themselves were higher than those of all enrollees. 
Table 4 
Members with care plans within 90 days of enrollment 
Quarter 
Total number of enrollees whose 
90th day of enrollment occurred 
within the reporting period 
Care plan completed within 90 days of enrollment 
All enrollees 
All enrollees not documented as unwilling 
to complete a care plan or unreachable 
2014       
Q1 5,871 22.8% 32.83% 
Q2 3,977 25.8% 41.0% 
Q3 6,330 24.8% 39.2% 
Q4 886 37.0% 59.1% 
(continued) 
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Table 4 (continued) 
Members with care plans within 90 days of enrollment 
Quarter 
Total number of enrollees whose 
90th day of enrollment occurred 
within the reporting period 
Care plan completed within 90 days of enrollment 
All enrollees 
All enrollees not documented as unwilling 
to complete a care plan or unreachable 
2015       
Q1 1,398 48.1% 65.18% 
Q2 748 54.3% 73.2% 
Q3 614 59.3% 80.4% 
Q4 821 68.3% 79.9% 
2016       
Q1 810 50.6% 63.5% 
Q2 291 61.5% 72.8% 
Q3 1,208 63.8% 81.1% 
Q4 1,317 56.4% 74.2% 
2017       
Q1 2,681 60.0% 76.9% 
Q2 2,048 59.7% 80.1% 
Q3 1,769 53.0% 68.2% 
Q4 1,830 47.8% 58.5% 
NOTES: Fallon Total Care withdrew from the demonstration on September 30, 2015. The data after Quarter 3, 2015 
are representative of the two other MMPs.  
SOURCE: RTI analysis of MMP reported data for State-specific measure MA 1.1 as of September 2018. The 
technical specifications for this measure are in the Medicare-Medicaid Capitated Financial Alignment Model Core 
Reporting Requirements document, which is available at: https://www.cms.gov/Medicare-Medicaid-
Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/InformationandGuidanceforPlans.html . 
In all quarters of 2016 and 2017, the percentage of the members with at least one 
documented discussion of a care goal was greater than 92 percent (see Table 5). 
Table 5 
Members with care goals 
Quarter 
Total number of members with 
a care plan completed 
Members with at least one documented 
discussion of care goals in the care plan 
2014     
Q1 — — 
Q2 — — 
Q3 — — 
Q4 — — 
(continued) 
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Table 5 (continued) 
Members with care goals 
Quarter 
Total number of members with 
a care plan completed 
Members with at least one documented 
discussion of care goals in the care plan 
2015     
Q1 — — 
Q2 — — 
Q3 — — 
Q4 — — 
2016     
Q1 501 98.0% 
Q2 565 96.6% 
Q3 618 99.0% 
Q4 970 100.0% 
2017     
Q1 1,562 99.9% 
Q2 1,574 99.7% 
Q3 1,540 99.4% 
Q4 1,257 92.4% 
— = not available. 
NOTES: Data are not available for year 2014 and 2015. Fallon Total Care withdrew from the demonstration on 
September 30, 2015. 
SOURCE: RTI analysis of MMP reported data for State-specific measure MA 1.2 as of September 2018. The 
technical specifications for this measure are in the Medicare-Medicaid Capitated Financial Alignment Model Core 
Reporting Requirements document, which is available at: https://www.cms.gov/Medicare-Medicaid-
Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/InformationandGuidanceforPlans.html. 
3.3.3 LTS Coordination and LTS Coordinator Role 
The LTS Coordinators in One Care are provided by CBOs, including Aging Services 
Access Points, Independent Living Centers (ILCs), and Recovery Learning Communities 
(RLCs).28 Although this model has received broad support and is considered by some to be a key 
feature of the demonstration, MassHealth officials, representatives from the MMPs and CBOs, as 
well as other stakeholders, have all reported varying degrees of success and challenge in 
implementation of the model.29 As in previous years feedback continues to be mixed across 
MassHealth, the MMPs, the CBOs and stakeholders. Additionally, the use of RLCs to provide 
LTS coordination appears very limited overall.  
                                                 
28 The RLCs are consumer-driven networks that focus on recovery and wellness for individuals with behavioral 
health needs and were included in the design of One Care to tailor the LTS Coordinator role for this population.  
29 The model and its implementation are described in previous Evaluation Reports.  
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At the time of the 2017 RTI telephonic site visit, MassHealth officials reported being in a 
“positive place” with respect to the implementation status of LTS Coordinators following 
convening a work group in the previous year to address this challenge. They reported that work 
resulted in better identification of roles and responsibilities and had addressed some of the billing 
and reimbursement issues that had been identified previously. MMPs generally also reported 
improvements and a continued focus in this area. One MMP noted a strong partnership on the 
clinical side of the relationship; some administrative challenges, though improved, continued. 
Officials of one MMP reported developing a new assessment in 2017 to be used by LTS 
Coordinators to better standardize assessment of functional need and service need development.  
Overall, one CBO representative noted that the role was still a “lighter involvement” than 
the CBO had initially anticipated, with limited ability to recommend services beyond 
standardized services allowed by the MMP. Another CBO representative noted that even if the 
LTS Coordinator was not always fully integrated into the interdisciplinary care team (ICT), the 
model was more integrated than before One Care. One particular challenge noted by 
representatives from some CBOs was the rate of turnover in MMP staff, requiring CBO staff to 
frequently educate and train new MMP staff about the original intent and ideals of the LTS 
Coordinator role. CBO representatives also noted different processes and procedures across the 
MMPs, including different levels of access to centralized enrollee records. Clarifying the role of 
the LTS Coordinator for beneficiaries continues to present challenges. As one MMP officials 
noted: 
There’s still confusion among the members about the LTS Coordinator, but it’s 
less about what services they may provide and more because they have three or 
four different folks who seem to be helping them with these things, and they’re 
just not sure who’s doing what. But their satisfaction levels with the LTS 
Coordinator when they have one, in terms of meeting their needs, is very high.  
3.4 Stakeholder Engagement 
Strong stakeholder engagement has continued to be a key feature of the One Care 
demonstration through activities of the consumer-led Implementation Council and the MMPs’ 
Member Advisory Boards. This section describes stakeholder engagement activities during the 
period of this report and the impact of those efforts on the demonstration. Notably, the 
Commonwealth reported that two additional CAHPS survey questions specific to persons with 
disabilities were approved for calendar year 2018 after MassHealth and CMS received feedback 
from stakeholders in the disability community, including one Council member. MassHealth and 
CMS officials cited the addition of these two questions to the CAHPS survey as an example of 
successful federal-State collaboration in jointly managing the demonstration. 
3.4.1 Commonwealth Open Meetings 
MassHealth held three public Open Meetings during demonstration year 4, which were 
convened in April, May, and November 2017.30 The first two Open Meetings discussed the 
procurement of the MassHealth Health Plan Ombudsman program, which serves all MassHealth 
                                                 
30 Agenda and meeting minutes can be accessed at: https://www.mass.gov/service-details/one-care-open-meetings.  
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managed care enrollees as of July 2018. MMP-level quality performance results and financial 
data from the MMPs were discussed at the third Open Meeting.  
3.4.2 Implementation Council Meetings 
The first term of the Implementation Council expired at the end of 2016. The Council 
began its second term in June 2017 with the selection and onboarding of 13 new and returning 
Council members. The Council continues to be consumer-led; by design, more than half of all 
members are required to be One Care enrollees or family members or guardians of One Care 
enrollees. At year end, the Council had formed one subcommittee to develop the Council work 
plan, and planned to develop three work groups to support the Council’s work plan. The 2017––
2018 work plan focuses primarily on enhancing communication access for One Care enrollees, 
particularly those who are deaf or hard of hearing; supporting enhanced integration of medical 
care, LTSS, and durable medical equipment; and supporting the sustainability of One Care. 
Officials from MassHealth, CMS and the MMPs, along with the One Care Ombudsman, 
continue to participate in all Council meetings. MMP and CMS officials were invited to “have a 
seat at the table” as non-voting participants after Council members learned about the structure of 
the Implementation Council established in Rhode Island’s demonstration, in which CMS and 
MMP officials regularly participate in meetings. This addition has been viewed positively by the 
Council “because they [CMS and the MMPs] can be part of the conversation.”  
The Implementation Council generally meets monthly but because of the re-solicitation 
of Council members, there were six meetings in 2017.31 Most were focused on onboarding 
processes for Council members and creating a work plan. In addition to its monthly meeting, the 
Implementation Council convened a Listening Session on December 8, 2017 to solicit direct 
feedback from One Care members about their experience in One Care and provide enrollees with 
information about the Implementation Council, the One Care Ombudsman, and MMP Member 
Advisory Boards. See Section 4.1, Beneficiary Experience, for a summary of the discussions.  
The Implementation Council continues to be a primary source of feedback for 
MassHealth and CMS on the demonstration and has led to occasional operational and policy 
changes. For example, at the suggestions of a Council member, MassHealth will begin to require 
a domain in assessments asking about an enrollee’s sexual orientation and gender identity to 
better address that individual’s needs. Additionally, proposed changes described in the three-way 
contract draft amendment incorporate input and feedback from the Implementation Council 
(MassHealth presentation to Implementation Council. January 8, 2018).  
While noting a close and collaborative working relationship with MassHealth, one 
stakeholder reported that it can still be difficult at times to engage in open dialogue due to the 
bandwidth issues and the “protectionist” approach of MassHealth:  
                                                 
31 Agenda and meeting minutes of the Implementation Council can be accessed at: https://www.mass.gov/service-
details/one-care-implementation-council.  
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If there’s always a defensive mode, that doesn’t lead to dialogue… when 
questions are raised about how things are being done, it’s not an attack. It may 
feel like it but it’s not an attack. 
MassHealth described their relationship with the Council as a working relationship that 
has evolved over time. As noted in prior Evaluation Reports, MassHealth officials have reported 
that One Care’s stakeholder structure has set a new standard for public engagement. During the 
2017 RTI telephonic site visit, MassHealth officials reported trying to replicate the robust 
structure of One Care’s Implementation Council across its ACO and MCO initiatives; they also 
reported that the stakeholder group for the Senior Care Options program has been influenced by 
One Care’s Council activities. 
3.4.3 Member Advisory Board Meetings 
As a requirement of the demonstration, each MMP operates a Member Advisory Board 
(MAB) to solicit feedback on enrollee experience and improve service delivery design. In 
meetings of the MABs, enrollees reportedly highlighted issues related to transportation services, 
access to dental services, and other experiences with receiving care from providers during 2017. 
One MMP official noted that they have shifted the focus of their MAB meetings in the past year 
from solely seeking feedback to gaining input from enrollees on how to modify programmatic 
elements and service delivery to be more “consumer focused.” This included discussions on 
improving conversations between staff and enrollees about denial of services, and how enrollees 
define “quality of care,” specifically around the LTS Coordinator role and experiences with 
transportation and dental services. Both MMPs view the MABs as a “very helpful” feature of the 
demonstration for engaging stakeholders and informing programmatic improvements. 
3.5 Financing and Payment 
This section outlines changes in financing and payment since demonstration year 3, 
relevant findings related to these changes, and an overview of cost experience as reported by 
MassHealth officials and MMP representatives.  
3.5.1 Rate Methodology  
CMS and MassHealth are each responsible for a portion of the overall capitation rate that 
is paid to MMPs.32 The Medicare Parts A and B rate component is risk adjusted using the 
Medicare Advantage CMS-Hierarchical Condition Category (HCC) and CMS HCC end-stage 
renal disease (ESRD) models. The Medicare Part D payment is risk adjusted using the Part D 
RxHCC model. The Medicaid component is risk adjusted through the assignment of one of six 
rating categories based on the enrollee’s clinical status and care setting. These are described 
more fully in prior Evaluation Reports. 
                                                 
32 As described more fully in previous Evaluation Reports, MMPs receive three monthly payments for each 
enrollee: one amount from CMS reflecting coverage of Medicare Parts A/B; one amount from CMS reflecting 
coverage of Medicare Part D services; and one amount from MassHealth reflecting coverage of Medicaid 
services. CMS makes a monthly payment reflecting coverage of Medicare Parts A and B services and a separate 
amount reflecting Part D services.  
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MassHealth in conjunction with CMS released the calendar year 2017 Final Rate Report 
February 2017; the report details the calendar year 2017 Medicaid and Medicare components of 
the capitation rates and other supporting information.33 The Medicare component incorporated 
new revisions to the CMS-CC Risk Adjustment Model to better predict costs for beneficiaries 
based on their dual status and aged/disabled status. MassHealth reported that the Medicaid rate 
increase included a $3.6 million investment in complex care management. 
As initially implemented, the financial structure of the demonstration also included 
establishment of savings percentages, performance incentives, high cost risk pools and risk 
corridors. Earlier reports discuss these in greater detail and provide information on the changes 
over the course of the first three years of the demonstration. There were no changes to these 
financing methodologies in 2017, other than scheduled adjustments as set forth in the three-way 
contract as amended. For example, the demonstration’s savings percentages increased from 0.0 
percent in calendar year 2016 to 0.25 percent for calendar year 2017, as established in the 
contract addendum executed in June 2016. The contract addendum also increased the quality 
withhold percent in demonstration year 4 to 1.25 percent from 1 percent the previous year (three-
way contract addendum, June 2016). 
3.5.2 Reported Cost Experience  
Overall, the two MMPs have reported different cost experiences with One Care. One 
MMP initially took on higher enrollment and reported losses in the first two years of the 
demonstration; the other grew enrollment more slowly and reported positive gains during that 
same period. At this point in the demonstration, the cost experiences of the two MMPs have 
shifted: the MMP that initially experienced losses has stabilized financially over the last 2 years 
and is projecting gains for 2017, whereas the other MMP is now projecting financial losses. 
Representatives from one of the MMPs described their financial results as 
“extraordinary” and reported that initial projections indicated that the MMP would have amounts 
due back to regulators under the terms of the risk corridors established by the three-way 
contract.34 Overall, they attributed this net positive operating margin to several factors, including 
enrollment growth that allowed the plan to spread fixed costs over a greater number of enrollees. 
Other factors included enrollees being reassessed into higher premiums/rating categories without 
a comparable increase in medical costs for those enrollees, attributed in part to effective 
assessment and care management; and improved Medicare rates for Medicare-Medicaid 
beneficiaries. 
Representatives from the other MMP noted that having a relatively small number of 
enrollees meant that small changes in enrollee mix or the number of catastrophic cases could 
significantly impact the MMP’s financial position. Specifically, the MMP reported that some of 
its losses were driven by the service costs of beneficiaries that transitioned to the plan when 
Fallon Total Care withdrew as an MMP from the demonstration in late 2015. The MMP noted 
that the 500 or so enrollees who transitioned from Fallon came in with a much higher entry cost 
                                                 
33 For more detail, see Demonstration to Integrate Care for Dual Eligible Individuals CY 2017 Final Rate Report 
for CCA and Tufts (February 2017), retrieved from https://www.mass.gov/service-details/one-care-capitated-
rate-reports.  
34 The risk corridors for One Care are described in the second Evaluation Report. 
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than the plan’s existing membership; MMP officials also noted that the costs on those enrollees 
generally accelerated rather than reverting to the mean.  
The MMP noted a similar trend in successive waves of enrollment, with each wave 
coming in at a higher starting point from a medical cost perspective than the previous one. 
Representatives from the MMP also believed this trend was due in part to the limited size and 
geographic coverage of the plan: 
The longer you stay in [the same geography] and you’re not expanding… your 
member base, what we’re getting is higher-risk members on capitation rates that 
for the most part were substandard. So that is certainly a compounding factor to 
each of the financial losses. 
The MMP reported those trends appeared to be settling down, particularly in the in the latter half 
of 2017. 
Although the MMP had set an initial goal of increasing its enrollment to 6,000 
beneficiaries, it scaled back that goal in light of the financial losses that were projected in early 
2017. Representatives from the MMP noted that although operations had since stabilized to some 
degree in the latter half of 2017, they had concerns that adding volume based on the projected 
cost trajectories could result in more significant financial loss. In terms of increasing enrollment, 
the MMP was in the process of evaluating its service territory and other considerations to 
determine how best to move forward in 2018. The plan also noted the importance of enrollee 
retention to capture longer term savings and offset up front investments in assessments and initial 
service use to address previously unmet needs of new enrollees.  
MassHealth officials reported an interest in working with the plan to better understand 
the root causes for the plan’s financial performance, including any potential issues around 
enrollee retention. MassHealth officials also expressed an interest in looking more closely at 
provider pricing in One Care to compare rates of reimbursement to Medicare or Medicaid fee for 
service rates. In part, MassHealth and MMP officials noted that not having some of the 
enrollment levers typically available in Medicaid managed care (e.g., fixed enrollment periods) 
created operational challenges in establishing sufficient enrollment to influence market behavior. 
MassHealth officials also noted that the membership mix in terms of rating categories differed 
across the two plans but “[they] were still trying to understand why and how various factors 
might be impacting on the differing cost experiences of the two MMPs.” They expressed interest 
in looking at individual level data, including encounters, but recognized that this type of detailed 
analysis was a longer term strategy.  
Overall, MassHealth leadership reiterated their support of the demonstration’s integrated 
care model and noted that their goal of increased access to this model is dependent on ensuring 
that the demonstration is financially sustainable. One MassHealth official reported that the 
Commonwealth was “significantly subsidizing the Medicare dollar” and that greater flexibility 
was needed around the pricing of the model:  
It’s hard to make the economics work for us from the State standpoint, meaning 
more spend on LTSS is a good thing that results in reduced medical spend, but the 
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economics of that are hard to capture [unless we] get the right flexibilities [to 
support] enrolling people into the program.  
MassHealth, including its leadership, expressed confidence in being able to work collaboratively 
in partnership with CMS to achieve this goal. 
3.6 Quality of Care 
This section provides information on the quality measures for the demonstration and 
updates on the quality management structure for the demonstration and includes HEDIS results. 
Results of quality measures for the demonstration period are discussed in Section 5, Service 
Utilization. Selected results of CAHPS data are discussed in Section 4, Beneficiary Experience. 
3.6.1 One Care Quality Measures 
As described in the First Annual Report, the demonstration design requires that MMPs 
report standardized quality measures. In October 2017, CMS released updated Core Reporting 
Requirements for calendar year 2018 with changes intended to “streamline, clarify, and simplify 
the measure specifications.” The Commonwealth reported that MassHealth and CMS have also 
been working together to update State-specific reporting requirements as applicable, in order to 
ensure that the new revisions do not cause a duplication of efforts between State- and core-
specific requirements. MassHealth described this revision process as “very collaborative” and 
that working with CMS on quality measures has “only gotten easier as time has gone on.” 
MassHealth noted that the majority of the reporting requirements continue to be helpful 
to the management of the demonstration; however, as one MassHealth official stated, “[the 
measures] don’t really give us a lot of information about outcomes and I don’t think that was 
necessarily what their purpose was.” As described in the Second Evaluation Report, MMP 
representatives continued to question the added value of some of the required reporting 
measures.  
3.6.2 Quality Management Structures and Activities 
MassHealth, CMS, the MMPs, and other independent organizations have a role in quality 
oversight of One Care.35 Dedicated officials within MassHealth’s One Care team oversee quality 
metrics and reporting on a daily basis. MassHealth officials also reported a shift toward an 
agency wide approach in quality monitoring, in order to align quality oversight and monitoring 
across MassHealth programs. MassHealth officials reported that they are increasingly focused on 
finding efficiencies and streamlining processes “to align the [quality] measures between the 
broader payment reform program, One Care, SCO, and the portfolio of unusual LTSS services 
that are in our State plan…[s]o that whichever model somebody chooses, you’re getting an 
aligned vision of what the quality looks like.” In 2017, MassHealth also launched a new 
webpage on One Care’s website to share One Care data reports and quality information with the 
public.36 
                                                 
35 The overall quality management structure and activities for One Care are described in the First Annual Report. 
36 https://www.mass.gov/service-details/one-care-data-reports-and-quality-information.  
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Both MMPs continue to participate in the required quality activities, including a chronic 
care improvement project and a quality improvement project (QIP). According to the 
Commonwealth, oversight of QIPs has shifted from joint review between MassHealth and CMS 
to a State-only review. MassHealth worked with both MMPs to ensure measurement accuracy 
between the proposed interventions, the member sample, and the objectives of the QIP, after 
reported measurement challenges with one MMP’s QIP. MassHealth conducted a number of 
efforts in 2017 to streamline Commonwealth- and MMP-level processes and programming 
related to QIPs, including revising quality reporting forms and timelines, and encouraging 
overlap of QIP programming with the plans’ other product lines.  
3.6.3 Independent Quality Activities 
The Implementation Council plays a key role in monitoring access to health care and 
compliance with the Americans with Disabilities Act, tracking quality of services, and promoting 
accountability and transparency. In light of MassHealth’s broader reforms, one Council member 
reported that supporting the alignment of One Care quality measures with quality activities 
across Massachusetts’ health care delivery system is a priority of the Council. 
The One Care Ombudsman (OCO) program is responsible for providing independent 
advocacy on behalf of beneficiaries and for identifying broader systematic issues impacting 
quality of care. The OCO reports on provision of individual enrollee services, outreach efforts, 
and number and type of complaints escalated to either MassHealth or the MMP on a quarterly 
basis to MassHealth. The OCO regularly attends and presents on quality issues, such as enrollee 
inquiries and complaints received, at the monthly Implementation Council meetings.  
In 2017, Massachusetts began restructuring MassHealth ombudsman services to create 
one ombudsman program to serve multiple MassHealth managed care and accountable care 
programs; ombudsman services for One Care are anticipated to be incorporated into this larger 
initiative. MassHealth released a procurement for ombudsman services in October 2017 which 
was implemented under the name “My Ombudsman” on July 1, 2018. In developing the 
procurement, MassHealth leveraged lessons learned from the OCO. MassHealth anticipates that 
a wide-reaching ombudsman program will allow for tracking trends and patterns related to 
service access for dual eligible individuals and others living with disabilities across populations 
and programs, and to more clearly identify systemic policy issues and potential improvements.  
Under Medicaid regulations (42 CFR Part 438, Subpart E), State Medicaid agencies 
contract with an External Quality Review organization (EQRO) on an annual basis to provide an 
independent assessment of their managed care plan performance. The EQRO conducts 
performance measure validation and validates each plan’s chronic care and QIPs. 
3.6.4 Results for Selected Quality Measures 
Thirteen Medicare HEDIS measures for MMP enrollees are reported in Table 6. RTI 
identified these measures after reviewing the list of measures we previously identified in RTI’s 
Aggregate Evaluation Plan as well as the available HEDIS data on these measures for 
completeness, reasonability, and sample size. Detailed descriptions of the measures can be found 
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in the RTI Aggregate Evaluation Plan.37 Results were reported for measures where sample size 
was greater than 30 beneficiaries. In addition to reporting the results for each MMP, the mean 
value for Medicare Advantage plans for each measure is provided for comparison.  
Table 6 
Selected HEDIS measures for One Care plans, 2015–16 
Measure 
National Medicare 
Advantage Plan 
mean (2016)  
(%) 
CCA 
(2015)  
(%) 
CCA 
(2016) 
(%) 
Tufts  
(2015) 
(%) 
Tufts 
(2016) 
(%) 
Adults’ access to preventive/ambulatory 
health services 
94.7 77.9 97.3 92.2 95.8 
Adults’ body mass index (BMI) 93.9 97.5 87.8 96.0 93.3 
Annual monitoring for patients on 
persistent medications  
          
Annual monitoring for members on 
angiotensin converting enzyme (ACE) 
inhibitors or angiotensin receptor 
blockers (ARBs) 
92.4 91.1 90.4 85.2 89.0 
Annual monitoring for members on 
digoxin 
57.3 62.1 61.3 66.7 50.0 
Annual monitoring for members on 
diuretics 
92.9 90.3 90.0 86.3 91.7 
Total rate of members on persistent 
medications receiving annual monitoring 
92.1 90.6 90.0 85.5 89.9 
Antidepressant medication management            
Effective acute phase treatment1 69.3 56.6 57.9 83.1 75.5 
Effective continuation phase treatment2 54.3 45.3 44.5 74.7 65.5 
Blood pressure control3  69.0 61.1 64.3 64.1 67.4 
Breast cancer screening 71.6 83.1 75.5 N/A 71.6 
Care for older adults4            
Advance care planning N/A 17.4 42.1 N/A N/A 
Medication review N/A 65.2 89.3 N/A N/A 
Functional status assessment N/A 78.3 71.9 N/A N/A 
Pain assessment N/A 80.4 83.5 N/A N/A 
Colorectal cancer screening 66.2 46.2 50.9 57.5 57.3 
Comprehensive diabetes care            
Received Hemoglobin A1c (HbA1c) 
testing 
93.4 93.2 91.5 88.8 92.0 
Poor control of HbA1c level (>9.0%) 
(higher is worse) 
27.2 58.2 45.5 29.7 33.1 
 (continued) 
                                                 
37 https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-Coordination/Medicare-
Medicaid-Coordination-Office/FinancialAlignmentInitiative/Downloads/EvalPlanFullReport.pdf  
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Table 6 (continued) 
Selected HEDIS measures for One Care plans, 2015–16 
Measure 
National Medicare 
Advantage Plan 
mean (2016)  
(%) 
CCA 
(2015)  
(%) 
CCA 
(2016) 
(%) 
Tufts  
(2015) 
(%) 
Tufts 
(2016) 
(%) 
Good control of HbA1c level (<8.0%) 62.2 35.0 45.5 62.0 59.9 
Received eye exam (retinal) 70.0 66.2 67.4 63.1 68.6 
Received medical attention for 
nephropathy 
95.6 93.7 93.9 93.7 93.2 
Blood pressure control (<140/90 mm Hg) 69.0 60.8 67.6 69.7 67.4 
Disease modifying anti-rheumatic drug 
therapy in rheumatoid arthritis 
76.6 84.3 84.4 N/A N/A 
Follow-up after hospitalization for 
mental illness (30 days)  
53.2 72.1 78.7 76.6 79.5 
Initiation and engagement of alcohol and 
other drug (AOD) dependence treatment  
          
Initiation of AOD treatment5 32.3 43.3 43.1 40.0 47.9 
Engagement of AOD treatment6 3.5 11.3 12.7 13.16 15.6 
Plan all-cause readmissions (average 
adjusted probability total)  
— 22.0 23.0 22.2 24.0 
Ambulatory care (per 1,000 members)           
Outpatient visits 9,181.9 12,192.0 12,572.5 9,581.0 9,389.3 
Emergency department visits 637.8 1,418.6 1,350.2 1,446.3 1,308.9 
1 Represents the percentage of members who remained on an antidepressant medication for at least 84 days (12 
weeks). 
2 Represents the percentage of members who remained on an antidepressant medication for at least 180 days (6 
months). 
3 The following criteria were used to determine adequate blood pressure control: less than 140/90 mm Hg for 
members 18–59 years of age; diagnosis of diabetes and <140/90 mm Hg for members 60–85 years of age; no 
diagnosis of diabetes and <150/90 mm Hg for members 60–85 years of age. 
4 For the Care for Older Adults measures, few enrollees are age 65 or older. Also, there is no Medicare Advantage 
benchmark for these measures as they are only required for Special Needs Plans and MMPs. 
5 Represents percentage of members who initiate treatment through an inpatient AOD admission, outpatient visit, 
intensive outpatient encounter or partial hospitalization within 14 days of the diagnosis. 
6 Represents the percentage of members who initiated treatment and who had two or more additional services with a 
diagnosis of AOD within 30 days of the initiation visit. 
NOTES: N/A = not applicable; — = not available or the number of enrollees in the plan’s provided HEDIS data 
available for inclusion in the measure was less than 30, and therefore not reported per RTI’s decision rule for low 
addressing sample size. Detailed descriptions of HEDIS measures presented can be found in the RTI Aggregate 
Evaluation Plan: https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-
Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/Downloads/EvalPlanFullReport.pdf 
SOURCE: RTI analysis of 2015 and 2016 HEDIS measures.  
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We provide national benchmarks from Medicare Advantage plans, where available, 
understanding that Medicare Advantage enrollees and demonstration enrollees may have 
different health and sociographic characteristics. Previous studies on health plan performance 
reveal poorer quality ratings for plans serving a higher proportion of dual eligible beneficiaries 
and beneficiaries with disabilities. HEDIS measure performance is slightly worse among plans 
active in areas with lower income and populations with a higher proportion of minorities (Office 
of the Assistant Secretary for Planning and Evaluation, 2016). Benchmarks should be considered 
with that limitation in mind. These findings on Massachusetts MMP HEDIS measure 
performance are likely to change over time as MMPs gain more experience in working with 
enrollees. Monitoring trends over time in MMP performance may be more important than the 
comparison to the national Medicare Advantage plans given the population differences. Several 
years of HEDIS results are likely needed to know how well MMPs perform relative to each other 
and whether they perform above or below any potential benchmark. 
For each measure, results across CCA and Tufts vary, and there was not a consistent 
trend across measures for one MMP versus the other. Results reported below compare the two 
plans, with the exception of some measures where sample size was less than 30 beneficiaries. 
For four of the 13 reported measures, both plans performed better than the national Medicare 
Advantage benchmark value in 2016. These measures were adults’ access to preventive/ 
ambulatory health services, breast cancer screening, follow-up after hospitalization for mental 
illness, and initiation and engagement of alcohol and other drug dependence treatment. Tufts 
performed better than the benchmark on antidepressant medication management. CCA 
performed better on disease modifying anti-rheumatic drug therapy in rheumatoid arthritis. For 
the remaining measures, both plans performed below the 2016 benchmark value.  
Performance on HEDIS measures remained relatively stable between 2015 and 2016. 
However, both plans experienced decreases in the percentages of enrollees with antidepressant 
medication management. Both CCA and Tufts experienced increases in the percentage of 
enrollees on persistent medications, particularly angiotensin converting enzyme (ACE) 
inhibitors, angiotensin receptor blockers (ARBs), and diuretics. Both the percentage of enrollees 
whose blood pressure was adequately controlled and the percentage of enrollees who initiated 
and engaged in alcohol and other drug (AOD) dependence treatments increased between 2015 
and 2016 for both CCA and Tufts. CCA experienced a nearly 20 percent increase in the number 
of enrollees who had an ambulatory or preventive care visit in the measurement year. CCA also 
saw an increase in eye exams, blood pressure control, and control of HbA1c levels (<8.0 percent) 
for those receiving diabetes care. Tufts experienced an increase in the percentage of beneficiaries 
on persistent medications receiving annual monitoring. CCA experienced increases in most Care 
for Older Adults measures, with over 20 percentage point increases in each of the advanced care 
planning and medication review measures. Ambulatory care per 1,000 members for outpatient 
visits increased between 2015 and 2016 for both CCA and Tufts, while ambulatory care for 
emergency department visits decreased for both plans. 
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4. Beneficiary Experience 
 
 
One of the main goals of the demonstration under the Financial Alignment Initiative is to 
improve the beneficiary experience accessing Medicare and Medicaid. This section highlights 
beneficiary experience with One Care, and provides information on beneficiary protections, data 
related to complaints and appeals, and critical incident and abuse reports. The section also 
includes information on the experience of special populations. 
4.1 Methods and Data Sources 
In line with all Medicare Advantage plans, One Care plans conducted annual assessments 
of beneficiary experiences using a Medicare Advantage and Prescription Drug Plan CAHPS 
survey instrument, which included question items added for the Financial Alignment Initiative 
evaluation of capitated model demonstrations. This section presents results from the 2015, 2016 
and 2017 CAHPS surveys. This section provides national benchmarks from Medicare Advantage 
plans, where available, understanding that Medicare Advantage enrollees and demonstration 
enrollees may have different health and sociographic characteristics which would affect the 
results. There are differences in the populations served by the One Care demonstration and the 
Medicare Advantage population, including health and socioeconomic characteristics that must be 
considered in the comparison of the demonstration to the national Medicare Advantage contracts. 
This section also presents findings from key informant interviews with MassHealth 
officials, One Care plan representatives, CBO staff, One Care Ombudsman staff and 
Implementation Council members. Complaint, grievance, and appeals data are also discussed in 
this section. Sources of these data include CMS’s Complaint Tracking Module, Report covering 
[October 2013–December 2017] MMP reported data for Core Measure 4.2; and IRE data for 
January 2014–December 2017. Data sources also include excerpts from a MassHealth survey 
conducted in the summer of 2016 in partnership with the University of Massachusetts Medical 
School (UMMS), of 1,532 randomly selected beneficiaries who had previously been enrolled 
with Fallon Total Care (Fallon), an MMP that withdrew from the demonstration in late 2015. 
Sixty-five percent of the respondents in the sample had transitioned to the FFS system, whereas 
35 percent had enrolled with a different One Care plan. 
Highlights 
• RTI focus group participants generally expressed satisfaction with One Care, often 
referencing the receipt of new or expanded services.  
• Most RTI focus group participants were able to identify a person responsible for 
coordinating their care; many participants also reported care coordinator turnover. 
• MassHealth and the One Care Ombudsman reported that the majority of grievances 
and appeals filed in 2017 primarily concerned denials for dental services or quality 
issues related to transportation services. 
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In April 2017 the RTI evaluation team conducted eight focus groups with a total of 44 
One Care enrollees who were receiving LTSS and had self-reported behavioral health needs. The 
focus groups explored enrollees’ experiences with care, their interactions with their providers, 
their experiences with One Care’s beneficiary protections, and the impact of demonstration 
services on their lives. For Spanish-speaking enrollees, the focus groups also aimed to 
understand their experience with the demonstration as a special population, including the 
availability of Spanish-speaking care coordinators, medical staff, or translators, and the level of 
cultural sensitivity care coordinators and other One Care staff exhibited. Findings from a 
previous round of focus groups conducted by RTI are presented in prior Evaluation Reports. See 
Section 1.2 for a full description of the focus group and other data sources.  
4.2 Impact of the Demonstration on Beneficiaries 
4.2.1 Overall Satisfaction with the Demonstration 
Many of the 2017 RTI focus group participants expressed satisfaction with One Care. 
Although some participants noted quality or access issues, they often characterized the 
demonstration overall as being better than the care they previously received. One participant 
described it as “more seamless,” and another as “all-inclusive.” As one participant remarked, 
“Everything is coordinated…You have two plans and they’re all under one, and it makes it easier 
for your healthcare to be more managed. So that is what I like most about it.”  
Several participants in one group described their experience with One Care as “more 
humane.” As one of the participants explained: 
They identify your needs better, instead of doing their job just for the money 
without actually caring how you feel…Also, the insurance benefits. In my case, 
they give me transportation, counseling. They come to my house from time to 
time to see what I need.  
Another participant rated experience in One Care as a “9 out of 10” because: 
I don’t have to spend hours and hours in stressful communications …Suffice it to 
say, [before One Care] it was nothing but runarounds, and nobody home and 
nobody called you back, etc. etc. When you are fine, it is difficult to play the 
runaround game, let alone when you are sick. I am very happy I don’t have to 
play the runaround game.  
Several participants across the RTI focus groups favorably mentioned the ability to call a 
single number when they needed help or assistance instead of “calling this person and calling 
that person.” Some of the factors contributing to satisfaction were consistent with those 
mentioned by RTI focus group participants in prior years.38 These included the elimination of 
co-payments on medications, the availability of new benefits, and the assistance provided 
through care coordination. 
                                                 
38 Findings from RTI focus groups conducted in 2015 and 2016 are described in the first Annual Report and the 
second Evaluation Report, respectively. 
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One Care stakeholders, including representatives from the Implementation Council and 
the One Care Ombudsman program, also provided positive feedback about beneficiary 
experience. As one stakeholder noted:  
I am convinced more than ever that the One Care design is working really, really 
well for a lot of people with complex healthcare needs. We hear time and time 
again how the flexibility and additional services make it a much better quality of 
life for a lot of people. 
As indicated in Table 7 below, most 2017 CAHPS survey respondents reported a high 
degree of satisfaction with their health and drug plans. When asked to provide an overall rating 
(on a scale of 0 to 10 with 10 being the best) of their One Care plan, most survey respondents 
ranked it as a 9 or 10. Most survey respondents reported that they “usually” or “always” received 
the information they needed from their One Care plan. Rates of beneficiary satisfaction across 
these measures for both MMPs are higher in 2017 than the first two demonstration years. As 
representatives from MassHealth, CMS and the MMPs noted, the CAHPS results generally show 
high satisfaction; One Care plans overall performed at or above the national distribution for 
Medicare Advantage and MMP contracts each year for all measures of beneficiary satisfaction 
considered.  
Of note, MassHealth conducted a survey in 2016 of beneficiaries who had been enrolled 
with Fallon, the MMP that withdrew from the demonstration in late 2015; the survey included 
beneficiaries who had either transitioned to a new One Care plan or back to FFS. Findings from 
this survey were made available in 2017.39 Participants were asked about their experiences with 
the transition, to compare their experiences and perceptions of care received while enrolled in 
Fallon to their new care. Although overall satisfaction with care was generally high for 
respondents moving back to the FFS system (66 percent) or to another MMP (69 percent), 
respondents who transitioned back to the FFS system were significantly more likely to rate their 
experience with the FFS system as worse compared to their experience with Fallon in meeting 
their needs for medications, dental care, and personal care services. In a number of other areas, 
there were no notable differences. As one MassHealth official noted:  
[We were hoping] we would get a really clear picture [from the survey results] of 
not just the FFS to One Care but the One Care to FFS experience, when people at 
least knew what they were comparing One Care to or comparing FFS to. It wasn’t 
as clear as I expected it to be for most people. 
Feedback on enrollee satisfaction with One Care was also solicited during a town hall 
listening session hosted by the Implementation Council on December 8, 2017. Sixty-seven 
enrollees participated, either by phone or in person at one of four sites. In general, enrollees 
reported satisfaction with both One Care coverage and benefits, as well as with their care 
coordinator. Common themes voiced at the listening session were consistent with focus group 
findings and included lack of continuity with either their care coordinator or LTS Coordinator 
                                                 
39 Survey findings were presented to the Implementation Council at its July 25, 2017 meeting. The presentation can 
be accessed at: https://www.mass.gov/files/documents/2017/08/31/170725-fallon-transition-survey-report.pdf  
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due to high turnover, issues with utilizing transportation services, and lack of awareness of 
supports available through the interdisciplinary care team (ICT).40  
Table 7 
Beneficiary overall satisfaction, 2015–17 
CAHPS survey 
item Year 
National 
distribution—all 
MA contracts 
(%) 
National 
distribution—all 
MMP contracts 
(%) 
MA 
distribution—
MMP contracts 
(%) 
CCA 
(%) 
Tufts  
(%) 
Percent rating 
health plan 9 or 10 
on scale of 0 
0(worst) to 10 
(best)  
2015 62 
(n=148,335) 
51 
(n=5,141) 
— 70 
(n=324) 
62 
(n=189) 
2016 61 
(n=142,984) 
59 
(n=9,765) 
— 77 
(n=342) 
58 
(n=169) 
2017 64 
(n=188,484) 
63 
(n=14,662) 
73 
(n=544) 
75 
(n=328) 
64 
(n=221) 
Percent rating drug 
plan 9 or 10 on 
scale of 0 (worst) 
to 10 (best)  
2015 62 
(n=136,044) 
56 
(n=5042) 
— 76 
(n=324) 
62 
(n=185) 
2016 61 
(n=132,613) 
61 
(n=9,617) 
— 78 
(n=343) 
67 
(n=168) 
2017 63 
(n=172,033) 
64 
(n=14,087) 
77 
(n=514) 
78 
(n=301) 
70 
(n=218) 
Percent reporting 
that health plan 
“usually” or 
“always” gave 
them information 
they needed 
2015 80 
(n=45,457) 
73 
(n=2,058) 
— 83 
(n=162) 
86 
(n=90) 
2016 81 
(n=42,677) 
79 
(n=3,669) 
— 82 
(n=154) 
76 
(n=92) 
2017 87 
(n=84,304) 
86 
(n=8,234) 
89 
(n=317) 
90 
(n=176) 
89 
(n=143) 
MA = Medicare Advantage; MMP = Medicare-Medicaid Plan. 
NOTES: (—) Indicates data not available. Data for Fallon Total Care is not available after 2015 due to the MMP’s 
withdrawal from the demonstration; data for Fallon Total Care for 2015 were reported in prior Evaluation Reports.  
SOURCE: CAHPS data for 2015–17. 
4.2.2 New or Expanded Benefits 
A key design feature of One Care is that it offers new and expanded benefits to enrollees. 
As detailed in prior Evaluation Reports, these benefits include diversionary health services, 
expanded Medicaid services, and new community LTSS. Consistent with prior RTI focus 
groups, many participants across the different focus groups cited the elimination of pharmacy co-
pays as an important advantage of the demonstration. In the words of one focus group 
participant, “One of the biggest things [about One Care] is not worrying about having to skip a 
prescription because I don’t have the copay to pay for it.”  
                                                 
40 The full summary of the December 8 Listening Session can be accessed at: 
https://www.mass.gov/files/documents/2018/02/02/Implementation%20Council%20December%208%202017%
20Listening%20Session%20Final%20Report.pdf  
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Many of the RTI focus group participants provided specific examples of new or 
expanded benefits they received under One Care. Examples included dental services, eyeglasses 
and contact lenses, acupuncture, nutrition classes, grab bars, homemaker services, transportation 
for grocery shopping, peer supports, and in-home behavioral health services. Although a few 
participants mentioned getting gym memberships, others reported being told by their plan that 
gym memberships were not a covered benefit. Overall, participants’ knowledge of available 
benefits under One Care varied; some participants were aware of the benefits offered through 
One Care, although others expressed surprise at hearing about these benefits from other focus 
group participants.  
A few participants noted that the availability of these services was important even if they 
did not need them: 
[I like] having as much independence as I can and depending on people to help 
me with things when it’s necessary. And when it’s not, I want to try to at least do 
some of it myself. But knowing I have [the services], it’s just a good thing. 
4.2.3 Medical and Specialty Services  
A combined set of Medicare and Medicaid benefits is offered as part of a single benefit 
package under the demonstration. Benefits include coordination by the One Care plans of all 
medical services, including primary care, behavioral health, specialty care, and prescription 
medications. Most RTI focus group participants expressed general satisfaction with their 
providers. Participants reported that being able to keep their doctor was an important 
consideration when choosing to participate in the demonstration.  
Some participants were dissatisfied with frequent turnover in some types of providers, 
particularly among primary care physicians and behavioral health counselors: 
My therapist, I lost her not long ago because she moved on to bigger and 
better…as far as PCPs [primary care physicians] are concerned, ha. I’ve had more 
PCPs than you can shake a stick at.  
A few participants commented negatively on being given “interim” providers who they 
saw only for a few months; one participant attributed this to clinics that were associated with 
teaching hospitals.  
Feedback was mixed from focus group participants on whether their providers worked as 
a team and communicated well with each other. Some participants described the team as being 
comprised of their primary care physician and specialists; some included their care coordinator 
when describing their team and others did not. A few focus group participants did not believe 
there was communication between their providers or did not feel there was a team approach. One 
participant reported not wanting communication between the care coordinator and other 
providers.  
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4.2.4 Care Coordination Services  
Care coordination is a central component of the One Care demonstration intended to 
ensure comprehensive assessment of enrollees’ medical, behavioral health, and LTSS needs, and 
to coordinate services across the various service systems and providers. By design, One Care 
enrollees may have multiple people coordinating their care. As discussed in Section 3.3, Care 
Coordination, plans have implemented different models of delivery for care coordination. As 
part of the design of One Care, enrollees are also offered an LTS Coordinator who is 
independent of the plans to coordinate LTSS needs. 
Almost all participants across the RTI focus groups identified a person (or persons) 
responsible for coordinating their care, although it was not always clear if that individual was a 
care coordinator at the MMP, an individual conducting assessments, an LTS Coordinator, or a 
social worker or other person affiliated with a provider agency or organization. Only a few 
participants reported not having a care coordinator or not knowing they had a person to call who 
could help them. Several participants could identify their care coordinator by name. Most 
participants spoke favorably about the person helping them or the care coordination services they 
were receiving. Common themes related to satisfaction with care coordination services included 
the ability to access new services, having a place to get information, facilitating easier access to 
services, and reduced stress. Some examples of feedback included: 
When I had MassHealth, I always had to call about everything even if it meant 
that I had to be on the phone one hour dealing with that machine, waiting for 
someone to answer. Now I have the option to call [my care coordinator] to make 
any inquiries and it doesn’t take that long either. 
It’s like a personal relationship that you create with them. At least mine. Not all 
the time, but most of the time, she is paying attention to when I have an 
appointment and she tries to be there for my appointments. 
[Care coordination services] have taken a lot of stress away. You don’t have to 
really think about things now because they are telling you what is available and 
what your needs are is in there…I like the ability to call up the coordinator and 
just have it done. 
A few participants reported that their care coordinator also assisted them with housing 
needs, although the reported level of assistance varied. For example, one participant reported 
being given a list of phone numbers to call, whereas another participant’s care coordinator 
provided all the paperwork to the individual and helped with filling out the forms.  
Some focus group participants, however, reported negative experiences with their care 
coordination services, usually citing a lack of responsiveness or competence of their care 
coordinator. The following are some examples of participant feedback: 
I have problems with case managers… the reason I picked the plan was because 
they said I would have a medical coordinator or case manager. A case manager 
was assigned to me to make sure everything went smoothly for all my behavioral 
health and [medical care] …and she didn’t follow through. So, I look up one day, 
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she was gone...they assign me another one. She was supposed to come out. She 
never showed. She was just too busy. 
[My care coordinator] doesn’t know anything, even to the smallest issue. 
A number of participants across the RTI focus groups reported that their care coordinator 
had changed several times since enrolling in One Care; a few commented that their care 
coordinator was overworked and responsible for too many people, and that this resulted in a lack 
of personalized service.41 
4.2.5 Quality and Access to Care  
Most participants, though not all, reported that they did not need to switch providers 
when they joined One Care. A few participants mentioned having to change their primary care 
practitioner or a specialist. As in prior years, participants reported that their decision to enroll in 
the demonstration was influenced by whether particular providers were participating in One 
Care. As one participant noted: 
It’s not easy starting with a new psychologist after you’ve known yours for so 
long, a psychiatrist who already knows what you’re like…To start over again? No 
way. 
Many participants reported satisfaction with their ability to access care since enrolling in 
the demonstration and reported access to services and providers had improved:  
They have gotten me a walker. They have gotten me diabetic sneakers. They’ve 
gotten me a bed. They have gotten me so much stuff that I have never had before. 
And it was a struggle to have MassHealth or Medicare before [One Care] entered 
my life. All I have to do is just ask, and when you ask, they go through the 
procedures they have to go through and come back later and say, “Okay, you’re 
approved.” 
Some participants reported favorably on their ability to access some services from their 
home; this included in-home medical and behavioral health services as well as being able to have 
prescription medications mailed to their homes. Some reported access to medical and specialist 
care was the same since enrolling in One Care; others reported it had improved. Participants 
reported wait times for some providers, especially for behavioral health services. Several 
participants felt that dental services were limited, both in terms of provider availability and 
coverage. 
Similar to prior years, a number of focus group participants reported issues and 
complaints about non-emergency transportation; lack of this service impeded access to 
appointments and other needed services. Issues included no-shows and wait times. Some 
participants reported they no longer used the transportation services because of quality issues; 
one participant reported being provided a bus pass because of the poor quality of the other 
                                                 
41 Care coordinator staffing ratios and turnover rates are reported in Section 3.3, Care Coordination. 
 40 
transportation services. A few participants noted that requiring transportation to be scheduled at 
least 48 hours in advance created barriers for the scheduling of some appointments. 
A few participants mentioned service delays of up to several months in getting in-home 
equipment such as hand rails and grab bars due to the number of authorizations required. Other 
participants reported being offered homemaker services, in some cases more than once, but those 
services were never provided. Several participants across the RTI focus groups reported 
receiving bills in error for health care services, including ambulance services, primary care 
physician visits, and behavioral health services. In most cases, participants were working with 
their care coordinators or with the provider directly to resolve the situation. 
Participants offered several suggestions for improving One Care: covering additional 
medications such as lidocaine patches; improving supervision over homemaker services; 
improving information to beneficiaries about benefits covered by One Care; increasing the 
number of care coordination staff; increasing the variety of vendors for homemaker and laundry 
services; maintaining updated provider directories; and offering more comprehensive dental 
services. One participant expressed interest in having more choices for community mental health 
residential placements as an alternative to inpatient hospitalization. 
4.2.6 Personal Health Outcomes and Quality of Life  
A key goal of One Care is to positively impact health outcomes and quality of life for 
beneficiaries. Generally, most RTI focus group participants reported that the demonstration had 
positively impacted their lives. Many of the participants attributed this to the services they 
received as well as the care coordination services that reduced stress. One participant reported an 
improved quality of life both because of receiving dental services (“I’m smiling [now]”) but also 
because One Care overall had promoted a change in attitude: 
I’ve changed my thought process about my health… Just that now I’m concerned 
about my health. At the end of the day, I smile because I’m in good health. 
Some participants reported that their health had deteriorated since enrolling with One 
Care, but very few attributed this to the demonstration. One participant commented that even 
though his heath was worse, “if I had been under some other plan, it would have been an 
absolute disaster.” The few participants who reported a worsening quality of life or deteriorated 
health condition due to One Care generally attributed that to the quality of provider services or 
specific access issues they had experienced.  
Some of the RTI focus group participants also reported that One Care had allowed them 
to engage, or re-engage, in life activities or hobbies they enjoyed. In some cases, participants 
attributed improved quality of life and well-being to receiving appropriate behavioral health 
services. Participants provided other examples of improvements in quality of life, including 
greater independence, being listened to instead of being ignored, and getting help they needed 
even when they had not previously realized they needed help. One participant reported: 
I am now looking for a job again… [Before One Care] I was virtually depending 
on government funds and the like. And now, thanks to the insurance that covered 
all these benefits, I can look for a job. 
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4.2.7 Experience of Special Populations 
This section summarizes the beneficiary experience for One Care special populations, 
including individuals with LTSS or behavioral health needs, and racial/ethnic or linguistic 
minorities. Because of the population served by One Care, many of the experiences of RTI focus 
group participants with behavioral health or LTSS needs are described as part of beneficiary 
experiences reported above and are not repeated here. 
Although many focus group participants did not report feeling that they were being 
treated differently based on race or ethnicity, a few participants reported feeling that they were 
treated disrespectfully because of their race or that they did not always receive the care or 
referrals they needed. As one participant remarked: 
[I felt] hostility…and racism against Latinos. Because she was very, very rude to 
me. She wanted me to do things I couldn’t do. And she tried to harass me. That’s 
how I felt. But what I sensed in her was contempt against Latinos, and I felt very 
bad about that.  
Spanish-speaking participants reported that language needs were an important aspect of 
receiving health care. Most participants who were Spanish-speaking reported having providers 
who spoke Spanish or being provided interpreter services. Participants generally reported 
receiving handbooks and other information from their plans in Spanish. A few participants 
reported problems with communication because of language barriers or disabilities such as 
hearing impairment.  
4.2.8 Beneficiary Protections  
The One Care demonstration was designed to “ensure that strong protections of enrollee 
health, safety, and access to high quality health and supportive services are in place” 
(Commonwealth Proposal, February 16, 2012, p. 23). Protections include, but are not limited to, 
complaint and appeals processes that provide an avenue for beneficiaries to seek redress when 
they have issues or disagree with decisions made by One Care plans or providers, and the 
availability of an Ombudsman Program to advocate for the beneficiary. Enrollees have the right 
to file a grievance, also known as a complaint, directly with their One Care MMP, MassHealth, 
Medicare or the One Care Ombudsman (OCO). Enrollees are also able to appeal decisions made 
by a One Care plan to deny, limit, terminate, or suspend a service or procedure through an 
appeals process developed by CMS and MassHealth.42  
Plans are required to record all grievances and track related actions and resolutions, 
which are then reported to MassHealth and CMS on a monthly basis. The OCO is similarly 
required to maintain a documentation and tracking system for grievances and appeals, and 
reports these to MassHealth on a quarterly basis.43 Beginning in September 2017, MassHealth 
expanded the detail with which plans reported complaints about service authorizations and 
                                                 
42 The processes under One Care for filing a grievance and appeal are described in the first Annual Report and the 
second Evaluation Report. 
43 Grievance and appeals reporting processes under MMPs and the OCO are described in the first Annual Report 
and the second Evaluation Report.  
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denials to include the following subcategories: behavioral health, durable medical equipment, 
home health, LTSS (broken down by a variety of subcategories, including, for example, Personal 
Care Attendant (PCA) homemaker heavy chore service, PCA companion services, and home 
delivered meals), dental (with additional subcategories), transportation, and other. MassHealth 
reported that this breakdown allows for more detail in reporting service denials.  
The OCO reported that approximately two-thirds of its caseload consists of assisting 
individuals with behavioral health needs. The OCO has been able to resolve the majority of cases 
brought forward in favor of the beneficiary. The OCO maintained a 90-95 percent approval 
rating from beneficiaries who utilized ombudsman services throughout 2017, according to the 
OCO Consumer Satisfaction Survey. Overall, participants in the RTI focus groups appeared to 
better recognize the OCO than in prior years. A number of focus group participants expressed 
some level of familiarity with the OCO, either with its name or its role; several participants 
reported having the OCO’s magnet on their refrigerators. One participant reported successfully 
contacting the OCO about issues with transportation services.  
Following is a summary of grievance (complaint) and appeals data received from (1) data 
reported by MMPs on complaints made directly to them;44 (2) data reported on the CTM for 
complaints received by MassHealth and 1-800-Medicare;45 (3) qualitative information received 
from key informant interviews;46 (4) data reported by the Independent Review Entity (IRE), 
which is a second-level review of appeals;47 and (5) qualitative information collected by the 
evaluation team. Reporting periods vary across these sources.  
In the first 2 years of the demonstration (Quarter 4 2013 through 201448, and 2015), the 
number of grievances per 1,000 enrollees reported by MMPs displayed a general upward trend, 
reaching a high of 77 in the last quarter of 2015. In 2016 the number of grievances per 1,000 
enrollees began declining and declined in each quarter. This measure fluctuated in 2017, with an 
increase in the first quarter of 2017 compared to the fourth quarter of 2016, followed by declines 
in the second and third quarters of 2017 and an increase to 35 in the fourth quarter of 2017.49 The 
number of complaints reported to 1-800-Medicare decreased from the fourth quarter of 2013 
through 2014 (demonstration year 1) (68) to 2016 (31), with a slight increase in the number of 
complaints from 2016 to 2017 (33).50 In 2017, the highest proportion of complaints were related 
to enrollment and disenrollment issues and benefits, access and quality of care. Compared with 
                                                 
44 MMP Reported Data provided to RTI by CMS. 
45 Data obtained from the Complaint Tracking Module (CTM) within HPMS by RTI.  
46 Information obtained by RTI during site visits. 
47 Data provided to RTI by CMS. 
48 Demonstration year 1 includes Quarter 4, 2013, and calendar year 2014. All demonstration years after 
demonstration year 1 are full calendar years. E.g., demonstration year 2 is calendar year 2015. 
49 Source: RTI analysis of MMP reported data for Core Measure 4.2, as of March 2018. The technical 
specifications for this measure are in the Medicare-Medicaid Capitated Financial Alignment Model Core 
Reporting Requirements document, which is available at: https://www.cms.gov/Medicare-Medicaid-
Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/FinancialModelstoSupportStatesEffortsinCareCoordination.html. 
50 Demonstration year 1 (October 2013–December 2014), demonstration year 2 (January 2015–December 2015) 
demonstration year 3 (January 2016–December 2016), demonstration year 4 (January 2017–December 2017). 
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prior years, a higher proportion of complaints were related to improper, insufficient or delayed 
claims payment in 2017.  
The OCO reported that the volume of calls the ombudsman received in 2017 is consistent 
with previous years; however, the ratio of complaints to inquiries has changed, with an increased 
number of complaints over inquiries at this point in the demonstration. The majority of 
complaints received by the ombudsman concerned accessing benefits, particularly dental 
services. The OCO also noted that in 2017 there was an uptick in complaints regarding the length 
of time involving redeterminations and reauthorizations, as well as increased beneficiary 
confusion around the various members of the ICT, especially the LTS Coordinator. Although the 
OCO is unsure of the exact causes of the increased complaints, a representative from the OCO 
indicated there is a need for greater provider and beneficiary education around the benefits of 
One Care and the role of members of the ICT.  
There has been no clear trend in the number of appeals per 1,000 enrollees over the first 
four years of the demonstration although on average appeals from year to year increased. The 
highest number of appeals per 1,000 enrollees was in the second quarter of 2016 (9.7) with the 
lowest in the first quarter of 2015 (2.1). Although the absolute number of appeals consistently 
increased over the course of the demonstration (from 24 in the first quarter of 2014 to a high of 
168 in the fourth quarter of 2017), the numbers of appeals in all quarters and years still reflect 
less than 1 percent of the total number of enrollees. Over the course of the demonstration, a 
higher proportion of appeals resulted in a fully favorable outcome for the beneficiary, increasing 
from 20.8 percent in the first quarter of 2014 to between 55 percent and 60 percent in each 
quarter of 201751; the portion of adverse outcomes decreased from 70.8 percent in the first 
quarter of 2014 to between 30 percent and 36 percent in each quarter of 2017. The number of 
appeals referred to the IRE ranged over the course of the demonstration, initially increasing from 
25 in 2014 to 55 in 2015, decreasing to 40 in 2016, and increasing again to 56 in 2017. In 2016 
and 2017, a majority of appeals (65 percent and 80 percent, respectively) were upheld. In 2016, 
the highest percentage of appeals were over turned in favor of beneficiaries; of the 40 appeals 
received, one-quarter were overturned. Of the 96 appeals to the IRE in 2016 and 2017 combined, 
the most common categories of appeals were related to practitioner services (33), durable 
medical equipment (17), and acute inpatient hospital services (13).  
MassHealth reported that trends in grievances and appeals are consistent with trends from 
previous years, in both volume and type. MassHealth reported that enrollment and disenrollment 
complaints typically are due to improper loss of eligibility after redetermination. MassHealth and 
the OCO reported that the majority of grievances and appeals filed primarily concern denials for 
dental services that are not covered or the quality of transportation services. CMS officials 
reported that there is not a clear picture of the exact causes contributing to the increased 
complaints concerning dental services, but that “[s]peaking very broadly, communication issues 
                                                 
51 Source: RTI analysis of MMP reported data for Core Measure 4.2, as of March 2018. The technical 
specifications for this measure are in the Medicare-Medicaid Capitated Financial Alignment Model Core 
Reporting Requirements document, which is available at: https://www.cms.gov/Medicare-Medicaid-
Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/FinancialModelstoSupportStatesEffortsinCareCoordination.html. 
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[about the scope of the dental benefit] are probably the overriding thing. I don’t think there’s any 
malfeasance where the plans are just closing the door on access to care, per se.”  
MassHealth and the OCO noted a need for provider education around plan processes and 
covered services, as some grievances and appeals are due to a lack of provider knowledge, which 
has resulted in incorrect denials of services. As one MassHealth official reported: 
[T]he member is seeing an out-of-network [provider] that is not used to the One 
Care plan’s authorization and billing processes. So instead of the dental providers 
outreaching the plans directly, they tell the member that they’ve been denied. The 
member calls the plan saying why has it been denied, so it’s more of a provider 
issue.  
Massachusetts requires MMPs to report on the number of critical incident and abuse 
reports received among members receiving LTSS.52 The number of reports received per 1,000 
members receiving LTSS remains low; however, the number appeared to be trending upward in 
2016 and 2017. The highest number of reports per 1,000 members receiving LTSS occurred in 
Quarter three of 2017 and Quarter four of 2017, 3.8 and 4.9 respectively. In the prior year, this 
number did not exceed 2.0 reports per 1,000 members.53  
                                                 
52 Critical incident refers to any actual or alleged event or situation that creates a significant risk of substantial or 
serious harm to the physical or mental health, safety or well-being of a member. Abuse refers to: Willful use of 
offensive, abusive, or demeaning language by a caretaker that causes mental anguish; Knowing, reckless, or 
intentional acts or failures to act which cause injury or death to an individual or which places that individual at 
risk of injury or death; Rape or sexual assault; Corporal punishment or striking of an individual; Unauthorized 
use or the use of excessive force in the placement of bodily restraints on an individual; and Use of bodily or 
chemical restraints on an individual which is not in compliance with federal or state laws and administrative 
regulations. 
53 Source: RTI analysis of MMP reported data for State-specific measure MA 2.1, as of March 2018. The technical 
specifications for this measure are available at: https://www.cms.gov/Medicare-Medicaid-
Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/FinancialModelstoSupportStatesEffortsinCareCoordination.html  
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5. Service Utilization  
The purpose of the analyses in this section is to understand the effects of the 
Massachusetts One Care demonstration through demonstration year 3 (ending calendar year 
2016) on all demonstration eligible beneficiaries, not just enrollees, using difference-in-
differences regression analyses. In addition, descriptive statistics on service utilization are 
provided for selected Medicare services in Appendix C. Utilization data were analyzed for only 
two of the three MMPs in One Care; Fallon Total Care encounters were not included or analyzed 
because Fallon exited the demonstration before the end of 2015, and therefore it was difficult to 
assess encounter completeness. 
Table 8 presents an overview of the cumulative results from analyses using Medicare and 
Minimum Data Set (MDS) data through demonstration year 3. The relative direction of all 
statistically significant results at the p < 0.10 significance level (derived from 90 percent 
confidence intervals) is shown.  
Table 8 
Summary of Massachusetts cumulative demonstration impact estimates for demonstration 
period (October 1, 2013–December 31, 2016) 
(p < 0.1 significance level) 
Measure 
All demonstration 
eligible beneficiaries 
Demonstration 
eligible beneficiaries 
with LTSS use 
Demonstration 
eligible beneficiaries 
with SPMI 
Inpatient admissions Increased NS NS 
Probability of ambulatory care sensitive 
condition (ACSC) admissions, overall 
Increased NS Increased 
Probability of ACSC admissions, chronic Increased Increased Increased 
All-cause 30-day readmissions Increased Increased Increased 
Emergency room (ER) visits NS NS NS 
Preventable ER visits NS NS NS 
30-day follow-up after mental health 
discharges 
NS N/A NS 
Probability of skilled nursing facility (SNF) 
admission 
NS Increased NS 
Probability of any long-stay nursing facility 
(NF) use 
Decreased N/A N/A 
Physician evaluation and management 
(E&M) visits 
NS NS NS 
LTSS = long-term services and supports; N/A = not applicable; NS = not statistically significant; SPMI = severe and 
persistent mental illness. 
SOURCE: RTI analysis of Medicare and Minimum Data Set data. 
The Massachusetts demonstration had a statistically significant cumulative effect on five 
utilization outcomes through demonstration year 3: monthly inpatient admissions, the probability 
of overall and chronic ambulatory care sensitive condition (ACSC) admissions, and all-cause 30-
day readmissions were higher for the demonstration group relative to the comparison group, 
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whereas the probability of any long-stay nursing facility (NF) use was lower. There was no 
statistically significant difference between the demonstration and comparison groups in monthly 
emergency room (ER) visits, preventable ER visits, monthly physician evaluation and 
management (E&M) visits, and the probability of skilled nursing facility (SNF) admissions. 
For most outcome measures, the relative direction of the impact estimates for the 
population receiving long-term supports and services (LTSS) and for those with severe and 
persistent mental illness (SPMI) were similar to the findings for the overall demonstration 
eligible population. One exception was in the LTSS population for which differences in monthly 
inpatient admissions and the probability of ACSC admissions (overall) were not statistically 
significant, while the probability of SNF admission was higher for the demonstration group 
relative to the comparison group. Likewise, for the SPMI population, there was not a statistically 
significant difference in monthly inpatient admissions between the demonstration and 
comparison groups. 
Table 9 summarizes annual impact estimates for all demonstration eligible beneficiaries. 
The undesirable impacts on ACSC inpatient admissions were concentrated in demonstration 
years 1 and 2, suggesting that the demonstration was making progress by demonstration year 3 in 
reducing these types of inpatient admissions since the demonstration year 3 result was not 
statistically significant. The desirable impacts on long-stay NF use were concentrated in 
demonstration years 2 and 3.  
Table 9 
Massachusetts annual demonstration impact estimates for all demonstration eligible 
beneficiaries (October 1, 2013–December 31, 2016) 
(p < 0.1 significance level) 
Measure 
Demonstration 
year 1 
Demonstration 
year 2 
Demonstration 
year 3 
Inpatient admissions NS Increased NS 
Probability of ambulatory care sensitive 
condition (ACSC) admissions, overall 
Increased Increased NS 
Probability of ACSC admissions, chronic Increased Increased NS 
All-cause 30-day readmissions Increased Increased Increased 
Emergency room (ER) visits NS NS NS 
Preventable ER visits NS NS NS 
30-day follow-up after mental health discharges NS Decreased NS 
Probability of skilled nursing facility (SNF) 
admission 
NS NS NS 
Probability of any long-stay nursing facility 
(NF) use 
NS Decreased Decreased 
Physician evaluation and management (E&M) 
visits 
Increased NS NS 
NS = not statistically significant. 
SOURCE: RTI analysis of Medicare and Minimum Data Set data. 
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5.1 Overview of Benefits and Services  
Under One Care, eligible beneficiaries enroll in a One Care plan that covers Medicare 
and Medicaid services, as well as new or expanded services available under the demonstration. 
Generally, these new services include a set of diversionary behavioral health services that have 
been available to Medicaid-only beneficiaries enrolled in managed care but have not otherwise 
been a covered service for Medicare-Medicaid beneficiaries in Massachusetts; services expanded 
in amount, duration, or scope over Medicaid State Plan services; and new community-based 
services. Targeted case management services and rehabilitation option services are not included 
as part of the integrated One Care benefit, but they continue to be provided as part of the 
Medicaid fee-for-service (FFS) system. As in Medicare Advantage, Medicare hospice services 
continue to be provided as part of the Medicare FFS system. 
5.2 Impact Analyses on the Demonstration Eligible Population  
The population analyzed in this section includes all beneficiaries who met demonstration 
eligibility criteria in Massachusetts or in the comparison areas for Massachusetts. For context, in 
Massachusetts, approximately 14 percent of eligible beneficiaries in demonstration year 3 whose 
utilization was analyzed were enrolled in One Care. Appendix A provides a description of the 
comparison group for Massachusetts. Please see Section 3.2 for details on demonstration 
eligibility. Subsections following this section present the results for demonstration eligible 
beneficiaries with any use of LTSS (defined as receipt of any institutional long-stay NF services 
because RTI did not have data in the demonstration period to identify correctly those with home 
and community-based services (HCBS) among the eligible but not enrolled population) and for 
demonstration eligible beneficiaries with SPMI. This report also presents results on traditionally 
Medicaid-reimbursed services such as HCBS and behavioral health services for One Care 
enrollees. 
Appendix B contains a description of the evaluation design, the comparison group 
identification methodology, data used, measure definitions, and regression methodology used in 
estimating demonstration impacts using a difference-in-differences approach. The regression 
methodology accounts for differences between the demonstration and comparison groups over 
the predemonstration period (October 1, 2011 to September 30, 2013) and the demonstration 
period (October 1, 2013–December 31, 2016) to provide estimates of demonstration impact.  
Regression results for all demonstration eligible beneficiaries over the entire 
demonstration period show at the 90 percent confidence interval (CI) that the Massachusetts 
demonstration increased inpatient admissions, all-cause 30-day readmissions, and the probability 
of chronic and overall ACSC admissions, while reducing the probability of any long-stay NF 
use. The statistical significance of these changes varied by demonstration year.  
Figures 1 and 2 display the Massachusetts demonstration’s effect on key service 
utilization measures for the demonstration group relative to the comparison group through 
demonstration year 3. The demonstration increased monthly inpatient admissions by 0.0015 
admissions per month (90 percent CI: 0.0005, 0.0025). The demonstration also resulted in a 0.47 
percentage point decrease (90 percent CI: –0.60, –0.34) in the probability of any long-stay NF 
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use over each demonstration year. There was no statistically significant demonstration effect on 
ER visits, physician E&M visits, or the probability of SNF admission. 
Figure 1 
Demonstration effects on service utilization for eligible beneficiaries in Massachusetts—
Difference-in-differences regression results for the demonstration period, 
October 1, 2013–December 31, 2016 
(90 and 80 percent confidence intervals)  
  
 
  
E&M = evaluation and management; ER = emergency room; SNF = skilled nursing facility.  
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent intervals are represented by the top bar 
(black), and the 80 percent intervals are represented by the bottom bar (green). 
SOURCE: RTI International analysis of Medicare data. 
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Tables 10 and 11 present the demonstration’s effects on service utilization relative to the 
predemonstration period for each of the demonstration years. Each number in Table 10 presents 
the monthly change in the measure during each demonstration year reported, whereas the 
numbers reported in Table 11 present the yearly change in the measure during each 
demonstration year reported. There was an increase in inpatient admissions in demonstration 
year 2 by 0.0026 admissions per month for the demonstration group relative to the comparison 
group (p = 0.0014). Physician E&M visits increased by 0.0696 visits per month for the 
demonstration group in year 1 relative to the comparison group (p =0.0001). The probability of 
any long-stay NF use decreased for the demonstration group relative to the comparison group in 
demonstration years 2 and 3, with percentage point decreases of 0.47 (p < 0.0001) in year 2 and 
0.76 (p < 0.0001) in year 3. This measure is defined as the number of individuals who stayed in a 
NF for 101 days or more, who were long-stay after the first month of demonstration eligibility, 
and includes both new admissions from the community and those with a continuation of a stay in 
a NF. There were no statistically significant effects of the demonstration on ER visits or the 
probability of SNF admission in any of the three demonstration years. 
  
Figure 2 
Demonstration effects on long-stay nursing facility use for eligible beneficiaries in 
Massachusetts—Difference-in-differences regression results for the demonstration period, 
October 1, 2013–December 31, 2016 
(90 and 80 percent confidence intervals) 
 
NF = nursing facility.  
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent interval is represented by the top bar 
(black), and the 80 percent interval is represented by the bottom bar (green). 
SOURCE: RTI International analysis of Minimum Data Set data. 
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Table 10 
Annual demonstration effects on service utilization for eligible beneficiaries in 
Massachusetts 
(* indicates significant at p < 0.20, ** indicates significant at p < 0.10) 
Utilization measure (per 
month) 
Demonstration year 1  
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Demonstration year 3 
(1/16–12/16) 
Inpatient admissions 0.0005 0.0026** 0.0015* 
ER visits  −0.0016 0.0003 0.0015 
Physician E&M visits 0.0696** 0.0094 0.0150 
Probability of SNF admission 0.0001 0.0003* −0.0001 
E&M = evaluation and management; ER = emergency room; SNF = skilled nursing facility. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based on 80 
percent confidence intervals are provided here for comparison purposes only.  
SOURCE: RTI International analysis of Medicare data. 
Table 11 
Annual demonstration effects on probability of long-stay nursing facility use for eligible 
beneficiaries in Massachusetts 
(* indicates significant at p < 0.20, ** indicates significant at p < 0.10) 
Utilization measure  
(per demonstration year) 
Demonstration year 1  
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Demonstration year 3 
(1/16–12/16) 
Probability of any long-stay 
NF use  
−0.0012* −0.0047** −0.0076** 
NF = nursing facility. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based on 80 
percent confidence intervals are provided here for comparison purposes only. 
SOURCE: RTI International analysis of Minimum Data Set data. 
Table 12 provides estimates of the regression-adjusted mean values of the utilization 
measures for the demonstration and comparison groups for the predemonstration and 
demonstration periods for each service. The purpose of this table is to understand the magnitude 
of the difference-in-differences estimate relative to the adjusted mean outcome value in each 
period. The values in the third and fourth columns represent the post-regression, mean predicted 
value of the outcomes for each group in each period, based on the composition of a reference 
population (the comparison group in the demonstration period). These values show how different 
the two groups were in each period as well as the relative direction of any potential effect in each 
group over time. In addition to the graphic representation above, the difference-in-differences 
estimate is also provided for reference, along with the p-value, and the relative percent change of 
the difference-in-differences estimate compared to an average mean use rate for the comparison 
group over the entire demonstration period.  
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Table 12 
Adjusted means and impact estimate for eligible beneficiaries in the demonstration and comparison groups in Massachusetts 
through December 31, 2016 
Measure Group 
Adjusted mean for 
predemonstration 
period 
Adjusted mean for 
demonstration 
period 
Relative difference 
(%) 
Regression-adjusted 
difference-in-
differences (90% 
confidence interval) p-value 
Inpatient admissions Demonstration group 0.0415 0.0376 3.8 0.0015 
0.0005, 0.0025 
0.0113 
  Comparison group 0.0452 0.0393       
ER visits Demonstration group 0.0998 0.0947 NS 0.0000 
0.0027, 0.0027 
0.9797 
  Comparison group 0.1005 0.0953       
Physician E&M visits Demonstration group 0.9673 0.9918 NS 0.0325 
−0.0007, 0.0656 
0.1071 
  Comparison group 0.9678 0.9588       
Probability of SNF 
admission 
Demonstration group 0.0042 0.0034 NS 0.0001 
−0.0001, 0.0003 
0.5299 
  Comparison group 0.0061 0.0048       
Probability of any 
long-stay NF use 
Demonstration group 0.0258 0.0143 −12.2 −0.0047 
−0.006, −0.0033 
<0.0001 
  Comparison group 0.0515 0.0382       
E&M = evaluation and management; ER = emergency room; NF = nursing facility; NS = not statistically significant; SNF = skilled nursing facility. 
NOTE: Standard statistical practice is to use confidence intervals of 90 percent or higher.  
SOURCE: RTI International analysis of Medicare and Minimum Data Set data. 
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To interpret the adjusted mean values in the third and fourth columns, as an example, the 
adjusted mean of monthly inpatient admissions was lower for the demonstration group than for 
the comparison group in both the predemonstration period and demonstration period. Similarly, 
the adjusted mean of the probability of any long-stay NF use was also lower for the 
demonstration group than for the comparison group in both the predemonstration period and 
demonstration period. 
To help interpret the relative percentage difference reported in the fifth column, the 
difference-in-differences estimate for monthly inpatient admissions implies an annual relative 
percentage increase of 3.8 percent in inpatient admissions as a result of the demonstration. 
Regression results on RTI quality of care and care coordination measures for all 
demonstration eligible beneficiaries over the entire demonstration period show, at the 90 percent 
CI, that the Massachusetts demonstration increased all-cause 30-day readmissions as well as the 
probabilities of chronic and overall ACSC admissions. The increase in all-cause 30-day 
readmissions was statistically significant (p < 0.10) in each of the three demonstration years, 
while the increase in the probabilities of chronic and overall ACSC admissions was statistically 
significant (p < 0.10) in the first two demonstration years only.  
Figure 3 displays the Massachusetts demonstration’s effects on RTI quality of care and 
care coordination measures for the demonstration group relative to the comparison group through 
demonstration year 3. The Massachusetts demonstration increased the probability of monthly any 
ACSC admission for overall conditions (0.04 percentage points; 90 percent CI: 0.02, 0.07) and 
chronic conditions (0.05 percentage points; 90 percent CI: 0.03, 0.07). The Massachusetts 
demonstration also increased all-cause 30-day readmissions (0.0310 admissions for each 
demonstration year over the demonstration period; 90 percent CI: 0.0181, 0.0439). There was no 
statistically significant demonstration effect on preventable ER visits or the probability of any 
30-day follow-up after a mental health discharge over the demonstration period in whole. 
Figure 3 
Demonstration effects on RTI quality of care measures for eligible beneficiaries in 
Massachusetts—Difference-in-differences regression results for the demonstration period, 
October 1, 2013–December 31, 2016 
(90 and 80 percent confidence intervals)  
 
(continued) 
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Table 13 presents the demonstration’s effects on the RTI quality of care and care 
coordination measures for each demonstration year. The probability of ACSC admissions 
(overall) was significantly higher in the first two periods (0.08 percentage points, p < 0.0001 in 
demonstration year 1; and 0.03 percentage points p = 0.0959 in demonstration year 2). Likewise, 
the probability of ACSC admissions (chronic) was also significantly higher in the first two 
periods (0.09 percentage points, p < 0.0001 in demonstration year 1; and 0.03 percentage points 
Figure 3 (continued) 
Demonstration effects on RTI quality of care measures for eligible beneficiaries in 
Massachusetts—Difference-in-differences regression results for the demonstration period, 
October 1, 2013–December 31, 2016 
 
ACSC = ambulatory care sensitive condition; ER = emergency room. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent intervals are represented by the top bar 
(black), and the 80 percent intervals are represented by the bottom bar (green). 
SOURCE: RTI International analysis of Medicare data.  
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p = 0.0394 in demonstration year 2). There was a 3.67 percentage point decline in the quarterly 
probability of a 30-day follow-up visit after a mental health discharge in the demonstration 
group, relative to the comparison group, in demonstration year 2 only (p = 0.0598). The increase 
in all-cause 30-day readmissions for the demonstration group relative to the comparison group 
was statistically significant in all three demonstration years (0.0248 readmissions, p = 0.0223 in 
demonstration year 1; 0.0375 readmissions, p = 0.0017 in demonstration year 2; and 0.0315 
readmissions, p = 0.0010 in demonstration year 3). There was no statistically significant effect 
on preventable ER visits in any of the demonstration years. 
Table 13 
Annual demonstration effects on quality of care and care coordination for eligible 
beneficiaries in Massachusetts  
(* indicates significant at p < 0.20, ** indicates significant at p < 0.10) 
Quality of care and  
care coordination measures 
Demonstration year 1  
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Demonstration year 3 
(1/16–12/16) 
Preventable ER visits −0.0016* −0.0011 −0.0003 
Probability of ACSC admissions, overall  0.0008** 0.0003** 0.0002 
Probability ACSC admissions, chronic 0.0009** 0.0003** 0.0002 
Probability of a 30-day follow-up after a 
mental health discharge 
−0.0127 −0.0367** 0.0021 
All-cause 30-day readmissions 0.0248** 0.0375** 0.0315** 
ACSC = ambulatory care sensitive conditions; ER = emergency room. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based on 80 
percent confidence intervals are provided here for comparison purposes only.  
SOURCE: RTI International analysis of Medicare data. 
Table 14 provides estimates for the regression-adjusted mean value for each of the 
demonstration and comparison groups for the predemonstration and demonstration periods for 
the RTI quality of care and care coordination measures. The purpose of this table is to 
understand the magnitude of the difference-in-differences estimates for quality of care outcomes 
relative to the adjusted mean values in each period. The values in the third and fourth columns 
represent the post-regression, mean predicted value of the outcomes for each group in each 
period, based on the composition of a reference population (the comparison group in the 
demonstration period). These values show how different the two groups were in each period and 
the relative direction of any potential effect in each group over time. In addition to the graphic 
representation above, the difference-in-differences estimate is also provided for reference, along 
with the p-value and the relative percent change of the difference-in-differences estimate 
compared to an average mean use rate for the comparison group during the entire demonstration 
period.  
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Table 14 
Adjusted means and impact estimate for eligible beneficiaries in the demonstration and comparison groups for Massachusetts 
through demonstration year 3 
Measure Group 
Adjusted mean for 
predemonstration 
period 
Adjusted mean 
for demonstration 
period 
Relative 
differenc
e (%) 
Regression-adjusted 
difference-in-differences 
estimate  
(90% confidence 
interval) p-value 
Preventable ER visits  Demonstration group 0.0437 0.0423 NS −0.0010 
−0.0025, 0.0004 
0.2434 
  Comparison group 0.0452 0.0448       
Probability of ACSC admission, 
overall 
Demonstration group 0.0040 0.0039 10.8 0.0004 
0.0002, 0.0007 
0.0025 
  Comparison group 0.0047 0.0041       
Probability of ACSC admission, 
chronic 
Demonstration group 0.0028 0.0030 19.0 0.0005 
0.0003, 0.0007 
<0.0001 
  Comparison group 0.0031 0.0027       
Probability of a 30-day follow-
up after a mental health 
discharge 
Demonstration group 0.5538 0.5881 NS −0.0132 
−0.0377, 0.0112 
0.3733 
  Comparison group 0.4571 0.4957       
All−cause 30-day readmission  Demonstration group 0.3783 0.4488 7.3 0.0310 
0.0181, 0.0439 
<0.0001 
  Comparison group 0.3819 0.4221       
ACSC = ambulatory care sensitive conditions; ER = emergency room; NS = not statistically significant. 
NOTE: Standard statistical practice is to use confidence intervals of 90 percent or higher. 
SOURCE: RTI International analysis of Medicare data. 
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To interpret the adjusted mean values in the third and fourth columns, as an example, the 
adjusted mean of the probability of ACSC admissions (overall) was lower for the demonstration 
group than for the comparison group in both the predemonstration period and the demonstration 
period. Alternatively, the adjusted mean of the probability of ACSC admissions (chronic) was 
lower for the demonstration group than for the comparison group in the predemonstration period 
only and higher than that for the comparison group during the demonstration period.  
To help interpret the relative percentage difference reported in the fifth column, the 
difference-in-differences estimate for all-cause 30-day readmissions implies an annual relative 
percentage increase of 7.3 percent as a result of the demonstration; and the difference-in-
differences estimate for the probability of ACSC admissions implies an annual relative 
percentage increase of 10.8 percent (overall) and 19.0 percent (chronic) as a result of the 
demonstration. 
5.2.1 Descriptive Statistics on the Demonstration Eligible Population 
In addition to the findings presented for the demonstration eligible population in this 
section, Appendix C, Tables C-1 through C-3 present descriptive statistics for the demonstration 
eligible population for each service for the predemonstration and demonstration years to help 
understand the utilization experience over time. We examined 12 Medicare service utilization 
measures, seven RTI quality of care measures, and five nursing facility-related measures derived 
from the MDS. No testing was performed between groups or years. The results reflect the 
underlying experience of the two groups, and not the difference-in-differences estimates 
presented earlier. 
The demonstration and comparison groups were similar across many of the service 
utilization measures in each of the predemonstration (baseline) years and the demonstration years 
(Table C-1). There was no notable difference in institutional or non-institutional service 
utilization between the comparison and demonstration group across the baseline and 
demonstration period. Similarly, the demonstration group was similar to the comparison group 
on many, but not all, of the RTI quality of care and care coordination measures (Table C-2). Key 
differences included higher rates of all-cause 30-day readmission for the demonstration group. 
Finally, there are more differences between the demonstration group and comparison group in 
long-stay nursing facility utilization (Table C-3), including fewer new long-stay NF admissions 
and fewer long-stay NF users in the demonstration group. Demonstration eligible beneficiaries 
also had a lower percentage with severe cognitive impairment relative to the comparison group.  
5.2.2 Impact Analysis on Demonstration Eligible Beneficiaries with LTSS Use 
Demonstration eligible beneficiaries were defined as using LTSS in a demonstration year 
if they received any institutional services. Approximately 1.5 percent of all eligible beneficiaries 
in demonstration year 3 were LTSS users. As was true for the overall demonstration eligible 
population, demonstration eligible beneficiaries with LTSS use had higher all-cause 30-day 
readmissions and a higher probability of ACSC admissions (chronic only) relative to the 
comparison group. In contrast to all demonstration eligible beneficiaries, those with LTSS use 
had a higher probability of SNF admission. The demonstration had no overall impact on 
inpatient admissions, ER visits, preventable ER visits, physician E&M visits, or the probability 
of ACSC (overall) admissions for demonstration eligible beneficiaries with LTSS use. However, 
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in demonstration year 3, LTSS users in the demonstration group had higher inpatient admissions, 
ER visits, SNF admissions, preventable ER visits, all-cause 30-day readmissions, and probability 
of ACSC chronic admissions, relative to the comparison group.  
Figure 4 displays the demonstration’s effects on key service utilization measures among 
demonstration eligible beneficiaries who were LTSS users in the demonstration group relative to 
the comparison group through demonstration year 3. The demonstration led to an increase in the 
probability of SNF admission (0.54 percentage points, 90 percent confidence interval: 0.08, 1.01 
percentage points). There were no statistically significant effects on inpatient admissions, ER 
visits, or physician E&M visits among demonstration eligible beneficiaries with LTSS use. 
Figure 4 
Demonstration effects on service utilization for eligible beneficiaries with LTSS use in 
Massachusetts—Difference-in-differences regression results for the demonstration period, 
October 1, 2013–December 31, 2016 
(90 and 80 percent confidence internals)  
 
 
(continued) 
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Table 15 presents the demonstration effects on key service utilization measures for the 
demonstration eligible population with LTSS use for each demonstration year. Inpatient 
admissions were higher in demonstration year 2 (0.0172 admissions per month, p = 0.0335) and 
in year 3 (0.0243 admissions per month, p = 0.0037) relative to the comparison group. Likewise, 
the probability of SNF admission was also higher in demonstration year 2 (1.15 percentage 
points, p = 0.0037) and in year 3 (1.30 percentage points, p = 0.0364). An increase in ER visits 
was statistically significant in demonstration year 3 only (0.0153 visits per month, p = 0.0886). 
There was no statistically significant effect at the 0.10 significance level of the demonstration on 
physician E&M visits in any of the demonstration years. 
  
Figure 4 (continued) 
Demonstration effects on service utilization for eligible beneficiaries with LTSS use in 
Massachusetts—Difference-in-differences regression results for the demonstration period, 
October 1, 2013–December 31, 2016 
 
E&M = evaluation and management; ER = emergency room; SNF = skilled nursing facility.  
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent intervals are represented by the top bar 
(black), and the 80 percent intervals are represented by the bottom bar (green). Beneficiaries who first met LTSS 
criteria during the demonstration period were removed from the regression model to address analytic issues in 
estimating results. Results should be interpreted with caution as there may be important observable and 
unobservable factors specific to the LTSS population that are not included in the propensity score model and 
weights. 
SOURCE: RTI International analysis of Medicare data. 
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Table 15 
Annual demonstration effects on service utilization for eligible beneficiaries, 
Massachusetts LTSS users 
(* indicates significant at p < 0.20, ** indicates significant at p < 0.10) 
Utilization measure (per month) 
Demonstration year 1  
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Demonstration year 3 
(1/16–12/16) 
Inpatient admissions −0.0065 0.0172** 0.0243** 
ER visits  0.0002 0.0018 0.0153** 
Physician E&M visits 0.0954* 0.0844 0.0898 
Probability of SNF admission −0.0016 0.0115** 0.0130** 
E&M = evaluation and management; ER = emergency room; SNF = skilled nursing facility. 
NOTE: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based on 80 
percent confidence intervals are provided here for comparison purposes only. Beneficiaries who first met LTSS 
criteria during the demonstration period were removed from the regression model to address analytic issues in 
estimating results. Results should be interpreted with caution as there may be important observable and 
unobservable factors specific to the LTSS population that are not included in the propensity score model and 
weights. 
SOURCE: RTI International analysis of Medicare data. 
Figure 5 displays demonstration effects on RTI quality of care and care coordination 
measures for the demonstration eligible population who were LTSS users through demonstration 
year 3. The Massachusetts demonstration increased the probability of chronic ACSC admissions 
by 0.21 percentage points (90 percent CI: 0.08, 0.35). The demonstration also increased all-cause 
30-day readmission by 0.1354 admissions for each demonstration year over the demonstration 
period (90 percent CI: 0.0546, 0.2162). There was no demonstration effect on preventable ER 
visits or the probability of ACSC admissions (overall) among the demonstration eligible 
population with LTSS use.  
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Figure 5 
Demonstration effects on RTI quality of care and care coordination for eligible 
beneficiaries with LTSS use in Massachusetts—Difference-in-differences regression results 
for the demonstration period, October 1, 2013–December 31, 2016 
(90 and 80 percent confidence intervals)  
  
 
 
ACSC = ambulatory care sensitive conditions; ER = emergency room.  
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent intervals are represented by the top bar 
(black), and the 80 percent intervals are represented by the bottom bar (green). Beneficiaries who first met LTSS 
criteria during the demonstration period were removed from the regression model to address analytic issues in 
estimating results. Results should be interpreted with caution as there may be important observable and 
unobservable factors specific to the LTSS population that are not included in the propensity score model and 
weights. The quarterly probability of a 30-day follow-up visit after a mental health discharge was not estimated 
among the LTSS population due to small sample size. 
SOURCE: RTI International analysis of Medicare data. 
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Table 16 displays the demonstration effects on RTI quality of care and care coordination 
measures for the demonstration eligible population with LTSS use for each demonstration year. 
Preventable ER visits were significantly higher relative to the comparison group in 
demonstration year 3 (0.0073 visits, p = 0.0720). An increase in the probability of ACSC 
admissions (chronic) was statistically significant in demonstration year 1 (0.26 percentage 
points, p = 0.0103) and in demonstration year 3 (0.24 percentage points, p = 0.0156). Finally, all-
cause 30-day readmissions were higher relative to the comparison group in demonstration year 2 
(0.2080 readmissions, p = 0.0071) and in demonstration year 3 (0.2360 readmissions, p = 
0.0023). There was no statistically significant demonstration effect on the probability of ACSC 
admissions (overall) in any demonstration year among demonstration eligible beneficiaries with 
LTSS use. 
Table 16 
Annual demonstration effects on quality of care and care coordination for eligible 
beneficiaries with LTSS use in Massachusetts 
(* indicates significant at p < 0.20, ** indicates significant at p < 0.10) 
Quality of care and  
care coordination measures 
Demonstration year 1  
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Demonstration year 3 
(1/16–12/16) 
Preventable ER visits 0.0009 0.0015 0.0073** 
Probability of ACSC admissions, 
overall  
0.0007 0.0014 0.0007 
Probability ACSC admissions, 
chronic 
0.0026** 0.0011 0.0024** 
Probability of a 30-day follow-up 
after a mental health discharge 
— — — 
All-cause 30-day readmission 0.0529 0.2080** 0.2360** 
ACSC = ambulatory care sensitive conditions; ER = emergency room; — = not available. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based on 80 
percent confidence intervals are provided here for comparison purposes only. Beneficiaries who first met LTSS 
criteria during the demonstration period were removed from the regression model to address analytic issues in 
estimating results. Results should be interpreted with caution as there may be important observable and 
unobservable factors specific to the LTSS population that are not included in the propensity score model and 
weights. The quarterly probability of a 30-day follow-up visit after a mental health discharge was not estimated 
among the LTSS population due to small sample size. 
SOURCE: RTI International analysis of Medicare data. 
5.2.3 Impact Analyses on the Demonstration Eligible Population with SPMI  
Demonstration eligible beneficiaries were defined for the Financial Alignment Initiative 
(FAI) evaluation as having SPMI if there were any inpatient or outpatient mental health visits for 
schizophrenia or bipolar disorders in the last 2 years (see Appendix B, page 6 for additional 
information). Approximately 60 percent of all eligible beneficiaries had SPMI in demonstration 
year 3. As was true for the overall demonstration eligible population, demonstration eligible 
beneficiaries with SPMI had increased all-cause 30-day readmissions and probabilities of ACSC 
admissions (overall and chronic); however, there was no statistically significant demonstration 
impact on monthly inpatient admissions among eligible beneficiaries with SPMI. As among all 
 62 
demonstration eligible beneficiaries, the demonstration had no impact on ER visits, preventable 
ER visits, physician E&M visits, the probability of SNF admission, or the quarterly probability 
of a 30-day follow-up visit after a mental health discharge among demonstration eligible 
beneficiaries with SPMI. 
Figure 6 displays the demonstration’s effects on key service utilization measures for the 
demonstration eligible population with SPMI. There was no statistically significant impact on 
inpatient admissions, ER visits, physician E&M visits, or the probability of SNF admission 
among beneficiaries with SPMI. 
Figure 6 
Demonstration effects on service utilization for eligible beneficiaries with SPMI in 
Massachusetts—Difference-in-differences regression results for the demonstration period, 
October 1, 2013–December 31, 2016 
 
 
(continued) 
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Table 17 displays the demonstration effects on key service utilization measures among 
beneficiaries with SPMI for each demonstration year. Monthly physician E&M visits were 
significantly higher relative to the comparison group in demonstration year 1 only (0.0550 visits 
per month; p = 0.0286), and there was a statistically significant increase in inpatient admissions 
in demonstration year 2 (0.0025 admissions per month, p = 0.0461). There were no statistically 
significant effects of the demonstration on ER visits or on the probability of SNF admission 
among beneficiaries with SPMI in any of the three demonstration years. 
Table 17 
Annual demonstration effects on service utilization for eligible beneficiaries with SPMI in 
Massachusetts 
(* indicates significant at p < 0.20, ** indicates significant at p < 0.10) 
Utilization measure (per month) 
Demonstration year 1  
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Demonstration year 3 
(1/16–12/16) 
Inpatient admissions −0.0008 0.0025** 0.0004 
ER visits  −0.0020 −0.0016 0.0017 
Physician E&M visits 0.0550** −0.0195 −0.0112 
Probability of SNF admission −0.0003* 0.0002 −0.0001 
E&M = evaluation and management; ER = emergency room; SNF = skilled nursing facility. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based on 80 
percent confidence intervals are provided here for comparison purposes only. 
SOURCE: RTI International analysis of Medicare data. 
Figure 6 (continued) 
Demonstration effects on service utilization for eligible beneficiaries with SPMI in 
Massachusetts—Difference-in-differences regression results for the demonstration period, 
October 1, 2013–December 31, 2016 
 
E&M = evaluation and management; ER = emergency room; SNF = skilled nursing facility.  
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent intervals are represented by the top bar 
(black), and the 80 percent intervals are represented by the bottom bar (green). 
SOURCE: RTI International analysis of Medicare data. 
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Figure 7 displays the demonstration’s effects on RTI quality of care and care 
coordination measures for the demonstration eligible population with SPMI. The demonstration 
increased the probability of ACSC admissions (overall) by 0.06 percentage points (90 percent 
CI: 0.03, 0.09) as well as the probability of ACSC admissions (chronic) by 0.07 percentage 
points (90 percent CI: 0.04, 0.10) among beneficiaries with SPMI. All-cause 30-day readmission 
was increased by 0.0354 readmissions for each demonstration year over the demonstration 
period (90 percent CI: 0.0181, 0.0526) relative to the comparison group. There was no 
demonstration effect on preventable ER visits or the probability of a 30-day follow-up visit after 
a mental health discharge for beneficiaries with SPMI. 
Figure 7 
Demonstration effects on quality of care and care coordination for eligible beneficiaries 
with SPMI in Massachusetts—Difference-in-differences regression results for the 
demonstration period, October 1, 2013–December 31, 2016 
(90 and 80 percent confidence internals) 
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Table 18 displays the demonstration effects on RTI quality of care and care coordination 
measures for the demonstration eligible population with an SPMI for each demonstration year. 
The Massachusetts demonstration increased the probability of monthly ACSC admissions 
(overall) in demonstration year 1 (0.10 percentage points, p < 0.0001) and in demonstration year 
2 (0.05 percentage points, p = 0.0895). Likewise, the probability of monthly ACSC admissions 
(chronic) increased in demonstration year 1 (0.11 percentage points, p < 0.0001) and in 
demonstration year 2 (0.05 percentage points, p = 0.0273). However, there was no statistically 
significant demonstration impact on the probability of ACSC admissions (overall or chronic) in 
demonstration year 3 among eligible beneficiaries with SPMI. Similar to the overall eligible 
population, there was a 3.67 percentage point decline in the quarterly probability of a 30-day 
follow-up visit after a mental health discharge in demonstration year 2 among those in the 
demonstration group, relative to the comparison group (p = 0.0300). All-cause 30-day 
readmissions were higher relative to the comparison group in all three demonstration years 
(0.0371 readmissions, p = 0.0046 in year 1; 0.0407 readmissions, p = 0.0102 in year 2; and 
0.0292 readmissions, p = 0.0523 in year 3). Finally, there was no statistically significant 
Figure 7 (continued) 
Demonstration effects on quality of care and care coordination for eligible beneficiaries 
with SPMI in Massachusetts—Difference-in-differences regression results for the 
demonstration period, October 1, 2013–December 31, 2016 
 
 
ACSC = ambulatory care sensitive conditions; ER = emergency room.  
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent intervals are represented by the top bar 
(black), and the 80 percent intervals are represented by the bottom bar (green). 
SOURCE: RTI International analysis of Medicare data. 
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demonstration effect on preventable ER visits in any of the three demonstration years for 
beneficiaries with SPMI. 
Table 18 
Annual demonstration effects on quality of care and care coordination for eligible 
beneficiaries with SPMI in Massachusetts 
(* indicates significant at p < 0.20, ** indicates significant at p < 0.10) 
Quality of care and  
care coordination measures 
Demonstration year 1  
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Demonstration year 3 
(1/16–12/16) 
Preventable ER visits −0.0016 −0.0019 0.0000 
Probability of ACSC admissions, overall  0.0010** 0.0005** 0.0003 
Probability ACSC admissions, chronic 0.0011** 0.0005** 0.0004* 
Probability of a 30-day follow-up after a 
mental health discharge 
−0.0127  −0.0367**  0.0021  
All-cause 30-day readmissions 0.0371** 0.0407** 0.0292** 
ACSC = ambulatory care sensitive conditions; ER = emergency room. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based on 80 
percent confidence intervals are provided here for comparison purposes only.  
SOURCE: RTI International analysis of Medicare data. 
5.2.4 Service Use for Enrollee and Non-Enrollee Populations in Massachusetts 
To provide insights into the utilization experience over time within the Massachusetts 
demonstration, Tables C-4 and C-5 in Appendix C present descriptive statistics for the enrolled 
population, compared to those demonstration eligible beneficiaries who were not enrolled, for 
each service by demonstration year.  
There were few clear differences in patterns of service utilization for demonstration 
eligible enrollees and non-enrollees over the three demonstration years, although enrollees were 
more likely to use ER care, but less likely have an inpatient admission in demonstration year 2 
and year 3 (Table C-4). For the quality of care and care coordination measures, enrollees and 
non-enrollees have a similar number of ACSC admissions and rates of all-cause 30-day 
readmissions, while enrollees are more likely to have higher preventable ER visits and lower 
rates of 30-day follow-up for hospitalization for mental illness (Table C-5). 
5.2.5 Summary of Baseline Medicaid Service Trends Among Eligible Beneficiaries in 
Massachusetts and Comparison Group 
• Use of personal care services in Massachusetts, as measured by Healthcare Common 
Procedure Coding System (HCPCS) codes, appears substantially lower than in the 
comparison areas, both in the fraction using services and in the intensity of use 
among users. We observe no trend in these descriptive statistics over the 2 years 
within either group (Table C-6). 
 67 
• Other home and community-based services (HCBS) appear to have increased in 
Massachusetts since the 2-year baseline period, due to an increased percentage of 
beneficiaries using those services. In the comparison areas, utilization fell somewhat, 
due to a drop in the percentage using any services. 
• Long-stay nursing facility care, less common in Massachusetts than in the comparison 
areas, appears to have dropped by about one-third in Massachusetts and held steady in 
the comparison group. Average days per user were stable, so the drop in 
Massachusetts was due to a decreased percentage of beneficiaries receiving this 
service. 
• The rate of use of behavioral health services, although higher in Massachusetts than 
in the comparison group, appears to have fallen substantially between the 2 baseline 
years. The drop is larger than we would expect, and we suspect it may be due to 
administrative lags in the submission of claims rather than a true drop in service use. 
• Non-emergency medical transportation in Massachusetts, used by a much larger share 
of beneficiaries than in the comparison areas, appears to have increased somewhat 
during the baseline period. 
Data for both the baseline and demonstration periods are calculated based on HCPCS 
codes included in FFS claims submitted by providers or managed care encounters submitted by 
MMPs, but caution should be taken in comparing levels of service use across the baseline and 
demonstration periods. First, data from the demonstration period include only MMP enrollees 
while data from the baseline period include both those who eventually enroll in a demonstration 
plan and those who do not. Thus, the demonstration period data come from a self-selected group 
of beneficiaries who may have different demands for services. Second, the HCPCS codes used to 
define service use were included in instructions for coding given to MMPs in Massachusetts. To 
our knowledge, no similar list of codes was given to FFS providers. As a result, the apparent 
increases in the use of personal care, other HCBS, and behavioral health services—sometimes as 
large as a 10-fold increase—may reflect not only the self-selected nature of enrollees but also a 
difference in coding behavior by plans. 
5.2.6 Summary of Massachusetts One Care Enrollee Utilization of Medicaid-Type 
Services Derived from Encounter Data 
• Personal care service use among enrollees increased steadily over the first three 
demonstration periods, primarily through increased numbers of users. Intensity of use 
among users remained stable over the 3 years (Table C-7). 
• During the second demonstration period, both the share of enrollees using other 
HCBS services and the intensity of use among users increased, but both measures fell 
somewhat in the third period as the percentage of enrollees receiving these services 
declined. 
• There was no appreciable change in long-stay nursing care according to the encounter 
data as submitted by MMPs. The demonstration year 3 result reflects service use 
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among the few service users, whereas there was no appreciable service use in earlier 
years. 
• Behavioral health service use increased somewhat over the three demonstration 
periods, both in the percentage of enrollees using such services and in the intensity of 
use among users. 
• Non-emergency medical transportation increased over the three periods, both in the 
share of enrollees using the service and in the average number of days on which the 
service was used in a month. Some of this increase may be the result of a change in 
the billing practice in October 2016 by a vendor. 
5.2.7 Service Use by Demographic Characteristics of Eligible Beneficiaries  
To examine any differences in racial and ethnic groups, Figures 8, 9, and 10 provide 
month-level results for five settings of interest for Massachusetts’ eligible beneficiaries: inpatient 
admissions, emergency department visits (non-admit), hospice admissions, primary care E&M 
visits, and outpatient therapy (physical therapy [PT], occupational therapy [OT], and speech 
therapy [ST]) visits. Results across these five settings are displayed using three measures: 
percentage with any use of the respective service, counts per 1,000 eligible beneficiaries with 
any use of the respective service, and counts per 1,000 demonstration eligible beneficiaries.  
Figure 8 presents the percentage of use of selected Medicare services. Black 
beneficiaries had slightly higher inpatient admissions and emergency department visits, relative 
to other racial categories. A higher percentage of Whites had monthly primary care visits, 
relative to other races. However, a higher percentage of Black beneficiaries received outpatient 
therapy visits in a month, compared to other races. 
Regarding counts of services used among users of each respective service, as presented in 
Figure 9, there were limited differences across racial groups for inpatient admissions, emergency 
department visits, hospice use, and physician E & M visits. However, Black and White 
beneficiaries received more outpatient therapy visits in months where there was any use, relative 
to other racial groups. 
Figure 10 presents counts of services across all Massachusetts demonstration eligible 
beneficiaries regardless of having any use of the respective services. Trends for utilization across 
all service settings were broadly similar to those displayed in Figure 8. 
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Figure 8 
Percent with use of selected Medicare services 
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Figure 9 
Service use among all demonstration eligible beneficiaries with use of service per 1,000 user months 
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Figure 10 
Service use among all demonstration eligible beneficiaries per 1,000 eligible months 
 
 
517.4
959.4
3.2
98.3
40.0
611.0
856.5
2.3
119.2
48.5
287.3
827.1
0.9
107.4
32.4
255.2
709.2
2.0
39.8
20.7
0 200 400 600 800 1,000 1,200
Outpatient Therapy (PT, OT, ST) Visits
Primary Care E&M Visits
Hospice Admissions
Emergency Department Visits (Non-Admit)
Inpatient Admissions
Asian Hispanic Black White
 72 
[This page intentionally left blank.] 
 73 
6. Cost Savings Calculation 
 
 
As part of the capitated financial alignment model, Massachusetts, CMS, and health plans 
have entered into a three-way contract to provide services to Medicare-Medicaid enrollees 
(CMS, 2013). Participating health plans receive prospective blended capitation payment to 
provide both Medicare and Medicaid services for enrollees. CMS and Massachusetts developed 
risk adjusted capitation rates for Medicare Parts A, B, and D, and Medicaid services to reflect the 
characteristics of enrollees. The Medicare component of the payment is risk adjusted using 
CMS’ hierarchical risk adjustment model. The rate development process is described in greater 
detail in the Memorandum of Understanding and the three-way contract, and a description of the 
risk adjusted Medicare components of the rate are described in the Final Rate Reports 
(MassHealth and CMS). As noted in Chapter 3, in April 2016, CMS finalized the revised risk 
adjustment model for Medicare Advantage for payment year 2017 in the calendar year 2017 
Final Rate Notice and Call Letter. See Section 3.5.1 for additional information about this change.  
The capitation payment incorporates savings assumptions over the course of the 
demonstration. The same savings percentage is prospectively applied to both the Medicare and 
Medicaid components of the capitation payment, so that both payers can recognize proportional 
savings from this integrated payment approach, regardless of whether the savings is driven 
disproportionately by changes in utilization of services typically covered by Medicare or 
Medicaid. The goal of this methodology is to minimize cost shifting, to align incentives between 
Medicare and Medicaid, and to support the best possible outcomes for enrollees.  
This chapter presents preliminary Medicare Parts A and B savings calculations for the 
first 39 months of the demonstration period using an intent-to-treat (ITT) analytic framework 
that includes beneficiaries eligible for the demonstration rather than only those who enrolled. 
Approximately 103,000 Medicare-Medicaid beneficiaries in Massachusetts were eligible for and 
18,000 (18 percent) enrolled in the demonstration as of December 2017.  
Highlights 
• RTI conducted a preliminary estimate of Medicare savings using a difference-in-
differences analysis examining beneficiaries eligible for the demonstration in the 
Massachusetts demonstration area and comparison areas. 
• The results of the preliminary cost analyses of beneficiaries eligible for the 
demonstration do not show statistically significant savings or losses as a result of the 
demonstration. This aligns with CMS expectations, given rate structure and 
modifications during the demonstration period covered.  
• The low rate of enrollment in the demonstration (approximately 18 percent of eligible 
beneficiaries actually enrolled) is one potential reason for the finding of no 
statistically significant savings or losses among beneficiaries eligible for the 
demonstration. For example, limited enrollment may have limited the potential impact 
on costs.  
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The Medicare calculation presented here uses the capitation rate for beneficiaries enrolled 
in the demonstration, and not the actual payments that plans made to providers for services, so 
the savings are calculated from the perspective of the Medicare program. A similar approach will 
be applied to the Medicaid savings calculation when data is available. Part D costs are not 
included in the savings analysis.  
The results shown here reflect quality withhold repayments the first three demonstration 
periods and risk corridor payments and recoupments through 2015. Note that Medicare and 
Medicaid savings calculations will be conducted by RTI for each year of the demonstration as 
data are available.  
The following sections discuss the analytic approach and results of these analyses.  
6.1 Evaluation Design  
To assess the impact of the demonstration on Medicare costs for Medicare-Medicaid 
enrollees, RTI used an ITT approach comparing the population eligible for the Massachusetts 
demonstration with a comparison group not affected by the demonstration. An ITT approach 
diminishes the potential for selection bias and highlights the effect of the demonstration on all 
beneficiaries in the demonstration eligible population. All Medicare-Medicaid enrollees eligible 
for the demonstration constitute the evaluation sample, regardless of whether they enrolled in the 
demonstration or actively participated in the demonstration care model. Therefore, the analyses 
presented here cover demonstration eligible beneficiaries including those who opted out, or who 
participated but subsequently disenrolled; who were eligible but were not contacted by the 
Commonwealth or participating plans; and those who enrolled but did not seek services.  
Beneficiaries eligible for the demonstration were identified using quarterly files 
submitted by the Commonwealth of Massachusetts. These files include information on all 
beneficiaries eligible for the demonstration, as well as indicators for whether each beneficiary 
was enrolled.  
A comparison group was identified in two steps. First, RTI identified comparison areas 
that are most similar to Massachusetts with regard to area-level measures of health care market 
characteristics such as Medicare and Medicaid spending and State policy affecting Medicaid-
Medicare enrollees. Second, beneficiaries were selected using a propensity score model 
(described in further detail below). Further discussion of the comparison group selection process 
is detailed in Appendix A.  
RTI used a difference-in-differences (DID) approach to evaluate the impact of the 
demonstration on Medicare costs. DID refers to an analytic strategy whereby two groups—one 
affected by the policy intervention and one not affected by it—are compared on an outcome of 
interest before and after the policy intervention. The predemonstration period included 2 years 
prior to the start of the Massachusetts demonstration (October 1, 2011–September 30, 2013), the 
first demonstration period (demonstration year 1) included the first 15 months of the 
demonstration (October 1, 2013–December 31, 2014), the second demonstration period 
(demonstration year 2) included calendar year 2015 (January 1, 2015–December 31, 2015), and 
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the third demonstration period (demonstration year 3) included calendar year 2016 (January 1, 
2016–December 31, 2016).  
To estimate the average treatment effect on the demonstration eligible population for 
monthly Medicare expenditures, RTI ran generalized linear models (GLMs) with a gamma 
distribution and a log link. This is a commonly used approach in analysis of skewed data or in 
cases where a high proportion of observations may have values equal to zero. The model also 
employed propensity score weighting and adjusted for clustering of observations at the county 
level. 
The GLM model included indicators for demonstration period, an indicator for 
assignment to the demonstration group versus the comparison group, and an interaction term for 
demonstration period and demonstration assignment. The model also included demographic 
variables and area-level variables. The interaction term represents the combined effect of being 
part of the demonstration eligible group during the demonstration periods and is the key policy 
variable of interest. The interaction term is a way to measure the impact of both time and 
demonstration group status. Separate models were run to distinguish between overall savings 
(pre- versus postdemonstration) as well as savings for each demonstration period. Because the 
difference-in-difference variable was estimated using a non-linear model, RTI employed a post-
estimation procedure to obtain the marginal effects of demonstration impact. The aggregation of 
the individual marginal effects represents the net demonstration impact and are reported below.  
• Demographic variables included in the model were: 
– gender,  
– race, and  
– ESRD status.  
• Area-level variables included in the savings model were:  
– Medicare spending per Medicare-Medicaid enrollee age 19 or older  
– Medicare Advantage penetration rate  
– Medicaid-to-Medicare FFS fee index for all services  
– Medicaid spending per Medicare-Medicaid enrollee age 19 or older  
– Proportion of Medicare-Medicaid enrollees using  
▪ Nursing facilities age 65 or older  
▪ Home and community-based services (HCBS) age 65 or older  
▪ Personal care age 65 or older  
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▪ Medicaid managed care age 19 or older 
– Population per square mile, and physicians per 1,000 population  
Additional area-based variables—such as the percent of adults with a college degree and 
proximity to hospitals or nursing facilities—were used as proxies for sociodemographic 
indicators and local area characteristics. Note that these variables were also used in the 
comparison group selection process. Though the One Care program targets beneficiaries younger 
than age 65, these variables are meant to control for health care market characteristics generally 
and will not bias the savings calculation for Massachusetts. Individual beneficiary demographic 
characteristics are controlled for in the models and are also accounted for in the propensity score 
weights used in the analysis.  
In addition to the variables noted here, the propensity score weights used in the cost 
savings analyses also include Hierarchical Condition Category (HCC) risk score. HCC risk score 
is not included as an independent variable in the regression models predicting costs because 
HCC risk score is directly related to capitated payments. Due to the potential for differences in 
diagnoses coding for enrollees compared to beneficiaries in FFS after the start of the 
demonstration, the HCC risk score used to calculate the weights was “frozen” to the value at the 
start of the demonstration period. Diagnoses codes are the basis for risk score calculations, and 
by freezing the score prior to any potential impact of the demonstration, we are able to control 
for baseline health status using diagnosis codes available prior to the demonstration. 
6.2 Medicare Expenditures: Constructing the Dependent Variable 
RTI gathered predemonstration and demonstration monthly Medicare expenditure data 
for both the demonstration and comparison groups from two data sources. Capitation payments 
paid to One Care plans during the demonstration period were obtained for all demonstration 
enrollees from CMS Medicare Advantage and Prescription Drug system (MARx) data. The 
capitation payments were the final reconciled payments paid by the Medicare program after 
taking into account risk score reconciliation and any associated retroactive adjustments in the 
system at the time of the data pull (July 2018). Medicare claims were used to calculate 
expenditures for all comparison group beneficiaries, demonstration beneficiaries in the 
predemonstration period, and demonstration eligible beneficiaries who were not enrolled during 
the demonstration period as summarized in Table 19. These FFS claims included all Medicare 
Parts A and B services. 
Table 19 
Data sources for monthly Medicare expenditures 
Group 
Predemonstration 
October 1, 2011–September 30, 2013 
Demonstration period 
October 1, 2013–December 31, 2016 
Demonstration group Medicare FFS Capitation rate for enrollees 
Medicare FFS for non-enrollees 
Comparison group Medicare FFS Medicare FFS 
FFS = fee for service. 
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A number of adjustments were made to the monthly Medicare expenditures to ensure that 
observed expenditures variations are not due to differences in Medicare payment policies in 
different areas of the country or the construction of the capitation rates. Table 20 summarizes 
each adjustment and the application of the adjustments to FFS expenditures or to the capitation 
rate.  
Table 20 
Adjustments to Medicare expenditures variable 
Data source 
Adjustment 
description Reason for adjustment Adjustment detail 
FFS Indirect Medical 
Education (IME) 
MMP capitation rates do not 
include IME. 
Do not include IME amount from 
FFS payments. 
FFS Disproportionate Share 
Hospital (DSH) 
Payments and 
Uncompensated Care 
Payments (UCP) 
The capitation rates reflect DSH 
and UCP adjustments.  
Include DSH and UCP payments 
in total FFS payment amounts. 
FFS Medicare Sequestration 
Payment Reductions 
Under sequestration Medicare 
payments were reduced by 2% 
starting April 1, 2013. Because the 
predemonstration period includes 
months prior to April 1, 2013 it is 
necessary to apply the adjustment 
to these months of data. 
Reduced FFS claim payments 
incurred before April 2013 by 
2%. 
Capitation rate Medicare Sequestration 
Payment Reductions 
Under sequestration Medicare 
payments were reduced by 2% 
starting April 1, 2013. 
Sequestration is not reflected in 
the capitation rates. 
Reduced capitation rate by 2%. 
Capitation rate Bad debt The Medicare portion of the 
capitation rate includes an upward 
adjustment to account for bad debt. 
Bad debt is included in the FFS 
claim payments and therefore 
needs to be removed from the 
capitation rate for the savings 
analysis. (Note, “bad debt” is 
reflected in the hospital “pass 
through” payment.)  
Reduced blended capitation rate 
to account for bad debt load 
(historical bad debt baseline 
percentage). This is 0.87 for 
CY13, 0.88 for CY14, 0.89 for 
CY15, and 0.94 for CY16. 
Reduced the FFS portion of the 
capitation rate by an additional 
1.89% for CY 2014, by an 
additional 1.71% for CY 2015, 
and by an additional 1.84% for 
CY 2016 to account for the 
disproportional share of bad debt 
attributable to Medicare-
Medicaid enrollees in Medicare 
FFS.  
(continued) 
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Table 20 (continued) 
Adjustments to Medicare expenditures variable 
Data source 
Adjustment 
description Reason for adjustment Adjustment detail 
FFS and 
capitation rate  
Average Geographic 
Adjustments (AGA) 
The Medicare portion of the 
capitation rate reflects the most 
current hospital wage index and 
physician geographic practice cost 
index by county. FFS claims also 
reflect geographic payment 
adjustments. In order to ensure that 
change over time is not related to 
differential change in geographic 
payment adjustments, both the 
FFS and the capitation rates were 
“unadjusted” using the appropriate 
county-specific AGA factor. 
Medicare expenditures were 
divided by the appropriate 
county-specific AGA factor for 
each year. Note that for 2014, a 
single year-specific AGA factor 
based on claims paid in the year, 
rather than the AGA factor used 
in Medicare Advantage (based on 
5 years of data and lagged 3 
years) was used to account for 
year-specific policies. Note also 
that the AGA factor applied to the 
capitated rates for 2014 reflected 
the 50/50 blend that was 
applicable to the payment year. A 
2015 and 2016 single year-
specific AGA factor will be 
incorporated in future 
calculations as it becomes 
available.  
Capitation rate Education user fee No adjustment needed.  Capitation rates in the MARx 
database do not reflect the 
education user fee adjustment 
(this adjustment is applied at the 
contract level). Note, education 
user fees are not applicable in the 
FFS context and do not cover 
specific Part A and Part B 
services. While they result in a 
small reduction to the capitation 
payment received by MMPs, we 
did not account for this reduction 
in the capitated rate. 
Capitation rate Quality withhold A 1% quality withhold was 
applied in the first and third 
demonstration years but was not 
reflected in the capitation rate used 
in the analysis.  
Final quality withhold 
repayments for 2013, 2014, 2015, 
and 2016 were incorporated into 
the dependent variable 
construction. Note that the 
demonstration year 2 quality 
withhold and repayment 
applicable to Fallon will be 
incorporated as this information 
becomes available. 
(continued) 
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Table 20 (continued) 
Adjustments to Medicare expenditures variable 
Data source 
Adjustment 
description Reason for adjustment Adjustment detail 
Capitation rate Risk corridor Risk corridor payments or 
recoupments are based on 
reconciliation after application of 
high cost risk pool or risk 
adjustment methodologies. 
Final risk corridor payments and 
recoupments were incorporated 
into the dependent variable 
construction for demonstration 
year 1 and demonstration year 2. 
Risk corridor payments and 
recoupments for demonstration 
year 3 will be incorporated as 
final information becomes 
available.  
CY = calendar year; FFS = fee for service; MMP = Medicare-Medicaid Plan. 
The capitation payments MARx reflect the savings assumptions applied to the One Care 
and Medicare components of the rate (1 percent for April 1, 2014–December 31, 2014, and zero 
percent for calendar year 2015 and 2016), but do not reflect the risk corridor payments or the 
quality withhold amounts (withhold of 1 percent in the first demonstration period, zero percent in 
the second demonstration period for two of the three plans and two percent for one of the plans, 
and 1 percent in the third demonstration period). The results shown here reflect quality withhold 
repayments for the three demonstration periods and the risk corridor payments and recoupments 
for both the first and second demonstration periods.  
6.3 Results 
The first step in the analysis was to plot the unweighted mean monthly Medicare 
expenditures for both the demonstration group and the comparison group. Figure 11 indicates 
that the demonstration group and the comparison group had parallel trends in mean monthly 
expenditures during the 24-month predemonstration period, which is an important assumption to 
the DID analysis.  
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Figure 11 
Mean monthly Medicare expenditures, predemonstration and demonstration period, 
One Care eligible and comparison group, 
October 2011–December 2016 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/RelativePercentTable_MADY3_sept). 
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Figure 12 demonstrates the same plot of mean monthly Medicare expenditures for both 
the demonstration group and the comparison group, after applying the propensity weights and 
establishes the parallel trends for both groups.  
Figure 12 
Mean monthly Medicare expenditures (weighted), predemonstration and demonstration 
period, One Care eligibles and comparison group, 
October 2011–December 2016 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/RelativePercentTable_MADY3_sept). 
Table 21, Table 22, and Table 23 show the mean monthly Medicare expenditures for the 
demonstration group and comparison group in the predemonstration and each demonstration 
period, unweighted. The unweighted tables show an increase in mean monthly Medicare 
expenditures during demonstration periods 1, 2, and 3 for both the demonstration group and the 
comparison group. The unweighted mean increase in demonstration period 1 was $14.24 for 
demonstration eligible beneficiaries and $32.15 for the comparison group. Increases were also 
shown for demonstration periods 1, 2, and 3 for both the demonstration group and the 
comparison group in the weighted tables (Table 24, Table 25, and Table 26).  
The DID values in each table represent the overall impact on savings using descriptive 
statistics. These effects are descriptive in that they are arithmetic combinations of simple means, 
without controlling for covariates. The change in the demonstration group minus the change in 
the comparison group is the DID value. This value would be equal to zero if the differences 
between predemonstration and the demonstration period were the same for both the 
demonstration group and the comparison group. A negative value would indicate savings for the 
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demonstration group, and a positive value would indicate losses for the demonstration group. 
Although the DID values in demonstration period 1 are negative, indicating savings, none of the 
DID values (weighted or unweighted) in period 1, period 2, or period 3 are statistically 
significant (illustrated by the 95 percent confidence intervals that include 0).  
Table 21 
Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
predemonstration period and demonstration period 1, unweighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 1 
Oct 2013–Dec 2014 Difference 
Demonstration group $876.95  
($846.38, $907.52) 
$891.19 
($868.16, $914.22) 
$14.24 
(−$6.00, $34.47) 
Comparison group  $1,038.02 
($986.19, $1,089.84) 
$1,070.17 
($1,010.46, $1,129.88) 
$32.15 
($17.67, $46.63) 
Difference-in-difference 
— — 
−$17.91  
(−$42.18, $6.35) 
— = data not available. 
NOTE: 95 percent confidence intervals are shown in parentheses below estimates. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/DescriptiveTables_ MADY3_sept). 
Table 22 
Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
predemonstration period and demonstration period 2, unweighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 2 
Jan 2015–Dec 2015 Difference 
Demonstration group $876.95 
($846.38, $907.52) 
$907.85 
($881.24, $934.46) 
$30.90 
($13.35, $48.46) 
Comparison group  $1,038.02 
($986.19, $1,089.84) 
$1,069.59 
($1,012.42, $1,126.77) 
$31.57 
($18.26, $44.89) 
Difference-in-difference 
— — 
−$0.67 
(−$21.92, $20.57) 
— = data not available. 
NOTE: 95 percent confidence intervals are shown in parentheses below estimates. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/DescriptiveTables_ MADY3_sept). 
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Table 23 
Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
predemonstration period and demonstration period 3, unweighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 3  
Jan 2016–Dec 2016 Difference 
Demonstration group $876.95 
($846.38, $907.52) 
$947.11 
($922.25, $971.97) 
$70.16 
($33.40, $106.91) 
Comparison group  $1,038.02  
($986.19, $1,089.84) 
$1,113.85 
($1,055.39, $1,172.32) 
$75.84 
($45.91, $105.76) 
Difference-in-difference 
— — 
−$5.68 
(−$51.93, $40.57) 
— = data not available. 
NOTE: 95 percent confidence intervals are shown in parenthesis below estimates. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/DescriptiveTables_ MADY3_sept). 
Table 24 
Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
predemonstration period and demonstration period 1, weighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 1 
Oct 2013–Dec 2014 Difference 
Demonstration group $876.95 
($846.38, $907.52) 
$891.19 
($868.16, $914.22) 
$14.24 
(−$6.00, $34.47) 
Comparison group  $928.42 
($883.50, $973.35) 
$961.10 
($904.81, $1,017.39) 
$32.67 
($10.57, $54.78)  
Difference-in-difference 
— — 
−$18.44 
(−$47.86, $10.98)  
— = data not available. 
NOTE: 95 percent confidence intervals are shown in parentheses below estimates. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/DescriptiveTables_MADY3_sept). 
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Table 25 
Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
predemonstration period and demonstration period 2, weighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 2 
Jan 2015–Dec 2015 Difference 
Demonstration group $876.95 
($846.38, $907.52) 
$907.85 
($881.24, $934.46) 
$30.90 
($13.35, $48.46) 
Comparison group  $928.42 
($883.50, $973.35) 
$953.17 
($903.79, $1,002.56) 
$24.75 
($2.44, $47.06)  
Difference-in-difference 
— — 
$6.15 
(−$21.28, $33.58)  
— = data not available. 
NOTE: 95 percent confidence intervals are shown in parenthesis below estimates. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/DescriptiveTables_ MADY3_sept). 
Table 26 
Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
predemonstration period and demonstration period 3, weighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 3 
Jan 2016–Dec 2016 Difference 
Demonstration group $876.95 
($846.38, $907.52) 
$947.11 
($922.25, $971.97) 
$70.16 
($33.40, $106.91)  
Comparison group  $928.42 
($883.50, $973.35) 
$1,004.68 
($955.90, $1,053.47) 
$76.26 
($36.34, $116.18) 
Difference-in-difference — — −$6.10 
(−$59.60, $47.39) 
— = data not available. 
NOTE: 95 percent confidence intervals are shown in parenthesis below estimates. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/DescriptiveTables_ MADY3_sept). 
6.3.1 Regression Analysis 
While the descriptive statistics are informative, to get a more accurate estimate of 
savings, RTI conducted a multivariate regression analysis to estimate savings controlling for 
beneficiary and area-level characteristics. Given the structure of the data, RTI used the GLM 
procedure in Stata with a gamma distribution and a log link, and adjusted for clustering at the 
county level. 
In addition to controlling for beneficiary and market area characteristics, the model 
included a time trend variable (coded as months 1–63), a dichotomous variable for whether the 
observation was from the predemonstration or demonstration period (“Post”), a variable to 
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indicate whether the observation was from a beneficiary in the comparison group or the 
demonstration group (“Intervention”), and an interaction term (“Intervention*Post”) which is the 
DID estimate in the multivariate model for the net effect of demonstration eligibility. We also 
ran a model specific to the year of the demonstration and for this we included a dummy variable 
for each year of the demonstration (“DemoYear1”, “DemoYear2”, and “DemoYear3”) and three 
interaction terms (“Intervention*DemoYear1”,“Intervention*DemoYear2”, and 
“Intervention*DemoYear3"). 
Table 27 shows the main results from the DID analysis for demonstration years 1, 2, 3 
and for the entire demonstration period, controlling for beneficiary demographics and market 
characteristics. To obtain the effect of the demonstration from the non-linear model we 
calculated the marginal effect of coefficient of the interaction term. The marginal effect of the 
demonstration for the intervention group over the three demonstration periods in aggregate was 
positive ($5.26) but losses were small and not statistically significant, indicating that there were 
no net losses to Medicare as a result of the demonstration using the ITT analysis framework. The 
estimate of the effect of the demonstration in period 1 indicated −$10.42 in savings, $9.82 in 
losses for demonstration period 2, and $20.09 in losses for demonstration period 3; however, 
these findings were not statistically significant, indicating no effect of the demonstration using 
the ITT framework.  
Table 27 
Demonstration effects on Medicare savings for eligible beneficiaries—Difference-in-
difference regression results, One Care eligibles and comparison group 
Covariate 
Adjusted 
coefficient 
DID p-value 
95% confidence 
interval 
90% confidence 
interval 
80% confidence 
interval1 
Intervention *DemoYear1  
(October 2013–December 2014) 
−$10.42 0.5093 (−41.36, 20.52) (−36.39, 15.55)  (−30.65, 9.81)  
Intervention *DemoYear2  
(January 2015–December 2015) 
$9.82 0.5259 (−20.53, 40.18)  (−15.65, 35.30)  (−10.03, 29.67)  
Intervention*DemoYear3 
(January 2016–December 2016)  
$20.09 0.3974 (−26.44, 66.62) (−18.96, 59.14) (−10.33, 50.52) 
Intervention*Demo Period  
(October 2013–December 2016) 
$5.26 0.7213 (−23.65, 34.17) (−19.00, 29.52) (−13.64, 24.17) 
1 80 percent confidence intervals are provided for comparison purposes only. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/DescriptiveTables_MADY3_sept). 
Table 28 shows the magnitude of the DID estimate relative to the adjusted mean outcome 
value in the predemonstration and demonstration periods. The second and third columns 
represent the post-regression, mean predicted savings or loss for each group and period, based on 
the composition of a reference population (the comparison group in the demonstration period). 
These values show how different the three groups were in each period, and the relative direction 
of any potential effect in each group over time. The remaining columns show the DID estimate 
(the coefficient on Intervention*Post), the p-value demonstrating significance, and the relative 
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percent change of the DID estimate compared to the mean monthly Medicare expenditures for 
the comparison group in the entire demonstration period.  
The adjusted mean for monthly expenditures decreased between the predemonstration 
and demonstration period for the demonstration and comparison groups. The DID estimate of 
5.26 (the coefficient on Intervention*Post) is positive, but the losses are not statistically 
significant (p < 0.7213), indicating that there were no statistically significant losses in Medicare 
Parts A and B from the demonstration, using the ITT analysis framework. The adjusted 
coefficient on the DID estimate for the demonstration overall ($5.26, in Table 28) is between the 
marginal effect of the DID estimate from demonstration year 1 (−$10.42 in Table 27), the 
marginal effect of the DID estimate from demonstration year 2 ($9.82, in Table 27), and the 
marginal effect of the DID estimate from demonstration year 3 ($20.09, in Table 27). The DID 
estimate for demonstration years 1, 2, and 3 in aggregate reflected an annual relative cost 
increase of 0.54 percent, but this was not statistically significant. 
Table 28 
Adjusted means and overall impact estimate for eligible beneficiaries in the demonstration 
and comparison groups, One Care eligibles and comparison group 
Group 
Adjusted mean for 
predemonstration 
period 
Adjusted mean for 
demonstration 
period 
Relative 
difference 
(%) 
Adjusted coefficient 
DID p-value 
Demonstration group 
$906.61 
($836.69, $976.52) 
$887.46 
($827.61, $947.31) 
0.54 
5.26 
95% CI (-23.65, 
34.17) 
90% CI (−19.00, 
29.52) 
0.7213 
Comparison group 
$1,004.11 
($960.87, $1,047.35) 
$977.32 
($928.30, $1,026.35) 
  
CI = confidence interval; DID = difference-in-differences 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/ RelativePercentTable_MADY3 and MA AR3 Output/DescriptiveTables_MADY3-sept). 
In addition to the cost savings analysis on all eligible beneficiaries (ITT approach), RTI 
conducted several sensitivity analyses to provide additional information on potential savings or 
losses associated with the demonstration overall and for the subset of beneficiaries enrolled in 
the demonstration. These sensitivity analyses included (1) simulating capitated rates for eligible 
enrollees not enrolled in the demonstration and comparing these rates to actual FFS 
expenditures; (2) predicting FFS expenditures for beneficiaries enrolled in the demonstration and 
comparing to the actual capitated rates; and (3) calculating a DID estimate based on a subgroup 
of beneficiaries enrolled in the demonstration with at least 3 months of eligibility in the baseline 
period. The results of these analyses are presented in Appendix D.  
The findings of the sensitivity analyses indicate that the predicted capitated rates are not 
statistically significantly different than actual FFS expenditures for non-enrollees and that 
predicted FFS expenditures are lower than actual capitated rates for enrollees. The enrollee 
subgroup DID analysis indicates additional costs compared to a comparison group, and this 
finding is statistically significant. Note that these analyses do not control for unobservable 
characteristics that may be related to the decision to enroll in the demonstration. The enrollee 
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subgroup DID analysis was conducted to learn more about the potential impact of the 
demonstration on the subset of beneficiaries touched by the demonstration for at least 3 months. 
Note that similar 3-month eligibility criteria were applied to the comparison group for the 
baseline and demonstration periods for this analysis and weights were recalculated. The enrollee 
subgroup analysis is limited by the absence of person-level data on characteristics that 
potentially would lead an individual in a comparison area to enroll in a similar demonstration, 
and thus the results should be considered in the context of this limitation.  
6.4 Discussion 
The results of the preliminary multivariate analyses presented here do not indicate 
statistically significant savings or losses during the first 39 months of the Massachusetts 
demonstration. The savings calculated here are based on capitation rates paid for enrollees and 
the FFS expenditures for eligible beneficiaries that did not enroll in the demonstration. The 
estimates do not take into account actual payments for services incurred by enrollees and paid by 
the One Care plans.  
One potential reason that savings were not identified in these analyses is that that there 
was not sufficient time for the program to demonstrate impact. For example, limited enrollment 
could limit the potential impact on costs because there was “no critical mass” achieved. It is also 
important to note that given the ITT framework used to calculate savings, all eligible 
beneficiaries, regardless of their enrollment status were included in the calculation. However, 
enrollment in Massachusetts was modest at best during the first 39 months of the demonstration. 
Approximately 103,000 Medicare-Medicaid beneficiaries in Massachusetts were eligible for and 
over 18,000 (18 percent) enrolled in the demonstration as of December 2017. The large majority 
of the eligible beneficiaries (82 percent) were not enrolled in a One Care plan and were therefore 
receiving usual FFS Medicare. While the ITT framework helps mitigate selection bias in 
evaluating the impact of an intervention, it may be more challenging to detect savings in an ITT 
framework where enrollment penetration is so low. It should also be noted that the demonstration 
year 2 and demonstration year 3 results for the enrollee subgroup in part reflect a risk 
adjustment-related change that increased the capitation payments for eligible individuals enrolled 
in Massachusetts MMPs in 2015. The associated risk adjustment change, which took effect 
across Medicare Advantage in 2017, will not be reflected in our analyses because the comparison 
groups are exclusively beneficiaries in Medicare FFS. 
The preliminary nature of these results is important to note, as they do not include final 
risk corridor data for demonstration year 3 (CY 2016). CMS has tentatively completed analysis 
of the One Care MMPs’ risk corridor data for demonstration year 3. This analysis suggests 
approximately $7.3 million to be recouped by CMS and Massachusetts from CCA (with the 
Medicare portion of this recoupment approximately $3.0 million) and a payment of 
approximately $1.1 million due to Tufts (with the Medicare portion of this payment 
approximately $0.7 million). The net Medicare impact of the payment and recoupment combined 
is approximately $2.3 million. This risk corridor recoupment and payment are not included in the 
cost savings analysis in this report given the timing of finalizing this analysis. 
Once Medicaid data become available to the Federal evaluator, and a similar calculation 
can be conducted on the Medicaid costs, it will be possible to have a more complete 
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understanding of potential savings from the first 3 years of the Massachusetts demonstration. In 
the meantime, preliminary analysis conducted by the Commonwealth of Massachusetts suggests 
the potential for savings to Medicaid and Medicare over time due to reduced inpatient and acute 
service utilization. Specifically, the Commonwealth has seen evidence that One Care Plans’ 
investment in Medicaid-covered services (e.g., LTSS) creates savings on Medicare-covered 
services (e.g., inpatient hospital, emergency department). The Commonwealth suggests that 
observed increases in Medicaid community LTSS under the demonstration is likely due, in part, 
to under-utilization prior to the demonstration due to a lack of navigation, care planning, and 
coordination in the FFS environment prior to the Financial Alignment Initiative. Massachusetts 
has also found that continuous enrollment for an extended period of time (18+ months) appears 
to be a key factor in achieving reduced acute and inpatient utilization and savings.54 
RTI will continue to examine these results and will rerun the analyses when complete 
information on risk corridors become available. Additional Medicare and Medicaid savings 
calculations will be conducted by the evaluation contractor for each year of the demonstration as 
data are available. Future reports will show updated results for the first 3 years of the 
demonstration based on data reflecting additional claims runout, risk score reconciliation, and 
any retroactive adjustments. 
                                                 
54 These estimates are assessed and provided by the Commonwealth of Massachusetts and are independent from 
analyses presented in this report. CMS has not validated these estimates. 
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7. Conclusions 
7.1 Implementation Successes, Challenges, and Lessons Learned  
Overall, MassHealth officials, One Care MMPs, and other stakeholders reported strong 
collaboration and continue to voice support for One Care, emphasizing that it is the right care 
model for this population. At the State level, support for One Care is evidenced in part by the 
decision to extend the demonstration through December 31, 2019, and by its incorporation of 
One Care’s goals of member-centered, coordinated and culturally competent care into broader 
MassHealth reforms related to its 1115(a) demonstration waiver. MassHealth, MMPs, enrollees 
and other stakeholders continue to report success stories from One Care. In RTI focus groups, 
many participants reported overall satisfaction with One Care although they also identified areas 
for improvement. The MMPs continue to modify and refine their practices, including those 
around the delivery of care coordination, to better meet the needs of One Care’s population. 
Although the Implementation Council did not convene meetings in the first half of 2017 
due to the re-solicitation of members, strong stakeholder involvement continues to be a hallmark 
of the demonstration. As an example, MassHealth and CMS agreed to add two additional 
CAHPS survey questions based on feedback MassHealth and CMS received from stakeholders in 
the disability community. Commonwealth officials also report efforts to incorporate the more 
robust stakeholder model designed for One Care into its other reforms and programs.  
Many of the demonstration changes in 2017 impacted eligibility and enrollment. 
Enrollment continued to build in 2017, increasing from approximately 16,000 to 18,500 by year 
end. To help grow enrollment, passive enrollment requirements were changed to allow passive 
enrollment in areas of the Commonwealth served by only one MMP and in counties only 
partially served by One Care. Other changes affecting enrollment included one MMP extending 
its coverage area and implementation of regularly scheduled quarterly passive enrollment. Even 
with these changes, the MMPs reported different enrollment experiences, with one plan seeking 
additional passive enrollment and the other suspending its participation in passive enrollment at 
the end of 2017. MassHealth also instituted online enrollment system for One Care in 2017; 
officials also reported that the challenges of integrating Medicare and Medicaid eligibility 
continued.  
In addition to integrating eligibility systems, representatives from the MMPs continued to 
note some operational systems challenges in integrating Medicare and Medicaid. These 
challenges related to internal processes at the plans and the resulting administrative costs of 
operating One Care in compliance with Medicare, Medicaid and demonstration requirements. 
Administrative costs, along with other factors, have influenced the financial performance of the 
MMPs. The cost experience of the MMPs participating in One Care has varied among MMPs 
and changed over the course of the demonstration. This, along with enrollment activities, are 
areas of focus for continued monitoring. 
7.2 Demonstration Impact on Service Utilization and Costs 
Difference-in-differences (DID) regression results of demonstration impacts show that 
the Massachusetts demonstration resulted in statistically significant changes in utilization 
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patterns, including changes in RTI quality of care and care coordination measures. These 
changes include higher monthly inpatient admissions (including inpatient admissions for overall 
and chronic ambulatory care sensitive conditions [ACSC]) and all-cause 30-day readmissions. 
Conversely, there was a lower probability of any long-stay nursing facility (NF) use over the 
year. The demonstration had no impact on monthly emergency room (ER) visits, preventable ER 
visits, physician evaluation and management (E&M) visits, or the probability of skilled nursing 
facility (SNF) admissions. The impacts on inpatient admissions were concentrated in 
demonstration year 2, whereas the impacts on long-stay NF use were concentrated in 
demonstration years 2 and 3. The impacts on ACSC overall and chronic inpatient admissions and 
all-cause 30-day readmission were concentrated in demonstration years 1 and 2, suggesting that 
the demonstration was making progress by demonstration year 3 in reducing these types of 
inpatient admissions since the demonstration year 3 result was not statistically significant. 
Massachusetts may be providing additional Medicaid-funded community-based follow-up 
services that are more extensive than those provided through Medicare funding. 
Results from subgroup analyses for the LTSS population—defined as those who used 
institutional long-stay NF services—were somewhat different from the broader demonstration 
eligible population described above. Among types of inpatient admissions among the LTSS 
population, as compared to the results on the all eligibles population, the results suggest that only 
the ACSC chronic care inpatient admissions and all-cause 30-day readmissions were higher, but 
the probability of SNF admission was also higher for this population. On the other hand, results 
for the population with a severe and persistent mental illness (SPMI) were qualitatively similar to 
those for the overall demonstration eligible population, except that inpatient admissions (as 
opposed to ACSC admissions and all-cause 30-day readmissions) were unchanged. Among One 
Care enrollees, non-personal care HCBS services appear to have increased since the 
predemonstration period, due to an increased percentage of beneficiaries using those services. 
The observed service use changes for the overall demonstration eligible population, as 
well as the SPMI subgroup, may be interpreted to be a result of the demonstration, including the 
provision of new and expanded diversionary behavioral health services to One Care enrollees. 
One MMP also developed two new enhanced crisis stabilization units to serve beneficiaries in 
the community who would otherwise be served in an institutional setting. Generally, however, 
the DID results indicate that reducing reliance on institutional service use and increasing 
community-based service use for the One Care eligible population continues to be challenging. 
The results of Medicare cost savings analyses using a DID regression approach on 
beneficiaries eligible for the One Care demonstration do not indicate statistically significant 
savings or losses as a result of the Massachusetts demonstration across the first three 
demonstration periods. 
7.3 Next Steps  
The RTI evaluation team will continue to collect information on a quarterly basis from 
Commonwealth officials through the online State Data Reporting System, covering enrollment 
statistics and updates on key aspects of implementation. The RTI evaluation team will continue 
conducting quarterly calls with the One Care Commonwealth and CMS staff and will request the 
results of any evaluation activities conducted by the Commonwealth or other entities, such as 
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results from the CAHPS and State-specific demonstration measures the plans are required to 
report to CMS. RTI will conduct additional qualitative and quantitative analyses over the course 
of the demonstration.  
As noted previously, the demonstration has been extended through December 2019, 
which will provide further opportunities to evaluate the demonstration’s performance. The next 
report will include a qualitative update on demonstration implementation and descriptive 
analyses of quality and utilization measures for those eligible for the demonstration and for an 
out-of-State comparison group. 
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Appendix A: 
Comparison Group Methodology for Massachusetts 
Demonstration Year 3 
CMS contracted with RTI International to monitor the implementation of demonstrations 
under the Financial Alignment Initiative (FAI) and to evaluate their impact on beneficiary 
experience, quality, utilization, and cost. This appendix presents the comparison group selection 
and assessment results for the FAI demonstration in the state of Massachusetts. 
Results for comparison group selection and assessment analyses are prepared for each 
demonstration year. The First Annual Report for Massachusetts that was publicly released in 
September 2016 describes the comparison group identification methodology in detail along with 
findings from demonstration year 1. 
This report provides the comparison group results for the third performance year for the 
One Care demonstration in Massachusetts (MA) (January 1, 2016 to December 31, 2016), and 
notes any major changes in the results since the previous performance year. The first MA 
demonstration year covered five quarters (October 1, 2013 to December 31, 2014) and the 
second demonstration year covered four quarters (January 1, 2015 to December 31, 2015). 
Demonstration and Comparison Group Characteristics 
The MA demonstration area consists of three large urban metropolitan statistical areas 
(MSAs) (Boston-Cambridge-Newton; Worcester; and Springfield) plus one Rest-of-State area 
containing rural areas. The comparison area is composed of 116 counties in 24 MSAs. These 
geographic areas have not changed since the Massachusetts First Annual Report. At time of 
eligibility, all targeted beneficiaries in the two groups are younger than 65 years of age.  
The number of demonstration group beneficiaries has remained stable over the two 
baseline years and the three demonstration years, ranging between 106,039 to 117,986 per year. 
In the comparison group, which is almost twice the size of the demonstration group, the number 
of beneficiaries has also been relatively stable (from 177,284 to 214,860 per year). 
Propensity Score Estimates 
RTI’s methodology uses propensity scores to examine initial differences between the 
demonstration and comparison groups in each analysis period and then to weight the data to 
improve the match between them. The comparability of the two groups is examined with respect 
to both individual beneficiary characteristics as well as the overall distributions of propensity 
scores.  
A propensity score (PS) is the predicted probability that a beneficiary is a member of the 
demonstration group conditional on a set of observed variables. Our PS models include a 
combination of beneficiary-level and region-level characteristics measured at the ZIP code (ZIP 
Code Tabulation Area) level. The Massachusetts First Annual Report provides a detailed 
description of these characteristics and how the PSs are calculated.  
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One change in the specification of the propensity score model is two new explanatory 
variables. One is for Black beneficiaries and the other is for those involved in other Medicare 
shared-savings initiatives (such as Accountable Care Organizations, which are prevalent in 
Massachusetts). The covariate for Black beneficiaries has been added to the model because they 
now represent more than 10 percent of the beneficiaries in either the demonstration or 
comparison groups. In the First Evaluation Report, before the addition of the shared savings 
programs covariate, any beneficiaries from practices participating in Medicare shared savings 
programs (labeled Other MDM for Master Data Management programs in our tables) were 
omitted from the analyses. Individuals aligned with Medicare shared savings initiatives are 
included in this report and the second evaluation report, both of which include the explanatory 
variables. 
The logistic regression coefficients and z-values for the covariates included in the 
propensity model for Massachusetts demonstration year 3 are shown in Table A-1. In the revised 
specification, the two variables most strongly associated with group status are the two new 
variables noted above. Demonstration beneficiaries in Massachusetts are much less likely to be 
Black (12.7 percent vs. 31.9 percent) and more likely to be part of a Medicare shared savings 
program (43.7 percent vs. 20.4 percent) than their comparison group counterparts. In addition, 
there are ZIP code-level group differences associated with rates of college-educated adults under 
the age of 65 and the distances to hospitals and nursing facilities. The magnitude of the group 
differences for all variables prior to PS weighting may also be seen in Table A-2. 
Propensity Score Overlap 
The distributions of PSs by group for demonstration year 3 are shown in Figure A-1 
before and after propensity weighting. Estimated scores covered nearly the entire probability 
range in both groups. Like the previous analyses, the unweighted comparison group (dashed line) 
is characterized by a spike in predicted probabilities in the range from 0 to 0.20. Inverse 
Probability of Treatment Weighting pulls the distribution of weighted comparison group PSs 
(dotted line) very close to that of the demonstration group (solid line).  
Any beneficiaries who have estimated PSs below the smallest estimated value in the 
demonstration group are removed from the comparison group. Because of the very broad range 
of PSs found in the Massachusetts demonstration data, 3,153 beneficiaries were removed from 
the comparison group in demonstration year 3.  
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Table A-1 
Logistic regression estimates for Massachusetts propensity score models 
in demonstration year 3 
Characteristic 
Demonstration year 3 
Coef. Standard error z-score 
Age (years) 0.013 0.000 33.320 
Died during year −0.306 0.032 −9.570 
Female (0/1) −0.227 0.009 −25.540 
Black (0/1) −1.389 0.012 −112.040 
Hispanic (0/1) 0.960 0.019 49.630 
Disability as reason for Original Medicare status (0/1) 2.158 0.022 98.880 
ESRD (0/1) −0.177 0.032 −5.490 
Share mos. elig. during year (prop.) 0.163 0.016 10.220 
HCC risk score −0.086 0.006 −14.610 
Other MDM 0.884 0.009 97.090 
MSA (0/1) −0.312 0.027 −11.710 
% of pop. living in married household −0.020 0.001 −37.630 
% of households with member >= 60 yrs. −0.006 0.001 −8.850 
% of those age < 65 yrs. with college education 0.030 0.000 72.370 
% of those age < 65 yrs. with self-care limitation −0.044 0.003 −14.740 
% of households with member < 18 yrs.  0.040 0.001 60.680 
% of those age < 65 yrs. unemployed −0.050 0.001 −33.530 
Distance to nearest hospital (mi.) −0.033 0.002 −21.640 
Distance to nearest nursing facility (mi.) −0.189 0.003 −59.240 
Intercept −2.233 0.064 −34.950 
ESRD = end-stage renal disease; HCC = Hierarchical Condition Category; MDM = Master Data Management 
database; MSA = metropolitan statistical area. 
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Figure A-1 
Distribution of beneficiary-level propensity scores in the Massachusetts demonstration and 
comparison groups, weighted and unweighted, January 1, 2016–December 31, 2016 
 
 
Group Comparability 
Covariate balance refers to the extent to which the characteristics used in the PS model 
are similar (or “balanced”) for the demonstration and comparison groups. Group differences are 
measured by a standardized difference (the difference in group means divided by the pooled 
standard deviation of the covariate). An informal standard has developed that groups are 
considered comparable if the standardized covariate difference is less than 0.10 standard 
deviations. 
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Table A-2 
Massachusetts dual eligible beneficiary covariate means by group before and after 
weighting by propensity score—demonstration year 3: January 1, 2016–December 31, 2016 
Characteristic 
Demonstration 
group mean 
Comparison 
group mean 
PS-weighted 
comparison 
group mean 
Unweighted 
standardized 
difference 
Weighted 
standardized 
difference 
Age 50.659 51.373 50.393 −0.060 0.024 
Died 0.016 0.025 0.017 −0.063 −0.003 
Female 0.515 0.528 0.505 −0.025 0.020 
Black 0.127 0.319 0.123 −0.474 0.013 
Hispanic 0.100 0.024 0.090 0.318 0.034 
Disability as reason for 
Original Medicare status 
0.974 0.832 0.972 0.493 0.010 
ESRD 0.015 0.033 0.017 −0.115 −0.017 
Share mos. elig. during year 0.871 0.810 0.861 0.211 0.037 
HCC score 1.020 1.047 1.018 −0.037 0.003 
Other MDM 0.437 0.204 0.435 0.517 0.004 
MSA 0.979 0.931 0.982 0.234 −0.018 
% of pop. living in married 
household 
64.750 62.566 66.203 0.130 −0.089 
% of households with 
member >= 60 yrs. 
35.937 37.868 36.111 −0.254 −0.024 
% of those age < 65 yrs. 
with college education 
32.492 25.360 33.515 0.435 −0.057 
% of those age < 65 yrs. 
with self-care limitation 
2.159 2.652 2.069 −0.239 0.053 
% of households with 
member < 18 yrs. 
31.191 30.203 31.377 0.136 −0.025 
% of those age < 65 yrs. 
unemployed 
8.224 9.494 8.029 −0.255 0.045 
Distance to nearest hospital 4.126 5.857 4.192 −0.404 −0.020 
Distance to nearest nursing 
facility 
2.579 3.827 2.667 −0.497 −0.054 
ESRD = end-stage renal disease; HCC = Hierarchical Condition Category; MDM=Master Data Management 
database; MSA = metropolitan statistical area. 
The group means and standardized differences for all beneficiary characteristics are 
shown for demonstration year 3 in Table A-2. The column of unweighted standardized 
differences indicates that several of these variables were not balanced before running the 
propensity model. In our model, six variables had the unweighted standardized difference 
exceeding 0.40 prior to PS model (percent Black, disabled, percent in other MDM (shared 
savings) programs, percent of those age < 65 years with college education, and the distances (in 
miles) to the nearest hospital and nursing facility).  
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The results of PS weighting for Massachusetts demonstration year 3 are illustrated in the 
far-right column (weighted standardized differences) in Table A-2. Propensity weighting reduced 
the standardized differences below the threshold level of an absolute value of 0.1 for all the 
covariates in our model.  
Summary 
Similar to the demonstration year 2 analysis, our Massachusetts demonstration year 3 
analyses added two new covariates (Black and other Medicare savings program participation) to 
our propensity model and included beneficiaries participating in shared savings programs. The 
Massachusetts demonstration and comparison groups were initially distinguished by differences 
in 15 variables. However, PS weighting successfully reduced all covariate discrepancies below 
the threshold for standardized differences. As a result, the weighted Massachusetts groups are 
adequately balanced with respect to all 19 variables we consider for comparability.  
In addition, we performed PS weighting on a subgroup of demonstration enrollees 
(approximately 14 percent of the eligible demonstration population) using a comparison group 
defined as follows: (1) The demonstration enrollees are those with at least one month of 
enrollment during the 3-year demonstration period as well as one month of eligibility during the 
2-year baseline period, and (2) The corresponding comparison group beneficiaries are those with 
at least one month of eligibility in both the 3-year demonstration period and the 2-year baseline 
period. The PS weighting analysis on enrollees and their associated comparison group yielded 
very similar results to the main analysis on the all eligible population presented in this appendix. 
The comparison group for enrollees is used only in cost savings analyses to be presented 
separately. 
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Appendix B: 
Analysis Methodology 
Methodology 
We briefly describe the overall evaluation design, the data used, and the populations and 
measures analyzed.  
Evaluation Design 
RTI International is using an intent-to-treat (ITT) approach for the quantitative analyses 
conducted for the evaluation, comparing the eligible population under each State demonstration 
with a similar population that is not affected by the demonstration (i.e., a comparison group). 
ITT refers to an evaluation design in which all Medicare-Medicaid enrollees eligible for the 
demonstration constitute the evaluation sample, regardless of whether they actively participated 
in demonstration models. Thus, under the ITT framework, analyses include all beneficiaries 
eligible for the demonstration, including those who are eligible but are not contacted by the 
Commonwealth or participating providers to enroll in the demonstration or care model; those 
who enroll but do not engage with the care model; and a group of similar eligible individuals in 
the comparison group.  
Results for sub-populations within each of the demonstration and comparison groups are 
also presented in this section (e.g., those with any LTSS use in the demonstration and 
comparison groups; those with any behavioral health claims in the demonstration and 
comparison groups). In addition, one group for which descriptive results are also reported are not 
compared to the comparison group because this group does not exist within the comparison 
group: Massachusetts demonstration enrollees. For this group, we compare them to in-State non-
enrollees. 
Comparison Group Identification 
The comparison group will serve to provide an estimate of what would have happened to 
the demonstration group in the absence of the demonstration. Thus, the comparison group 
members should be similar to the demonstration group members in terms of their characteristics 
and health care and long-term services and supports (LTSS) needs, and they should reside in 
areas that are similar to the demonstration State in terms of the health care system and the larger 
environment. For this evaluation, identifying the comparison group members entailed two steps: 
(1) selecting the geographic area from which the comparison group would be drawn and 
(2) identifying the individuals who would be included in the comparison group. 
To construct Massachusetts’s comparison group, we used both in-state and out-of-State 
areas. We compared demonstration and potential comparison areas on a range of measures, 
including spending per Medicare-Medicaid enrollee by each program, the shares of LTSS 
delivered in facility-based and community settings, and the extent of Medicare and Medicaid 
managed care penetration. Using statistical analysis, we selected the individual comparison 
metropolitan statistical areas (MSAs) that most closely match the values found in the 
demonstration area on the selected measures. We also considered other factors when selecting 
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comparison States, such as timeliness of Medicaid data submission to CMS. We identified a 
comparison group from MSAs in Alabama, Kentucky, Maryland, Massachusetts, Mississippi, 
North Carolina, Pennsylvania, Virginia, West Virginia, and Wisconsin at least as large as the 
eligible population in Massachusetts. For details of the comparison group identification strategy, 
see Appendix A. 
Data 
Evaluation Report analyses used data from a number of sources. First, the State provided 
quarterly finder files containing identifying information on all demonstration eligible 
beneficiaries in the demonstration period. Second, RTI obtained administrative data on 
beneficiary demographic, enrollment, and service use characteristics from CMS data systems for 
both demonstration and comparison group members. Third, these administrative data were 
merged with Medicare claims and encounter data on utilization of Medicare services, as well as 
the MDS. 
Medicaid service data on use of LTSS, behavioral health, and other Medicaid-reimbursed 
services were available for One Care enrollees in the baseline and demonstration periods. CMS 
administrative data identifying eligible beneficiaries who used any Medicaid-reimbursed long-
stay nursing home services or any Medicare behavioral health services were also available, so 
that their Medicare service use could be presented in this report. Future reports will continue to 
include findings on Medicaid service use once data are available. 
Populations and Services Analyzed 
The populations analyzed in the report include all demonstration eligible beneficiaries, as 
well as the following special populations: those receiving any long-stay nursing home services; 
those with any behavioral health service use in the last 2 years for a severe and persistent mental 
illness (SPMI); and demonstration enrollees.  
For each group and service type analyzed, we provide estimates of three access to care 
and utilization measures: the percent of demonstration eligible beneficiaries with any use of a 
service and counts of service use for both all eligible beneficiaries and users of the respective 
service. 
The 12 service settings analyzed include both institutional (inpatient, inpatient 
psychiatric, inpatient non-psychiatric, emergency department visits not leading to admission, 
emergency department psychiatric visits, observation stays, skilled nursing facility, and hospice) 
and community settings (primary care, outpatient as well as independent physical, speech, and 
occupational therapy, durable medical equipment, and other hospital outpatient services).  
In addition, five quality measures representing specific utilization types of interest are 
presented: 30-day all-cause risk-standardized readmission rate; preventable emergency room 
visits; ACSC overall composite rate (AHRQ PQI#90); ACSC chronic composite rate (AHRQ 
PQI#92); and depression screening rate. 
Five nursing facility-related measures are presented from the Minimum Data Set: two 
measures of annual NF utilization (admission rate and percentage of long-stay NF users) and 
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three characteristics of new long-stay NF residents at admission (functional status, percent with 
severe cognitive impairment, percent with low level of care need).  
The analyses were conducted for each of the years in the 2-year predemonstration period 
(October 1, 2011 to September 30, 2013) and for the first, second, and third demonstration 
periods (October 1, 2013 to December 31, 2014, January 1 to December 31, 2015, and January 1, 
2016 to December 31, 2016) for both the demonstration and comparison groups in each of the 
five analytic periods.  
Table B-1 presents descriptive statistics on the independent variables used in multivariate 
difference-in-differences (DID) regressions for impact analyses. Independent variables include 
demographic and health characteristics and market- and area-level characteristics. Results are 
presented for six groups: all demonstration eligibles in the FAI State, its comparison group, 
demonstration enrollees, non-enrollees, demonstration eligibles with any long-stay NF use, and 
demonstration eligibles with an SPMI.  
In demonstration period 3, there were 113,801 eligible beneficiaries in the demonstration 
group, and 211,665 beneficiaries in the comparison group. Age 45 and older was the most 
prevalent age category across all groups. In both the comparison and demonstration groups, 
about 70 to 72 percent were 45 years and older. Across most groups, the majority of eligible 
beneficiaries were female (51.5 to 55.9 percent), with exception of LTSS users. Across all 
groups, the majority were white (59.1 to 79.2 percent in the enrolled and LTSS groups, 
respectively), and had disability as their reason for original entitlement to Medicare (83.3 to 97.9 
percent in the comparison and enrolled populations, respectively). The average percentage of 
months with full-dual eligibility during the year ranged from 79.2 percent to 90 percent for LTSS 
users and those with SPMI diagnosis. HCC scores ranged from 1.01 to 1.90 in the eligible 
population and in the those with LTSS users, respectively.  
There were limited differences in area- and market-level characteristics. Those who were 
in the comparison group resided in counties with slightly higher average Medicare spending per 
dual, relative to those in the demonstration group ($18,114 vs $16,854, respectively). 
Additionally, those with LTSS use resided in counties with a higher percentage of adults with a 
college education, relative to the demonstration group overall and the comparison group (37 
percent vs. 32.5 and 33.5 percent, respectively).  
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Table B-1 
Characteristics of demonstration eligible beneficiaries in current demonstration year by group 
Characteristics Demonstration Comparison Enrollees Non-enrollees LTSS users 
SPMI 
diagnosis 
Number of beneficiaries 113,801 211,665 16,158 97,643 1,682 67,920 
Demographic characteristics             
Age             
21 to 44 28.2 29.7 27.5 28.3 7.8 29.4 
45 and older 71.8 70.3 72.5 71.7 92.2 70.6 
Female             
No 48.5 47.2 48.2 48.5 55.2 44.1 
Yes  51.5 52.8 51.8 51.5 44.8 55.9 
Race              
White 69.2 60.4 59.1 70.9 79.2 71.8 
Black 12.7 31.8 21.1 11.3 11.8 11.3 
Hispanic 10.0 2.5 12.6 9.6 4.6 10.0 
Asian 1.9 1.4 1.9 1.9 1.1 1.5 
Disability as reason for original Medicare entitlement             
No (0) 3.0 16.7 2.1 3.1 5.5 1.6 
Yes (1) 97.0 83.3 97.9 96.9 94.5 98.4 
ESRD status             
No (0) 98.6 97.0 98.7 98.6 95.0 98.9 
Yes (1) 1.4 3.0 1.3 1.4 5.0 1.1 
MSA              
Non-metro (0) 2.1 6.4 0.6 2.3 2.3 2.1 
Metro (1) 97.9 93.6 99.4 97.7 97.7 97.9 
Months with full-dual eligibility during year (%)  87.1 86.1 95.4 85.7 79.2 90.0 
HCC score  1.0 1.0 1.0 1.0 1.9 1.1 
 (continued) 
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Table B-1 (continued) 
Characteristics of demonstration eligible beneficiaries in current demonstration year by group 
Characteristics Demonstration Comparison Enrollees Non-enrollees LTSS users 
SPMI 
diagnosis 
Market characteristics             
Medicare spending per dual, ages 19+ ($) 16,854 18,114 16,798 16,863 17,037 16,870 
MA penetration rate 0.2 0.2 0.2 0.2 0.2 0.2 
Medicaid-to-Medicare fee index (FFS) 0.8 0.7 0.8 0.8 0.8 0.8 
Medicaid spending per dual, ages 19+ ($) 22,484 22,337 22,548 22,473 22,474 22,485 
Fraction of duals using NF, ages 65+  0.2 0.3 0.2 0.2 0.2 0.2 
Fraction of duals using HCBS, ages 65+ 0.1 0.1 0.1 0.1 0.1 0.1 
Fraction of duals using personal care, ages 19+  0.0 0.0 0.0 0.0 0.0 0.0 
Patient care physicians per 1,000 population  1.1 0.9 1.1 1.1 1.1 1.1 
Area characteristics             
% of pop. living in married households  64.7 66.2 59.2 65.7 68.1 65.1 
% of adults with college education  32.5 33.5 30.9 32.8 37.0 33.2 
% of adults who are unemployed  8.2 8.0 9.1 8.1 7.5 8.1 
% of adults with self-care limitations 2.2 2.1 2.4 2.1 1.9 2.1 
Distance to nearest hospital  4.1 4.2 3.4 4.2 4.0 4.1 
Distance to nearest nursing home  2.6 2.7 2.2 2.6 2.6 2.6 
% of household with individuals younger than 18 31.2 31.4 30.8 31.3 30.3 31.0 
% of household with individuals older than 60 35.9 36.1 33.9 36.3 36.5 35.8 
ESRD = end-stage renal disease; HCC = Hierarchical Condition Category; MA = Medicare Advantage, MSA = metropolitan statistical area; NF = nursing 
facility.  
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Detailed Population Definitions 
Demonstration eligible beneficiaries. Beneficiaries are identified in a given month if they 
were a Medicare-Medicaid enrollee and met any other specific demonstration eligibility criteria. 
Beneficiaries in the demonstration period are identified from quarterly State finder files, whereas 
beneficiaries in the 2-year baseline period preceding the demonstration implementation date are 
identified by applying the eligibility criteria in each separate baseline quarter. 
Additional special populations were identified for the analyses as follows: 
• Enrollees. A beneficiary was defined as an enrollee if they were enrolled in the 
demonstration during the demonstration period.  
• Age. Age was defined as a categorical variable where beneficiaries were identified as 
21 to 44, and 45 years and older during the observation year (e.g., baseline period 1, 
baseline period 2, and demonstration periods 1, 2, and 3.) 
• Gender. Gender was defined as binary variable where beneficiaries were either male 
or female.  
• Race. Race was defined as a categorical variable where beneficiaries were 
categorized as White, African American, Hispanic, or Asian.  
• LTSS. A beneficiary was defined as using LTSS if there was any use of institutional 
based services during the observation year. Information on home and community-
based services to identify the LTSS population was not available for use in Medicare 
analyses. 
• SPMI. A beneficiary was defined as having a SPMI if a beneficiary had incurred a 
claim for severe and persistent mental illness within the past 2 years.  
Detailed Utilization and Expenditure Measure Definitions 
For any health care service type, the methodology for estimating average monthly 
utilization and the percentage of users takes into account differences in the number of eligibility 
months across beneficiaries. Because full-benefit dual eligibility status for the demonstration can 
vary by month over time for any individual, the methodology used determines dual eligibility 
status for the demonstration for each person on a monthly basis during a baseline or 
demonstration period. That is, an individual is capable of meeting the demonstration’s eligibility 
criteria for up to 12 months during the observation year. The methodology adds the total months 
of full-benefit dual eligibility for the demonstration across the population of interest and uses it 
in the denominator in the measures in Section 1.3, creating average monthly utilization 
information for each service type. The methodology effectively produces average monthly use 
statistics for each year that account for variation in the number of dual eligible beneficiaries in 
each month of the observation year.  
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The utilization measures below were calculated as the aggregate sum of the unit of 
measurement (e. g. counts) divided by the aggregated number of eligible member months [and 
user months] within each group (g) where group is defined as (1) Massachusetts Base Year 1, 
(2) Comparison Base Year 1, (3) Massachusetts Base Year 2, (4) Comparison Base Year 2, 
(5) Massachusetts Demonstration Period 1, (6) Comparison Demonstration Period 1, 
(7) Massachusetts Demonstration Period 2, (8) Comparison Period 2, (9) Massachusetts 
Demonstration Period 3, (10) Comparison Period 3. 
We calculated the average number of services per 1,000 eligible months and per 1,000 
user months by beneficiary group (g). We defined user month as an eligible month where the 
number of units of utilization used [for a given service] was greater than zero. We weight each 
observation using yearly propensity weights. The average yearly utilization outcomes are 
measured as:  
 
Where  Yɡ  = average count of the number services used [for a given service] per eligible or 
user month within group g.  
Ȥiɡ  = the total units of utilization [for a given service] for individual i in group g. niɡ  = the total number of eligible/user months for individual i in group g.  
The denominator above is scaled by  such that the result is interpreted in terms of 
average monthly utilization per 1,000 eligible beneficiaries. This presentation is preferable, 
compared with per eligible, because some of the services are used less frequently and would 
result in small estimates. 
The average percentage of users [of a given service] per eligible month during the 
baseline or demonstration year is measured as follows: 
Where 
Uig  = average percentage of users [for a particular service] in a given month among 
beneficiaries in group g.  
Xig  = the total number of eligible months of service use for an individual i in group g niɡ = the total number of eligible or user months for an individual i in group g.  
𝑌𝑌𝑔𝑔 =  Σ𝑖𝑖𝑔𝑔𝑍𝑍𝑖𝑖𝑔𝑔11,000 ∗ Σ𝑖𝑖𝑔𝑔𝑛𝑛𝑖𝑖𝑔𝑔  
11,000 
𝑈𝑈 = Σ𝑖𝑖𝑔𝑔𝑋𝑋𝑖𝑖𝑔𝑔
Σ𝑖𝑖𝑔𝑔𝑛𝑛𝑖𝑖𝑔𝑔
 x 100  
( )
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Quality of Care and Care Coordination Measures 
Similar to the utilization measures, the quality of care and care coordination measures 
were calculated as the aggregated sum of the numerator divided by the aggregated sum of the 
denominator for each respective outcome within each beneficiary group.  
Average 30-day all-cause risk-standardized readmission was calculated as follows: 
 
Where 
C = the national average of 30-day readmission rate, .238. 
Xig = the total number of readmissions for individual i in group g. niɡ = the total number of hospital admissions for individual i in group g. 
Probg = the annual average adjusted probability of readmission for individuals in 
group g. The average adjusted probability equals: 
Average adjusted probability of readmission by 
demonstration group 
Demonstration group 
Average adjusted probability 
of readmission 
Baseline period 1 
Massachusetts 0.212 
Comparison 0.223 
Baseline period 2 
  
Massachusetts 0.214 
Comparison 0.223 
Demonstration period 1 
  
Massachusetts 0.221 
Comparison 0.228 
Demonstration period 2 
  
Massachusetts 0.220 
Comparison 0.227 
Demonstration period 3 
  
Massachusetts 0.226 
Comparison 0.229 
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Average 30-day follow-up in a physician or outpatient setting after hospitalization for 
mental illness was calculated as follows: 
𝑀𝑀𝑀𝑀𝑀𝑀𝑈𝑈 = Σ𝑖𝑖𝑖𝑖𝑥𝑥𝑖𝑖𝑖𝑖
Σ𝑖𝑖𝑖𝑖n𝑖𝑖𝑖𝑖 
Where 
MHFU  = the average rate of 30-day follow-up care after hospitalization for a mental 
illness for individuals in group g.  
Xig = the total number of discharges from a hospital stay for mental health that 
had a follow-up for mental health within 30 days of discharge for individual 
i in group g.  niɡ = the total number of discharges from a hospital stay for mental health for 
individual i in group g.  
Average ACSC admissions per 1,000 eligible beneficiaries, overall and chronic 
composite (PQI #90 and PQI #92) was calculated as follows:  
𝐴𝐴𝐶𝐶𝑆𝑆𝐶𝐶𝑖𝑖𝑖𝑖  = Σ𝑖𝑖𝑖𝑖𝑥𝑥𝑖𝑖𝑖𝑖11000 ∗ Σ𝑖𝑖𝑖𝑖n𝑖𝑖𝑖𝑖 
Where 
ACSCg =  the average number of ACSC admissions per 1,000 eligible months for 
overall/chronic composites for individuals in group g.  
Xig =  the total number of discharges that meet the criteria for AHRQ PQI #90 [or 
PQI #92] for individual i in group g.  niɡ = the total number of eligible months for individual i in group g. 
Preventable ER visits per 1,000 eligible months was calculated as follows: 
𝐸𝐸𝑅𝑅𝑖𝑖𝑖𝑖  = Σ𝑖𝑖𝑖𝑖𝑥𝑥𝑖𝑖𝑖𝑖11000 ∗ Σ𝑖𝑖𝑖𝑖n𝑖𝑖𝑖𝑖 
Where  
ERg = the average number of preventable ER visits per 1,000 eligible months for 
individuals in group g.  
Xig = the total number ER visits that are considered preventable based in the diagnosis 
for individual i in group g.  niɡ = the total number of eligible months for individual i in group g. 
(
(
)
)
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Average number of beneficiaries per 1,000 eligible months who received depression 
screening during the observation year was calculated as follows: 
𝐷𝐷𝑖𝑖  = Σ𝑖𝑖𝑖𝑖𝑥𝑥𝑖𝑖𝑖𝑖11000 ∗ Σ𝑖𝑖𝑖𝑖n𝑖𝑖𝑖𝑖 
Where  
Dg = the average number of beneficiaries per 1,000 eligible months who received 
depression screening in group g 
Xig = the total number eligible beneficiaries age 65+ who ever received depression 
screening in group g.  niɡ = the total number of eligible months among beneficiaries in group g. 
Average rate of beneficiaries per positive depression screening who received a follow-up 
plan during the observation year was calculated as follows: 
𝑃𝑃𝐷𝐷𝑖𝑖  = Σ𝑖𝑖𝑖𝑖𝑥𝑥𝑖𝑖𝑖𝑖Σ𝑖𝑖𝑖𝑖n𝑖𝑖𝑖𝑖 
Where  
PDg = the average number of beneficiaries per positive depression screening who 
received a follow-up plan among beneficiaries in group g.  
Xig = the total number beneficiaries who received a positive depression screen and a 
follow-up plan in group g. niɡ = the total number of beneficiaries who received a positive depression screen in 
group g.  
Minimum Data Set Measures 
Two measures of annual nursing facility-related utilization are derived from the MDS. 
The rate of new long-stay NF admissions per 1,000 eligible beneficiaries is calculated as the 
number of NF admissions for whom there is no record of NF use in the 100 days prior to the 
current admission and who subsequently stay in the NF for 101 days or more. Individuals are 
included in this measure only if their NF admission occurred after their first month of 
demonstration eligibility. The percentage of long-stay NF users is calculated as the number of 
individuals who have stayed in a NF for 101 days or more, who were long-stay after the first 
month of demonstration eligibility. The probability of any long-stay NF use includes both new 
admissions from the community and continuation of a stay in a NF.  
Characteristics of new long-stay NF residents at admission are also included in order to 
monitor nursing facility case mix and acuity levels. Functional status and low level of care need 
are determined by the Resource Utilization Groups Version IV (RUG-IV). Residents with low 
care need are defined as those who did not require physical assistance in any of the four late-loss 
activities of daily living (ADLs) and who were in the three lowest RUG-IV categories. Severe 
( )
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cognitive impairment is assessed by the Brief Interview for Mental Status, poor short-term 
memory, or severely impaired decision-making skills. 
Regression Methodology for Determining Demonstration Impact  
The regressions across the entire demonstration period compare all demonstration eligible 
beneficiaries in the FAI State to its comparison group. The regression methodology accounts for 
both those with and without use of the specific service (e.g., for inpatient services, both those 
with and without any inpatient use). A restricted DID equation will be estimated as follows: 
Dependent variablei = β0 + β1PostYear + β2Demonstration +  
β3PostYear * Demonstration + β4Demographics + β5-j Market + ε 
where separate models will be estimated for each dependent variable. PostYear is an indicator of 
whether the observation is from the pre- or postdemonstration period, Demonstration is an 
indicator of whether the beneficiary was in the demonstration group, and PostYear * 
Demonstration is an interaction term. Demographics and Market represent vectors of beneficiary 
and market characteristics, respectively. 
Under this specification, the coefficient β0 reflects the comparison group 
predemonstration period mean adjusted for demographic and market effects, β1 reflects the 
average difference between postperiod and predemonstration period in the comparison group, β2 
reflects the difference in the demonstration group and comparison group at predemonstration, 
and β3 is the overall average demonstration effect during the demonstration period. This last term 
is the DID estimator and the primary policy variable of interest, but in all regression models, 
because of nonlinearities in the underlying distributions, post-regression predictions of 
demonstration impact are performed to obtain the marginal effects of demonstration impact. 
In addition to estimating the model described in the equation above, a less restrictive 
model was estimated to produce year-by-year effects of the demonstration. The specification of 
the unrestricted model is as follows: 
Dependent variable = β0 + β1-kPostYear1-n + β2Demonstration +  
β3-kPostYear1-n * Demonstration + β4 Demographics + β5-j Market + ε 
This equation differs from the previous one in that separate DID coefficients are 
estimated for each year. Under this specification, the coefficients β3-k would reflect the impact of 
the demonstration in each respective year, whereas the previous equation reflects the impact of 
the entire demonstration period. This specification measures whether changes in dependent 
variables occur in the first year of the demonstration only, continuously over time, or in some 
other pattern. Depending on the outcome of interest, we will estimate the equations using logistic 
regression, Generalized Linear Models with a log link, or count models such as negative 
binomial or Poisson regressions (e.g., for the number of inpatient admissions). We used 
regression results to calculate the marginal effects of demonstration impact. We checked for 
multicollinearity to further specify the covariates used in the regression model.  
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Impact estimates across the entire demonstration period are determined using the DID 
methodology and presented in figures for all demonstration eligible beneficiaries, and then for 
two special populations of interest—demonstration eligible beneficiaries with any LTSS use, and 
demonstration eligible beneficiaries with SPMI. A table follows each figure displaying the 
annual demonstration DID effect for each separate demonstration period for each of these 
populations. In each figure, the point estimate is displayed for each measure, as well as the 90 
percent confidence interval (black) and the 80 percent confidence interval (green). The 80 
percent confidence interval is narrower than the 90 percent confidence interval. If the confidence 
interval includes the value of zero, it is not statistically significant at that confidence level. 
For only the full demonstration eligible population and not each special population, an 
additional table presents estimates of the regression-adjusted mean values of the utilization 
measures for the demonstration and comparison groups by year for each service. The purpose of 
this table is to understand the magnitude of the DID estimate relative to the adjusted mean 
outcome value in each period. The adjusted mean values show how different the two groups 
were in each period, and the relative direction of any potential effect in each group over time. 
The values in the third and fourth columns represent the post-regression, mean predicted value of 
the outcomes for each group and period, based on the composition of a reference population (the 
comparison group in the demonstration period). The DID estimate is also provided for reference, 
along with the p-value and the relative percent change of the DID estimate compared to an 
average mean use rate for the comparison group in the entire demonstration period. 
The relative percent annual change for the DID estimate for each outcome measure is 
calculated as [Overall DID effect] / [Adjusted mean outcome value of comparison group in the 
demonstration period].  
Table B-2 provides an illustrative example of the regression output for each independent 
variable in the negative binomial regression on monthly inpatient admissions across the entire 
demonstration period. 
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Table B-2 
Negative binomial regression results on monthly inpatient admissions 
(n=15,445,452 person months) 
Independent variables Coefficient Std. err. z-value p-value 
Post period −0.1403 0.0152 −9.2100 0.0000 
Demonstration group −0.0841 0.0403 −2.0900 0.0370 
Interaction of post period x demonstration group 0.0398 0.0163 2.4500 0.0140 
Trend 0.0006 0.0006 1.0200 0.3050 
Age −0.0023 0.0011 −2.0600 0.0390 
Female −0.0130 0.0133 −0.9800 0.3270 
Black −0.0357 0.0268 −1.3300 0.1830 
Asian −0.5608 0.0715 −7.8500 0.0000 
Other race −0.3530 0.0387 −9.1300 0.0000 
Hispanic −0.2617 0.0357 −7.3300 0.0000 
Disability as reason for original Medicare entitlement 0.0870 0.0185 4.7000 0.0000 
End-stage renal disease 1.4466 0.0340 42.5500 0.0000 
Hierarchical condition category (HCC) score 0.4406 0.0079 55.7900 0.0000 
Percent of months of demonstration eligibility −1.0316 0.0354 −29.1300 0.0000 
Metropolitan statistical area (MSA) residence 0.0098 0.0630 0.1600 0.8760 
Percent of households with family member greater than or 
equal to 60 years old 
−0.0058 0.0010 −5.7500 0.0000 
Percent of households with family member less than 18 
years old 
−0.0062 0.0012 −5.2500 0.0000 
Percent of adults with college education −0.0013 0.0007 −1.9600 0.0500 
Percent adult unemployment rate 0.0048 0.0018 2.7000 0.0070 
Percent of adults with self-care limitation −0.0038 0.0075 −0.5100 0.6130 
Distance to nearest hospital −0.0027 0.0031 −0.8700 0.3840 
Distance to nearest nursing home −0.0027 0.0056 −0.4900 0.6230 
Medicare Advantage penetration rate −0.1361 0.2042 −0.6700 0.5050 
Medicaid spending per full-benefit dual eligible  0.0000 0.0000 1.4700 0.1410 
Nursing facility users per full-benefit dual eligible over 65 0.4167 0.2954 1.4100 0.1580 
State plan personal care users per full-benefit dual eligible 
over 65 
−0.9635 0.5292 −1.8200 0.0690 
Home and community-based services (HCBS) users per 
full-benefit dual eligible over 65 
1.0359 0.2776 3.7300 0.0000 
Medicaid-to-Medicare fee index 0.1306 0.4126 0.3200 0.7520 
Patient care physicians per 1,000 (total) population 0.2196 0.0839 2.6200 0.0090 
Participating in shared savings program 0.1668 0.0383 4.3500 0.0000 
Intercept −2.9894 0.4542 −6.5800 0.0000 
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Appendix C: 
Descriptive Tables 
Tables in Appendix C present results on the average percentage of demonstration eligible 
beneficiaries using selected Medicare service types during the months in which they met 
demonstration eligibility criteria in the predemonstration and demonstration periods. In addition, 
average counts of service use are presented across all such eligible months, and for the subset of 
these months in which eligible beneficiaries were users of each respective service type. Data is 
shown for the predemonstration and demonstration period for both Massachusetts eligible 
beneficiaries (a.k.a. the demonstration group) and the comparison group. Similar tables of 
Medicaid service utilization are also presented, as well as tables for the RTI quality of care and 
care coordination measures.  
Tables are presented for the overall demonstration eligible population (Tables C-1 
through C-3), followed by tables on Massachusetts demonstration eligible beneficiaries who 
enrolled in the demonstration and those who did not enroll (Tables C-4 through C-5). Finally, 
Tables C-6 and C-7 present results on services traditionally paid by Medicaid, first for all 
demonstration and comparison group eligibles, and then for One Care enrollees. 
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Table C-1 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration eligible 
beneficiaries and comparison groups 
Measures by setting Group 
Baseline year 
1 
Baseline year 
2 
Demonstration 
period 1 
Demonstration 
period 2 
Demonstration 
period 3 
Number of demonstration beneficiaries   108,347 117,966 96,589 103,679 113,801 
Number of comparison beneficiaries    176,882 188,447 198,235 204,198 211,665 
Institutional setting             
Inpatient admissions1  Demonstration group           
% with use   3.5 3.4 3.3 3.3 3.2 
Utilization per 1,000 user months   1,178.0 1,170.1 1,094.9 1,111.2 1,169.6 
Utilization per 1,000 eligible months   41.4 39.6 38.5 38.7 36.9 
Inpatient admissions Comparison group           
% with use   3.5 3.5 3.3 3.3 3.3 
Utilization per 1,000 user months   1,165.1 1,165.1 1,161.5 1,154.3 1,154.7 
Utilization per 1,000 eligible months   40.2 40.5 38.4 37.8 38.2 
Inpatient psychiatric Demonstration group           
% with use   0.8 0.7 0.7 0.7 0.6 
Utilization per 1,000 user months   1,083.4 1,085.4 1,026.8 1,038.8 1,083.3 
Utilization per 1,000 eligible months   8.5 8.0 7.9 7.7 7.0 
Inpatient psychiatric Comparison group           
% with use   0.7 0.7 0.7 0.6 0.6 
Utilization per 1,000 user months   1,100.3 1,108.8 1,094.5 1,082.2 1,092.1 
Utilization per 1,000 eligible months   7.7 7.9 7.5 6.5 6.7 
 (continued) 
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Table C-1 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration eligible 
beneficiaries and comparison groups 
Measures by setting Group 
Baseline year 
1 
Baseline year 
2 
Demonstration 
period 1 
Demonstration 
period 2 
Demonstration 
period 3 
Inpatient non-psychiatric Demonstration group           
% with use   2.8 2.7 2.6 2.7 2.6 
Utilization per 1,000 user months   1,164.8 1,156.8 1,079.2 1,096.9 1,158.4 
Utilization per 1,000 eligible months   32.9 31.6 30.6 31.0 29.9 
Inpatient non-psychiatric Comparison group           
% with use   2.8 2.8 2.7 2.7 2.8 
Utilization per 1,000 user months   1,150.9 1,145.4 1,146.4 1,142.7 1,139.0 
Utilization per 1,000 eligible months   32.5 32.5 30.8 31.2 31.5 
Emergency department use (non-admit) Demonstration group           
% with use   7.7 7.6 7.5 7.7 7.5 
Utilization per 1,000 user months   1,320.0 1,314.9 1,264.9 1,280.7 1,328.5 
Utilization per 1,000 eligible months   101.9 99.7 100.3 101.9 100.1 
Emergency department use (non-admit) Comparison group           
% with use   6.9 6.9 7.1 7.4 7.2 
Utilization per 1,000 user months   1,337.1 1,321.9 1,329.0 1,315.8 1,312.1 
Utilization per 1,000 eligible months   92.1 91.1 94.4 97.4 94.3 
Emergency department use (psychiatric) Demonstration group           
% with use   0.8 0.8 0.9 0.9 0.9 
Utilization per 1,000 user months   1,282.6 1,321.5 1,298.6 1,325.0 1,361.2 
Utilization per 1,000 eligible months   10.6 10.7 12.0 12.5 11.9 
Emergency department use (psychiatric) Comparison group           
% with use   0.6 0.6 0.6 0.6 0.5 
Utilization per 1,000 user months   1,239.4 1,235.8 1,231.0 1,251.1 1,210.5 
Utilization per 1,000 eligible months   7.0 7.0 7.0 7.3 6.4 
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Table C-1 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration eligible 
beneficiaries and comparison groups 
Measures by setting Group 
Baseline year 
1 
Baseline year 
2 
Demonstration 
period 1 
Demonstration 
period 2 
Demonstration 
period 3 
Observation stays Demonstration group           
% with use   0.7 0.8 0.8 0.8 0.9 
Utilization per 1,000 user months   1,070.5 1,073.9 1,012.8 1,021.2 1,073.0 
Utilization per 1,000 eligible months   7.5 8.3 8.6 8.5 9.5 
Observation stays Comparison group           
% with use   0.6 0.6 0.7 0.8 0.8 
Utilization per 1,000 user months   1,060.8 1,060.8 1,066.5 1,059.3 1,056.6 
Utilization per 1,000 eligible months   6.0 6.8 7.7 8.0 8.4 
Skilled nursing facility Demonstration group           
% with use   0.4 0.4 0.4 0.4 0.3 
Utilization per 1,000 user months   1,091.1 1,089.2 979.7 1,003.3 1,091.0 
Utilization per 1,000 eligible months   4.0 4.3 3.9 3.9 3.7 
Skilled nursing facility Comparison group           
% with use   0.5 0.5 0.5 0.5 0.5 
Utilization per 1,000 user months   1,094.9 1,089.4 1,080.4 1,088.7 1,082.3 
Utilization per 1,000 eligible months   5.2 5.9 5.0 4.9 5.4 
Hospice  Demonstration group           
% with use   0.2 0.2 0.1 0.1 0.1 
Utilization per 1,000 user months   1,048.4 1,037.6 901.6 933.9 1,026.8 
Utilization per 1,000 eligible months   1.6 1.6 1.2 1.1 1.1 
Hospice  Comparison group           
% with use   0.2 0.2 0.2 0.2 0.2 
Utilization per 1,000 user months   1,063.8 1,033.9 1,017.0 1,026.6 1,023.0 
Utilization per 1,000 eligible months   2.3 2.2 2.0 2.2 2.2 
 (continued) 
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Table C-1 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration eligible 
beneficiaries and comparison groups 
Measures by setting Group 
Baseline year 
1 
Baseline year 
2 
Demonstration 
period 1 
Demonstration 
period 2 
Demonstration 
period 3 
Non-institutional setting             
Primary care E&M visits Demonstration group           
% with use   43.1 49.8 52.2 51.6 51.9 
Utilization per 1,000 user months   1,678.6 1,756.2 1,733.1 1,745.4 1,835.0 
Utilization per 1,000 eligible months   722.7 874.5 955.9 940.3 951.8 
Primary care E&M visits Comparison group           
% with use   42.1 47.8 49.7 52.3 52.8 
Utilization per 1,000 user months   1,702.5 1,773.3 1,784.6 1,834.0 1,856.5 
Utilization per 1,000 eligible months   717.2 847.3 886.2 959.2 980.5 
Outpatient therapy (PT, OT, ST) Demonstration group           
% with use   2.5 2.5 2.4 2.4 2.5 
Utilization per 1,000 user months   9,554.2 9,389.2 9,409.9 9,237.3 9,935.0 
Utilization per 1,000 eligible months   236.8 232.2 242.6 239.5 247.9 
Outpatient therapy (PT, OT, ST) Comparison group           
% with use   2.5 2.5 2.5 2.8 3.1 
Utilization per 1,000 user months   13,999.5 13,559.5 15,673.3 16,039.8 16,798.4 
Utilization per 1,000 eligible months   346.0 343.5 393.8 444.8 520.0 
Independent therapy (PT, OT, ST) Demonstration group           
% with use   1.3 1.3 1.4 1.4 1.5 
Utilization per 1,000 user months   9,607.7 9,723.8 10,990.7 10,936.0 11,693.9 
Utilization per 1,000 eligible months   120.7 123.7 158.4 160.0 173.9 
Independent therapy (PT, OT, ST) Comparison group           
% with use   1.3 1.3 1.4 1.6 1.7 
Utilization per 1,000 user months   10,827.2 11,447.4 12,726.2 13,674.6 14,018.4 
Utilization per 1,000 eligible months   139.9 153.0 183.5 220.4 241.5 
 (continued) 
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Table C-1 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration eligible 
beneficiaries and comparison groups 
Measures by setting Group 
Baseline year 
1 
Baseline year 
2 
Demonstration 
period 1 
Demonstration 
period 2 
Demonstration 
period 3 
Other hospital outpatient services  Demonstration group           
% with use   37.3 36.6 36.2 36.0 36.2 
Utilization per 1,000 user months   — — — — — 
Utilization per 1,000 eligible months   — — — — — 
Other hospital outpatient services  Comparison group           
% with use   21.5 22.1 22.4 23.4 24.1 
Utilization per 1,000 user months   — — — — — 
Utilization per 1,000 eligible months   — — — — — 
— = data not available. E&M= evaluation and management; OT = occupational therapy, PT = physical therapy, ST = speech therapy. 
1 Includes acute admissions, inpatient rehabilitation, and long-term care hospital admissions. 
SOURCE: RTI International analysis of Medicare data. 
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Table C-2 
Quality of care and care coordination outcomes for demonstration eligible and comparison beneficiaries 
for the Massachusetts demonstration 
Quality and care 
coordination measures Group 
Baseline year 
1 
Baseline year 
2 
Demonstration 
year 1 
Demonstration 
year 2 
Demonstration 
year 3 
30-day all-cause risk-
standardized readmission 
rate (%) 
Demonstration group 21.3 21.1 20.2 21.1 19.7 
  Comparison group 19.7 19.7 19.0 18.7 18.6 
Preventable ER visits per 
eligible months 
Demonstration group 0.0482 0.0466 0.0455 0.0457 0.0440 
  Comparison group 0.0437 0.0435 0.0453 0.0461 0.0433 
Rate of 30-day follow-up 
after hospitalization for 
mental illness (%) 
Demonstration group 59.3 59.7 58.8 53.8 50.7 
  Comparison group 50.6 52.1 52.9 49.7 43.7 
Ambulatory care sensitive 
condition admissions per 
1,000 eligible months—
overall composite (AHRQ 
PQI # 90) 
Demonstration group 0.0039 0.0037 0.0041 0.0041 0.0043 
  Comparison group 0.0040 0.0040 0.0037 0.0045 0.0048 
Ambulatory care sensitive 
condition admissions per 
1,000 eligible months—
chronic composite (AHRQ 
PQI # 92) 
Demonstration group 0.0023 0.0022 0.0029 0.0030 0.0031 
  Comparison group 0.0024 0.0024 0.0022 0.0031 0.0033 
Screening for clinical 
depression per eligible 
months 
Demonstration group 0.0001 0.0008 0.0021 0.0036 0.0028 
  Comparison group 0.0001 0.0007 0.0018 0.0034 0.0037 
SOURCE: RTI International analysis of Medicare data 
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Table C-3 
Minimum Data Set long-stay nursing facility utilization and characteristics at admission for the 
Massachusetts demonstration and comparison groups 
Measures by setting Group 
Pre-
demonstration 
year 1 
Pre-
demonstration 
year 2 
Demonstration 
period 1 
Demonstration 
period 2 
Demonstration 
period 3 
Annual nursing facility utilization             
Number of demonstration beneficiaries Demonstration group 87,900 95,775 80,214 89,447 98,649 
New long-stay nursing facility admissions 
per 1,000 eligibles 
  3.3 2.8 3.7 2.3 2.9 
Number of comparison beneficiaries  Comparison group 113,229 120,644 121,401 128,739 129,417 
New long-stay nursing facility admissions 
per 1,000 eligibles 
  4.4 4 3.9 3.4 3.6 
Number of demonstration beneficiaries Demonstration group 89,522 97,559 81,087 90,272 99,439 
Long-stay nursing facility users as % of 
eligibles 
  2.1 2.1 1.5 1.2 1.1 
Number of comparison beneficiaries  Comparison group 118,773 126,170 125,874 133,750 135,431 
Long-stay nursing facility users as % of 
eligibles 
  5.1 4.8 4 4.1 4.8 
Characteristics of new long-stay nursing 
facility residents at admission 
            
Number of admitted demonstration 
beneficiaries 
Demonstration group 294 269 296 206 290 
Number of admitted comparison 
beneficiaries  
Comparison group 497 482 478 443 460 
Functional status (RUG-IV ADL scale) Demonstration group 6.5 7.3 6.8 7.3 7.2 
Functional status (RUG-IV ADL scale) Comparison group 7.5 7.3 7.6 7.6 7.9 
Percent with severe cognitive impairment Demonstration group 14.4 13.5 14 17.9 14.7 
Percent with severe cognitive impairment Comparison group 24.1 23 15.7 20.1 19.2 
Percent with low level of care need Demonstration group 2.6 3.9 3.3 2.5 1.8 
Percent with low level of care need Comparison group 2.3 4.4 2.4 3.1 1.6 
SOURCE: RTI International analysis of Minimum Data Set data. 
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Table C-4 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration enrollees and 
non-enrollees 
Measures by setting Group 
Demonstration 
period 1 
Demonstration 
period 2 
Demonstration 
period 3 
Number of enrollees   13,934 12,956 16,158 
Number of non-enrollees   82,655 90,723 97,643 
Institutional setting         
Inpatient admissions1  Enrollees       
% with use   2.4 2.9 2.2 
Utilization per 1,000 user months   1,489.1 1,907.7 1,136.0 
Utilization per 1,000 eligible months   27.5 33.8 24.5 
Inpatient admissions Non-enrollees       
% with use   3.3 3.3 3.3 
Utilization per 1,000 user months   1,646.2 1,230.0 1,172.5 
Utilization per 1,000 eligible months   39.2 39.2 38.4 
Inpatient psychiatric Enrollees       
% with use   0.4 0.6 0.6 
Utilization per 1,000 user months   939.9 1,347.9 1,094.5 
Utilization per 1,000 eligible months   4.6 6.6 6.5 
Inpatient psychiatric Non-enrollees       
% with use   0.7 0.7 0.6 
Utilization per 1,000 user months   1,631.3 1,216.0 1,082.2 
Utilization per 1,000 eligible months   8.1 7.8 6.9 
Inpatient non-psychiatric Enrollees       
% with use   2.0 2.4 1.6 
Utilization per 1,000 user months   1,651.7 2,071.5 1,117.0 
Utilization per 1,000 eligible months   22.9 27.2 18.1 
 (continued) 
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Table C-4 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration enrollees and 
non-enrollees 
Measures by setting Group 
Demonstration 
period 1 
Demonstration 
period 2 
Demonstration 
period 3 
Inpatient non-psychiatric Non-enrollees       
% with use   2.7 2.7 2.7 
Utilization per 1,000 user months   1,601.5 1,198.1 1,161.8 
Utilization per 1,000 eligible months   31.1 31.5 31.5 
Emergency department use (non-admit) Enrollees       
% with use   7.4 8.5 8.5 
Utilization per 1,000 user months   1,260.5 1,528.8 1,372.2 
Utilization per 1,000 eligible months   99.6 116.9 117.0 
Emergency department use (non-admit) Non-enrollees       
% with use   7.4 7.5 7.3 
Utilization per 1,000 user months   1,864.7 1,392.1 1,319.9 
Utilization per 1,000 eligible months   97.4 99.1 96.5 
Emergency department use (psychiatric) Enrollees       
% with use   1.0 1.1 1.1 
Utilization per 1,000 user months   1,428.4 1,776.0 1,344.6 
Utilization per 1,000 eligible months   14.0 16.9 14.6 
Emergency department use (psychiatric) Non-enrollees       
% with use   0.8 0.9 0.8 
Utilization per 1,000 user months   1,834.5 1,440.8 1,366.0 
Utilization per 1,000 eligible months   11.2 11.7 11.3 
 (continued) 
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Table C-4 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration enrollees and 
non-enrollees 
Measures by setting Group 
Demonstration 
period 1 
Demonstration 
period 2 
Demonstration 
period 3 
Observation stays Enrollees       
% with use   0.6 0.9 1.2 
Utilization per 1,000 user months   519.7 837.6 1,087.9 
Utilization per 1,000 eligible months   6.0 9.2 13.1 
Observation stays Non-enrollees       
% with use   0.8 0.8 0.8 
Utilization per 1,000 user months   1,437.0 1,019.9 1,070.3 
Utilization per 1,000 eligible months   8.6 8.3 8.9 
Skilled nursing facility Enrollees       
% with use   0.2 0.3 0.3 
Utilization per 1,000 user months   797.4 1,125.8 1,083.8 
Utilization per 1,000 eligible months   2.6 3.5 3.6 
Skilled nursing facility Non-enrollees       
% with use   0.4 0.4 0.3 
Utilization per 1,000 user months   1,639.5 1,193.2 1,092.4 
Utilization per 1,000 eligible months   4.1 3.9 3.7 
Hospice  Enrollees       
% with use   0.0 0.0 0.0 
Utilization per 1,000 user months   625.0 852.5 1,000.0 
Utilization per 1,000 eligible months   0.3 0.4 0.5 
Hospice  Non-enrollees       
% with use   0.1 0.1 0.1 
Utilization per 1,000 user months   1,625.3 1,057.4 1,028.5 
Utilization per 1,000 eligible months   1.3 1.2 1.2 
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Table C-4 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration enrollees and 
non-enrollees 
Measures by setting Group 
Demonstration 
period 1 
Demonstration 
period 2 
Demonstration 
period 3 
Non-institutional setting         
Primary care E&M visits Enrollees       
% with use   43.2 42.9 45.9 
Utilization per 1,000 user months   1,836.2 1,748.1 1,809.7 
Utilization per 1,000 eligible months   813.0 747.9 830.4 
Primary care E&M visits Non-enrollees       
% with use   53.0 52.8 52.7 
Utilization per 1,000 user months   2,529.9 1,879.5 1,837.8 
Utilization per 1,000 eligible months   967.2 968.3 968.4 
Outpatient therapy (PT, OT, ST) Enrollees       
% with use   1.5 1.9 2.0 
Utilization per 1,000 user months   3,903.3 5,567.5 5,382.2 
Utilization per 1,000 eligible months   74.8 104.2 107.6 
Outpatient therapy (PT, OT, ST) Non-enrollees       
% with use   2.5 2.5 2.6 
Utilization per 1,000 user months   14,625.4 10,413.2 10,521.0 
Utilization per 1,000 eligible months   266.8 259.2 269.3 
 (continued) 
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Table C-4 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration enrollees and 
non-enrollees 
Measures by setting Group 
Demonstration 
period 1 
Demonstration 
period 2 
Demonstration 
period 3 
Independent therapy (PT, OT, ST) Enrollees       
% with use   1.1 0.7 1.0 
Utilization per 1,000 user months   11,463.5 8,761.1 10,678.1 
Utilization per 1,000 eligible months   111.1 83.8 107.1 
Independent therapy (PT, OT, ST) Non-enrollees       
% with use   1.4 1.5 1.6 
Utilization per 1,000 user months   14,942.5 11,239.1 11,806.3 
Utilization per 1,000 eligible months   161.8 171.5 184.4 
Other hospital outpatient services  Enrollees       
% with use   26.2 31.6 32.8 
Utilization per 1,000 user months   — — — 
Utilization per 1,000 eligible months   — — — 
Other hospital outpatient services  Non-enrollees       
% with use   36.7 36.6 36.5 
Utilization per 1,000 user months   — — — 
Utilization per 1,000 eligible months   — — — 
— = data not available. E&M = evaluation and management; OT = occupational therapy; PT = physical therapy; ST = speech therapy. 
1 Includes acute admissions, inpatient rehabilitation, and long-term care hospital admissions. 
SOURCE: RTI International analysis of Medicare data. 
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Table C-5 
Quality of care and care coordination outcomes for demonstration enrollees and non-enrollees for the Massachusetts 
demonstration 
Quality and care coordination measures Group 
Demonstration 
period 1 
Demonstration 
period 2 
Demonstration 
period 3 
30-day all-cause risk-standardized readmission rate (%) Enrollees 20.3 20.4 18.6 
  Non-enrollees 20.2 21.3 19.8 
Preventable emergency room visits per eligible months Enrollees 0.0454 0.0527 0.0520 
  Non-enrollees 0.0447 0.0450 0.0423 
Rate of 30-day follow-up after hospitalization for mental illness (%) Enrollees 40.8 39.6 46.3 
  Non-enrollees 61.0 56.5 51.2 
Ambulatory care sensitive condition admissions per eligible 
months—overall composite (AHRQ PQI # 90) 
Enrollees 0.0021 0.0043 0.0023 
  Non-enrollees 0.0043 0.0042 0.0045 
Ambulatory care sensitive condition admissions per eligible 
months—chronic composite (AHRQ PQI # 92) 
Enrollees 0.0016 0.0034 0.0018 
  Non-enrollees 0.0030 0.0030 0.0032 
Screening for clinical depression per eligible months Enrollees 0.0005 0.0004 0.0003 
  Non-enrollees 0.0026 0.0043 0.0032 
SOURCE: RTI International analysis of Medicare data 
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Table C-6 
Medicaid utilization among Massachusetts and comparison group eligible beneficiaries 
Service 
Baseline period 1 
Massachusetts 
October 2011–
September 2012 
Baseline period 1 
comparison group 
October 2011–
September 2012 
Baseline period 2 
Massachusetts 
October 2012–
September 2013 
Baseline period 2 
comparison group 
October 2012–
September 2013 
Home and community-based services (HCBS)         
Personal care         
Users as % of enrollees per enrollee month (%) 2.0 4.6 2.1 4.7 
Service days per enrollee month 0.03 1.21 0.03 1.26 
Service days per user month 1.35 26.42 1.31 26.70 
Other HCBS services         
Users as % of enrollees per enrollee month (%) 2.7 20.8 4.8 18.6 
Service days per enrollee month 0.65 5.53 1.19 4.87 
Service days per user month 24.65 26.54 24.82 26.22 
Institutional services         
Medicaid long-stay nursing         
Users as % of enrollees per enrollee month (%) 1.2 2.9 0.8 2.9 
Service days per enrollee month 0.34 0.85 0.23 0.84 
Service days per user month 27.54 29.19 27.27 29.22 
Non-institutional services         
Behavioral health services         
Users as % of enrollees per enrollee month (%) 8.9 1.0 2.5 0.9 
Service days per enrollee month 0.21 0.03 0.06 0.02 
Service days per user month 2.36 2.43 2.28 2.52 
Non-emergency transportation         
Users as % of enrollees per enrollee month (%) 8.6 0.9 9.3 0.6 
Service days per enrollee month 0.96 0.13 1.06 0.07 
Service days per user month 11.25 14.70 11.40 10.80 
SOURCE: RTI International analysis of Medicaid data. 
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Table C-7 
Medicaid utilization among Massachusetts One Care enrollees 
Service 
Demonstration 
period 1 
October 2013–
December 2014 
Demonstration 
period 2 
January 2015–
December 2015 
Demonstration 
period 3 
January 2016–
December 2016 
Home and community-based services (HCBS)       
Personal care       
Users as % of enrollees per enrollee month (%) 6.7 8.9 10.2 
Service days per enrollee month 1.70 2.24 2.57 
Service days per user month 25.42 25.24 25.11 
Other HCBS services       
Users as % of enrollees per enrollee month (%) 12.5 17.7 14.9 
Service days per enrollee month 1.83 2.96 2.45 
Service days per user month 14.64 16.79 16.37 
Institutional services       
Medicaid long-stay nursing       
Users as % of enrollees per enrollee month (%) 0.0 0.0 0.1 
Service days per enrollee month 0.00 0.00 0.02 
Service days per user month 0.00  0.00  19.13 
Non-institutional services       
Behavioral health services       
Users as % of enrollees per enrollee month (%) 32.6 34.7 34.9 
Service days per enrollee month 1.66 1.90 2.12 
Service days per user month 5.09 5.48 6.09 
Non-emergency transportation       
Users as % of enrollees per enrollee month (%) 10.5 13.6 15.3 
Service days per enrollee month 0.41 0.56 0.72 
Service days per user month 3.94 4.11 4.71 
SOURCE: RTI International analysis of Medicare/Medicaid encounter data. 
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Appendix D: 
Sensitivity Analysis Tables 
Tables in Appendix D present results from sensitivity analyses focusing on the Massachusetts 
demonstration cost saving models.  
D.1 Predicting Medicare Capitated Rates for Non-Enrollees 
D.1.1 Sample Identification 
• Eligible but non-enrolled Massachusetts beneficiaries in demonstration period 1 
(October 1, 2013–December 31, 2014). Predicted Medicare capitated rates were 
calculated using the beneficiary risk score and the county of residence.  
D.1.2 Calculating the Medicare Capitated Rate for Eligible but Non-Enrolled 
Beneficiaries 
• Predicted Medicare capitated rates were calculated using the monthly beneficiary risk 
score (final resolved) and the base rate associated with the beneficiary’s county of 
residence. Differences in ESRD, non-ESRD, and dialysis risk scores and base rates 
were taken into account. 
• Mean predicted Medicare capitated rates were compared to mean Medicare FFS 
expenditures (non-Winsorized). Note that bad debt was removed from the Medicare 
capitated rate as this is not reflected in Medicare FFS payments. Sequestration was 
reflected in both the FFS payments and the capitated payment. Disproportionate share 
hospital payments and uncompensated care payment amounts were included in the 
FFS expenditures as these amounts are reflected in the capitated rates.  
Table D-1 
Observed Medicare FFS and predicted cap rates for eligible but not enrolled beneficiaries 
Variable Observed Mean Std. err. Std. dev. [95% conf. interval] 
Predicted cap  1,158,079 $978.4 $1.0 $1,118.4 $976.4 $980.4 
Observed FFS  1,158,079 $981.0 $4.1 $4,389.4 $973.0 $989.0 
Diff   −$2.59 $3.9 $4,240.3 −$10.3 $5.1 
FFS = fee-for-service. 
RTI also tested the accuracy of the predicted capitated rate by generating a predicted 
capitated rate for enrollees and comparing it to the actual capitated rate from the plan payment 
files. RTI’s mean predicted capitated rate for enrollees was $891.3 compared to an actual 
capitated rate of $889.7 (difference of $1.5). Observed FFS and predicted capitated values reflect 
parallel adjustments. 
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D.2 Predicting Medicare FFS Expenditures for Enrollees 
The goal of this analysis is the converse of what is presented in Table D-1. Here, we look 
at predicted Medicare FFS expenditures for enrollees based on a model predicting Medicare FFS 
expenditures for non-enrollees. 
D.2.1 Methods 
A dataset with observations from base year 2 and from demonstration year 1 was created 
from the full data set to allow us to look at Medicare expenditures between the two periods. 
Beneficiary expenditures were summed across all months of each period and then “annualized” 
to represent the full 12 months of base year 1 (or 15 months of base year 2).  
The estimation process involved two steps. First, using non-enrollees, we regressed 
demonstration year 1 expenditures on base year 2 expenditures, base year 2 Hierarchical 
Condition Category (HCC) score, and a set of base year 2 demographic and area-level variables. 
We used an unlogged dependent variable and ran ordinary least squares (OLS) models with and 
without propensity score weights (using the frozen HCC scores in the composition of the 
weights). The data were clustered by Federal Information Processing Standards code. This model 
explained 26.8 percent of the variation in expenditures for non-enrollees. 
In the second step, we used the covariate values for demonstration enrollees estimated in 
the OLS non-enrollee model (from step 1) to calculate predicted expenditures for enrollees. We 
compared the predicted expenditure values for enrollees to the actual capitated payments made 
under the demonstration. 
D.2.2 Results 
Table D-2 shows enrollees had lower predicted Medicare expenditures in base year 2 
($8,825 for enrollees versus $11,313 for non-enrollees) and a mean HCC score below 1 (0.969 
for enrollees versus 1.022 for non-enrollees). 
Table D-3 shows that actual Medicare capitated per member per month (PMPM) 
payments for enrollees were, on average, $22 per month higher than the predicted mean 
Medicare expenditures for enrollees in demonstration year 1. Mean predicted Medicare 
expenditures for enrollees were $2,962 lower than actual expenditures for non-enrollees (mean = 
$16,279, not shown). Translating these findings into monthly Medicare expenditures, the mean 
predicted FFS expenditures for enrollees was $887 per month which was $198 per month lower 
than actual mean expenditures for non-enrollees ($1,085, not shown in Table D-3). 
  
 D-3 
Table D-2 
Mean values of model covariates by group 
Covariate 
Non-enrolled, both comparison 
group and eligible 
(observations = 215,198) 
Enrolled 
(N = 21,880) 
FFS expenditures in base year 2  $11,313 $8,825 
HCC score in base year 2 1.022 0.969 
Age 46.029 46.25 
Also in another CMS demonstration  0.427 0.473 
Female 0.520 0.519 
Black 0.249 0.164 
Asian 0.014 0.017 
Other 0.014 0.026 
Hispanic 0.047 0.146 
Disabled 0.933 0.955 
ESRD  0.025 0.011 
Patient care physicians per 1,000 population 0.930 1.019 
% of households with member >= 60 years  35.085 32.772 
% of households with member < 18 years 31.790 32.981 
% of those aged < 65 years, with college education  26.903 26.922 
% of those aged < 65 years, unemployed  11.169 11.868 
% of those aged < 65 years, with self-care limitation  2.331 2.497 
Fraction of duals with Medicaid managed care, ages 19 0.297 0.093 
Medicare Advantage penetration rate  0.207 0.229 
% of pop. living in married household  64.384 59.676 
Population per square mile, all ages  1,067 981 
Medicaid spending per dual, ages 19+  $21,723 $22,682 
Medicare spending per dual, ages 19+  $17,444 $16,436 
Fraction of duals using nursing facilities, ages 65+  0.261 0.258 
Fraction of duals using personal care, ages 65+  0.041 0.047 
Distance to nearest hospital (miles) 5.293 3.796 
Distance to nearest nursing home (miles) 3.380 2.604 
FFS = fee-for-service; HCC = hierarchical condition category. 
SOURCE: RTI Program: predictFFSJan29: Summary statistics: mean by categories of enrollee. 
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Table D-3 
Expenditures prediction results from an unweighted OLS model 
Enrollee observations = 21,880 
Mean expenditures over the first year of 
the demonstration (15 months) 95% confidence interval 
Actual PMPM for enrollees $13,642 $13,455 $13,829 
Predicted FFS for enrollees $13,317 $13,098 $13,535 
Difference $325 ($22 per month) P = 0.0000 
FFS = fee-for-service; PMPM = per-member per-month. 
SOURCE: RTI program: predictFFSJan29 unweighted FFS3b. 
D.3 Enrollee Subgroup Analyses  
The enrollee subgroup analyses focused on a subgroup of beneficiaries identified as 
enrolled for at least 3 months in the demonstration period and with at least 3 months of baseline 
eligibility. Note that a subset of the comparison group developed for the ITT analysis was used 
in the enrollee subgroup analyses. Comparison group beneficiaries used in the enrollee subgroup 
analyses were required to have at least 3 months of eligibility in the demonstration period 
(October 1, 2013–December 31, 2016) and at least 3 months of eligibility in the 
predemonstration period (October 1, 2011–September 30, 2013), analogous to the criteria for 
identifying enrollees. The results indicate additional costs associated with enrollees. This 
enrollee subgroup analysis is limited by the absence of person-level data on characteristics that 
potentially would lead an individual in a comparison area to enroll in a similar demonstration, 
and thus the results should be considered in the context of this limitation. 
Table D-4 
Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
enrollee subgroup analysis, predemonstration period and demonstration period 1, weighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 1 
Oct 2013–Dec 2014 Difference 
Demonstration group $729.29 
($684.51, $774.06) 
$879.42 
($820.62, $938.21) 
$150.13 
($126.96, $173.29) 
Comparison group  $777.05 
($732.73, $821.37) 
$852.59 
($810.88, $894.29) 
$75.53 
($58.91, $92.16) 
Difference-in-difference — — $74.59 
($47.55, $101.64) 
— = data not available.  
95 percent confidence intervals are shown in parenthesis below estimates. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/EnroleeSubGroup3months_MADY3_sept). 
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Table D-5 
Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
enrollee subgroup analysis, predemonstration period and demonstration period 2, weighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 2 
Jan 2015–Dec 2015 Difference 
Demonstration group $729.29  
($684.51, $774.06) 
$877.99 
($829.11, $926.88) 
$148.70 
($125.94, $171.47) 
Comparison group  $777.05 
($732.73, $821.37) 
$855.42 
($822.06, $888.78) 
$78.37 
($59.26, $97.49) 
Difference-in-difference 
— — 
$70.33 
($41.96, $98.71) 
— = data not available.  
95 percent confidence intervals are shown in parenthesis below estimates. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/ EnroleeSubGroup3months_MADY3_sept). 
Table D-6 
Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
enrollee subgroup analysis, predemonstration period and demonstration period 3, weighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 3 
Jan 2016–Dec 2016 Difference 
Demonstration group $729.29 
($684.51, $774.06) 
$944.54 
($893.12, $995.97) 
$215.26 
($180.27, $250.24) 
Comparison group  $777.05 
($732.73, $821.37) 
$912.36 
($870.26, $954.46) 
$135.31 
($87.40, $183.22) 
Difference-in-difference 
— — 
$79.95 
($22.04, $137.85) 
— = data not available.  
95 percent confidence intervals are shown in parenthesis below estimates. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/ EnroleeSubGroup3months_MADY3_sept). 
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Table D-7 
Demonstration effects on Medicare savings, enrollee subgroup analysis, difference-in-
difference regression results, One Care eligibles and comparison group 
Covariate 
Adjusted 
coefficient 
DID p-value 
95% confidence 
interval 
90% confidence 
interval 
80% confidence 
interval1 
Intervention *DemoYear1  
(October 2013–December 2014) 
$90.60 0.0000 ($60.48, $120.73) ($65.32, $115.88) ($70.90, $110.30) 
Intervention *DemoYear2  
(January 2015–December 2015) 
$71.80 0.0000 ($41.41, $102.18) ($46.30, $97.30) ($51.93, $91.66) 
Intervention *DemoYear3  
(January 2016–December 2016) 
$88.33 0.0092 ($21.88, $154.78) ($32.57, $144.10) ($44.88, $131.78) 
Intervention*Demo Period 
(October 2013–December 2015)  
$83.32  0.0000 ($50.72, $115.93) ($55.96, $110.69) ($62.00, $104.64) 
DID = difference-in-differences. 
1 80 percent confidence intervals are provided for comparison purposes only. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
MA AR3 Output/ EnroleeSubGroup3months_MADY3_sept). 
 
